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Thesis outlines. 
 
The aim of this PhD thesis work has been the synthesis of novel antimicrobial 
amphiphilic polymers to prevent microbial biofilm related-infections and counteract 
microbial resistance onset. In fact, microbial biofilms are difficultly eradicable due to 
their high antibiotic resistance. To reach this purpose different strategies along this work 
were exploited. 
In the first Chapter, a briefly dissertation of polymers in medical field and their choice 
as materials of election for manufacturing a wide range of products, such as implantable 
medical devices, was reported. Such materials have responded to the need of replacing 
or repairing damaged human tissues or organs not more active under functional or 
metabolic point of view. Despite the enormous progress in the optimization of operative 
procedures for medical device implantation, clinical complications are still associated 
with the use of medical devices. In fact, when a biomaterial is implanted in the body, a 
biological response of the organism occurs causing the covering of the medical device 
surface with a film rich in proteins, polysaccharides and cells. This process, known as 
biofouling, is usually the first stage of a cascade of biological events which can lead to 
the development of infective complications up to device failure. Microbial cells can 
adhere to the material surface and proliferate building up a peculiar tridimensional 
structure known as biofilm. Microbial biofilms consist of microrganisms embedded in a 
self-secreted exopolysaccharide matrix (EPS) enabling the diffusion of nutrient and 
signaling molecules.  
Approximately ten thousand deaths per year are related to medical device related 
infections. This problem is multifold. In fact, on one hand these infections are 
associated with prolonged hospitalization and growing medical costs and, on the other 
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hand, the massive use of antibiotics to treat these infections is promoting the 
development of bacterial resistance at an alarming rate. A worrying feature of biofilm-
based infections is represented by the higher resistance of bacterial and fungal cells 
growing as biofilm with respect to the planktonic ones. The resistance to normal 
antibiotics that bacteria in biofilms exhibit respect to the planktonic counterpart can get 
up to 1000 times. For these reasons, a number of different strategies for the prevention 
of biofilm formation on medical devices have been investigated. 
According to the mechanism of biofilm formation, the main approach pursued at this 
aim is the prevention of microbial adhesion and colonization of the material surface. 
Particularly, the development of antifouling or antimicrobial polymers has emerged as 
the most promising strategy to prevent microbial adhesion and biofilm formation. Such 
materials either repel microbes (antifouling) or kill bacteria (antimicrobial) present on 
the surrounding of general surface. 
Mainly two strategies can be pursued to develop antimicrobial polymers: i) polymer 
impregnation with antibiotics or other biocides; ii) polymer functionalization with 
groups exerting antimicrobial activity. In particular, development of intrinsically 
antimicrobial cationic polymers were highlighted with emphasis. 
In Chapter II, the synthesis and characterization of a novel intrinsically antimicrobial 
basic polyacrylamide (pAcDED) were reported. In addition, since pAcDED resulted to 
be water soluble, we have investigated the possible use of pAcDED as carrier for 
insoluble acidic drugs, such as usnic acid, chosen as a model drug.  
The polymer was able to establish multipoint acid-base interactions with the drug 
phenolic groups leading to a high water solubility of polymer/UA complexes. The 
shielding of polymer positive charges by usnic acid allowed the obtainment of 
polymer/UA complexes with size in water smaller than those of polymer alone. Due to 
3 
 
their reduced size, complexes possessed increased activity against Stahylococcus 
epidermidis thanks to an efficient cellular uptake. This work has been recently 
published as Francolini I., Taresco V., Crisante F., Martinelli A., D’Ilario L., Piozzi A., Int J 
Mol Sci., 2013; 14(4), 7356-7369. 
In Chapter III, the same polymer, pAcDED, was used as coating for manganese ferrite 
nanoparticles (MNPs) to obtain hydrophilic core/shell magnetic systems with a good 
antimicrobial activity. In this regard, an interesting strategy for fighting biofilm 
formation on device surfaces and surrounding tissues could be represented by the use of 
MNPs able to target antimicrobial agents in the body sites interested by the infection. In 
fact, applying an appropriate magnetic field, MNPs can be easily guided and 
concentrated in a narrow body area, thus reducing both drug administration dose and 
toxicity. Therefore, in Chapter III the experimental work concerning MNPs coating with 
either a hydrophilic (pAcDED) or a hydrophobic (a star branched polycaprolactone) 
polymer was reported. The developed systems were investigated to elucidate their 
possible role in controlling drug adsorption and release of usnic acid. The activity of 
usnic acid-loaded polymer-coated MNPs was evaluated against S. epidermidis.  
In Chapter II and III, the combination of two antimicrobial agents having different 
mechanisms of action was exploited in order to minimize bacterial resistance onset. 
Indeed, the polymer positively charge side chain can adsorb on the negative charged 
bacterial membrane provoking cell disruption while usnic acid can inhibit bacterial 
metabolic functions. 
Recently, it was observed that survival bacteria mechanism is due to genetic mutations 
provoked by oxidative stress. Indeed, in response to antibiotic administration, bacteria 
produce reactive oxygen species (ROS). In this regard, to prevent microbial adhesion 
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and biofilm development a potentially winning strategy could be to combine antibiotics 
with ROS inhibitors.  
Therefore, considering the good antimicrobial and antioxidant properties of phenolic 
and catecholic moieties, in Chapter IV the synthesis and characterization of a novel 
hydroxytyrosol-based polyacrylate (pAcHTy) was reported. A water insoluble polymer 
was obtained possessing nanometric size, good antimicrobial and  antioxidant activity. 
In addition, pAcHTy also showed a good chelating activity with respect to Cu
2+
 ions. 
This last property can find important application in the medical field, especially in 
chelation therapy. The use of polymers containing substances bearing cathecolic 
moieties could be a promising therapeutic approach for developing new agents for 
neurodegeneration or cancer treatment.  
Amphiphilic cationic random copolymers are known to be an alternative strategy to 
counteract the emergent risk of microbial resistance. To achieve high antimicrobial 
activity, these polymers have been designed with a suitable balance of hydrophobic 
content and cationic charges. Generally, this has been obtained by using a monomer 
containing in side chain primary or tertiary amines as cationic functionality, and a 
hydrophobic monomer without any biological activity. 
In Chapter V, for the first time, novel antimicrobial amphiphilic cationic polymers have 
been synthesized by copolymerization of two monomers one bearing a positive charge 
and the other one a hydrophobic compound possessing antimicrobial and antioxidant 
activity. Also in this case, the use of polymer possessing both antimicrobial and 
antioxidant properties should reduce the emergence of drug resistant bacteria and better 
combat biofilm infections. Particularly, the starter monomers introduced in Chapter II 
and IV in different molar ratio were copolymerized to obtain a suitable amphiphilic 
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balance. Resulting copolymers showed a discrete water solubility and an enhanced 
antimicrobial and antioxidant activity compared to homopolymers alone.  
Finally, in an appendix of this thesis, a preliminary investigation to obtain a soluble 
catecholic-moiety-containing homopolymer, possessing antimicrobial and antioxidant 
properties, was performed through the synthesis of a dopamine-based acrylic monomer. 
A selective protection of the catecholic group of dopamine was carried out before 
polymer synthesis by Atom Transfer Radical Polymerization (ATRP).  
An interesting development of this work could be the synthesis of soluble block 
copolymers from this dopamine–based monomer and AcDED with controlled block 
length in order to tailor physical properties of the materials and to improve their 
biological activity. 
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CHAPTHER I 
INTRODUCTION 
1.1 Polymers in medicine 
 
The numerous advances achieved in the area of synthetic materials has allowed making 
significant improvements in medical field 
1
, where polymers have become the materials 
of choice for manufacturing a wide range of products among which implantable medical 
devices are the prevailing ones. 
Such materials have responded to the need of replacing or repairing damaged human 
tissues or organs not more active under functional or metabolic point of view. The 
development and application of new, high-performance polymer materials together with 
therapeutic innovations have enabled the healing of damaged parts of the body and the 
survival of a large number of patients. 
Both natural, such as collagen and polysaccharides, and synthetic polymers can be used 
in biomedical applications. Synthetic polymers offer several advantages over the natural 
ones. In fact, the versatility of the macromolecular chemistry allows tailoring polymer 
physico-chemical properties (in terms of molecular weight, composition, functionality, 
mechanical features, degradation rate) to fulfill different applications. In addition, 
polymers can be easily functionalized with bioactive molecules and processed in 
different shape and size.  
                                                          
1
 a. Hench L.L., Biomaterials Science, 1980; 208, 826-31.  
  b. Hanker J.S., Giammara B.L., Science, 1988; 242, 885-92. 
  c. Sawan S. P., Manivannan G. Antimicrobial/Anti-infective Materials:principles, applications  
      and devices, Lavoisier S.A.S., 2013. 
  d. Donelli G., Francolini I., Di Carlo V., Di Rosa R., Rapporti ISISTAN 02/34, 2002. 
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Therefore, numerous types of medical devices, including intravascular vascular grafts, 
catheters, heart valves, dental implants and contact lenses, are currently made with 
polymers and employed in medicine (Table 1). 
 
Polymer Acronym Mainly applications 
Polyglicolic acid PGA 
Biodegradable sutures, plates and 
intramedullary nails, degradable fracture plates 
Polylactic acid PLA 
Plates and intramedullary nails, artificial 
ligaments, degradable fracture plates, 
controlled drug release  
Styrene-butadiene copolymers BS Disposable products, packaging 
Acrylonitrile-Styrene copolymers  SAN Hemodialyzers components  
Polyacrylonitrile PAN Hemodialysis membrane 
Polyamide PA Sutures 
Polycarbonate PC Hemodialysis membrane and oxigenators 
Polyhydroxyethylmetha 
acrylate 
PHEMA Contact lenses, artificial plates 
Polyethylene, Low Density 
Polyethylene 
PE; LDPE 
Films, packaging, catheters, tubing, 
connectors, drug controlled administration  
Ultra High Molecular Weight 
Polyethylene  
UHMWPE 
Articular surfaces, fibers for composites, 
orthopedic plates.ì 
Polyethylenterephtalate PET 
Vascular prostheses, sutures, transdermal 
steps, components of prosthetic heart valves, 
cardiac care components 
Polymethylmethacrylate PMMA 
Bone cement, contact lenses, intraocular 
lenses, membranes for hemodialysis, dental 
materials 
Polypropylene PP 
Sterile packs, strings, connectors, oxygenator 
membranes, sutures, support loops, intraocular 
lenses 
Polysulfone PSO Oxigenator and hemodialysis membranes 
Polytetrafluoroethylene PTFE 
Vascular prostheses, components of prosthetic 
valves, artificial ligaments, coatings 
Polyurethane PU 
Catheters, cannulae, prosthesis valves, 
hemocompatible coatings, cardiac assist 
devices, controlled drug delivery, vascular 
prostheses 
Polyvinyl chloride PVC 
Blood bags, endotracheal tubes, disposable 
gloves, catheters, disposable accessories 
Silicon  
Catheters, drains, membranes, artificial 
leather, plants for plastic surgery 
 
Table 1. Examples of polymers employed in medicine with relative applications. 
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Possible release of substances (such as monomers, catalysts and additives) into the 
body, the ease adsorption of water and biomolecules from the surrounding environment 
are some drawbacks associated with use of polymers. 
Despite the enormous progress in the optimization of operative procedures for medical 
device implantation, clinical complications are still associated with the use of medical 
devices, the most common being the onset of local and systemic infections. 
In fact, when a biomaterial is implanted in the body, a biological response of the 
organism occurs causing the covering of the medical device surface with a film rich in 
proteins, polysaccharides and cells. This process, known as biofouling, is usually the 
first stage of a cascade of biological events which can lead to the development of 
complications, such as thrombosis and infections, and device failure. 
 
1.1.1 Biofouling 
 
Any synthetic or natural material, when exposed to a moist environment, is soon 
covered by an organic film constituted by biomacromolecules and cells including 
microorganisms.  
Depending on the implantation site, the conditioning film will be composed by a 
different type of adsorbed proteins. In the case of serum, the adsorbed proteins, consist 
mainly of albumin, immunoglobulin, fibrinogen and fibronectin. 
The presence of such a surface film plays an important role in the early stages of 
microbial biofilm formation, as it alters the surface properties of the biomaterial thereby 
influencing the magnitude and speed of microbial adhesion. Moreover, the adsorbed 
proteins can function as surface receptors facilitating such adhesion 
2
. 
                                                          
2
 Fitzpatrick F., Humphreys H., O’Gara J. P., Clin. Microbiol. Infect., 2005, 11, 967–973. 
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Microbial cells adhered to the material surface proliferate building up a peculiar 
tridimensional structure known as biofilm. Microbial biofilms consist of microrganisms 
embedded in a self-secreted exopolysaccharide matrix (EPS) enabling the diffusion of 
nutrient and signaling molecules.  
The biofilm-like growth mode permits the survival of microbial cells under high 
antibiotic concentration and extreme conditions of temperature, pH, ionic strength and 
shear stress.  
The biofouling process occurs spontaneously and, in many cases, represents an adverse 
event. Particularly, biofouling is a critical issue in water membrane and wastewater 
treatment as it greatly compromises the efficiency of the treatment processes. In the 
food industry, bacterial adhesion to food products or product contact surfaces leads to 
important hygienic problems and economic losses due to food spoilage 
3
.  
 Biofilm formation on the surface of the pipe walls of drinking water distribution 
systems can be responsible for the decrease of water quality in terms of increasing 
bacterial levels, reduction of dissolved oxygen, taste and odor change 
4
. 
In the biomedical field, the development of microbial biofilms is a critically important 
global healthcare issue. In fact, they play a pivotal role in healthcare-associated 
infections (HAIs), especially those associated to implantable medical devices such as 
intravascular catheters, urinary catheters and orthopedic implants 
5
. 
Statistic data concerning the incidence of infectious disease in European or USA 
hospitals clearly show the impact of this issue on public health.  
The European Center for Disease Prevention and Control reported in 2008 that 
approximately 4 million patients per year are estimated to acquire an HAI in European 
                                                          
3
 Kumar C., Anand S., Int. J. Food Microbiol., 1998, 42, 9-27. 
4
 Block J., Haudidier K., Pasquin J., Miazga J., Levi Y., Biofouling, 1993, 6, 333-343. 
5
 Francolini I., Donelli G., FEMS Immunol. Med. Microbiol., 2010, 59, 227-238. 
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hospitals. The number of deaths occurring as a consequence of these infections is 
estimated to be at least 37, 000. 
In US hospitals, about 2 million people acquire bacterial infections each year with a 5% 
of mortality. Approximately 50,000 deaths per year are related to catheter infections. 
This problem is multifold. On one hand, these infections are associated with prolonged 
hospitalization and growing medical costs. On the other hand, the massive use of 
antibiotics to treat these infections is promoting the development of bacterial resistance 
at an alarming rate. 
For these reasons, a number of different strategies for the prevention of biofilm 
formation on medical devices have been proposed in the last three decades. Particularly, 
since the materials commonly used for manufacturing medical devices are in majority 
polymers, research interest has been mainly focused on the development of novel 
selective antifouling or antimicrobial polymers that have the potential to be employed 
for a wide range of biomedical products including sterile clothing, air filters and 
medical devices. 
 
1.1.2 Medical device-related infections 
 
In modern medicine, medical devices are used for a wide range of applications. Some of 
these devices, including heart valves, artificial joints and pace makers, are permanently 
implanted in the patients to repair or replace damaged parts of the body. Other devices, 
such as intravascular and  urinary catheters, are temporary implanted and allow 
clinicians to deliver drugs or nutrition fluids into the body, to expel fluids out of the 
body and to monitor the status of critically ill patients.  
12 
 
In all of these applications, the control of phenomena occurring at the biological 
tissue/material interface is of paramount importance for the success of the implanted 
medical device. In fact, as stated above, soon after the exposure of the device to 
physiologic fluids and tissues, the device surfaces are coated by a film of biological 
material mainly consisting of proteins, polysaccharides and cells that makes the device 
more suitable to biofilm formation.  
The type of implanted device, the material used for its manufacturing, the body site 
interested by the implant as well as patient features all contribute to the overall risk of 
device-related infection.  
As for material features, surface hydrophobicity and roughness seem to affect microbial 
adhesion more than other physico-chemical properties. Particularly, the presence of 
surface microcavities or microfractures allows bacteria to anchor and provide them with 
a temporary protection from the action of the host fluids. This permits the irreversible 
bacterial adhesion to the surface through the expression of specific adhesins. As for 
material hydrophobicity, given the hydrophobic nature of microbial membrane, usually 
microorganisms prefer hydrophobic surfaces. However, this is strongly dependent on 
the bacterial species and generalization at the species or even strain level is often 
difficult. 
The infectious risk as well as the severity of the infections, in terms of morbidity and 
mortality, are strongly dependent on the type of implanted device. Among employed 
medical devices, those associated with a high risk of development of infection are 
intravascular catheters, urinary catheters and orthopedic implants.  
Intravascular catheters are extensively used. There are two types: (i) intravascular 
catheters (ICs) used for short-time vascular access, such as peripheral venous catheters, 
or the non-tunneled central venous catheters (CVCs); (ii) ICs used for long-term 
13 
 
(indwelling) vascular access, such as the tunneled CVCs. Central venous catheters 
(CVCs) are responsible for the highest proportion of bloodstream infections. Especially, 
non tunneled-CVCs account for an estimated 90% of all catheter-related bloodstream 
infections. Coagulase-negative staphylococci, especially Staphylocococcus epiderimidis 
and S. aureus, and yeasts, especially Candida albicans, are the most commonly isolated 
pathogens in CVC-related infections 
6
. 
The microbial contamination of non-tunneled CVCs is usually extra-luminal, with 
microrganisms originating from the skin, and, less commonly, intra-luminal from 
hematogenous seeding of the catheter tip. The intra-luminal colonization of the hub and 
lumen of the CVC is instead the most common route of infection for tunneled-CVCs.  
Urinary catheters are associated with a high rate of development of urinary tract 
infections (UTIs). In fact, about half of hospitalized patients bearing an urinary catheter 
for longer than a week will get an urinary tract infection 
7
.  
Catheter-associated urinary tract infections affects 449,334 patients per year in US 
hospitals 
8, 9
.  
The most common pathogen causing these infections is Escherichia coli but other 
bacterial species can be involved such as Pseudomonas aeruginosa, Enterococcus spp, 
Klebsiella spp, or Enterobacter spp 
10, 11
.  
Orthopedic devices are of great relevance for public health due to the increasing number 
of aged and disabled people. Thanks to the improvement in the surgical procedures as 
well as to the availability of novel biocompatible materials, the risk for orthopedic 
device-related infections is nowadays low and less than 1-2%. However, these 
                                                          
6
 Mermel L.A., Farr B.M., Sherertz R.J., Raad I.I., O'Grady N., Harris J.S., Craven D.E., Clin. Infect. 
Dis., 2001, 32, 1249-1272. 
7
 Schumm K., Lam T.B., Neurourol. Urodyn., 2008, 27, 738-746. 
8
 Klevens R.M., Edwards J.R., Richards C.L., Horan T.C., Gaynes R.P., Pollock D.A., Cardo D.M., 
Public Health Rep,, 2007, 122, 160-166. 
9
 Lodbell K.W., Stamou S., Sanchez J.A., Surg. Clin. North Am., 2012, 92, 65-77. 
10
 Lohr J.A., Donowitz L.G., Sadler J.E., Pediatrics, 1989, 83, 193-199. 
11
 Kalsi J., Arya M., Wilson P., Mundy A., Int. J. Clin. Pract., 2003, 57, 388-391. 
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infections are relevant for the healthcare system since a high number of patients is 
annually subjected to surgery for orthopedic device implantation. In fact, more than 
200,000 and more than 400,000 hip replacements and primary total knee arthroplasties 
are performed each year in the United States, respectively 
12
.  
The early prosthetic joint infection, occurring within the first 3 months after surgery, is 
usually caused by S. aureus or S. epidermidis. Delayed infection (within 2 years from 
surgery) is instead caused by microorganisms of low virulence.  
When an implant-related infection occurs, simple chemotherapy with antimicrobial 
agents is not always effective to eradicate the infection. Therefore, a new surgery for 
prosthesis removal and replacement is usually needed leading to an increase of the 
hospitalization time and significant associated health costs 
13
. 
To understand how these complications can be prevented, in the following section a 
brief overview of phenomena occurring during microbial biofilm formation will be 
presented since biofilm is considered the causative agent of the device-related 
infections.  
Then, on the basis on the mechanism of biofilm formation, the main strategies to 
prevent biofilm development will be discussed paying particular attention on those 
based on antimicrobial polymers that are of interest for this thesis. 
 
1.2 Mechanism of biofilm formation  
 
Understanding the mechanism of biofilm formation has been of fundamental 
importance in the design of biomaterials able to prevent biofilm growth on their 
surfaces.  
                                                          
12
 Widmer A.F., Clin. Infect. Dis., 2001, 33, S94-S106. 
13
 Campoccia D., Montanaro L., Arciola C.R., Biomaterials, 2006, 27, 2331-2339. 
15 
 
The use of confocal laser scanning microscopy has clarified the complex morphology 
that surface-adherent bacteria assume during growth 
14
. Biofilms are defined as 
microbial sessile communities irreversibly attached to a surface in which bacteria are 
immersed in an exopolysaccharide matrix produced by bacteria themselves 
15
. They are 
characterized by a heterogeneous structure in which individual microcolonies are 
located in mushroom-like structures. In this particular structure, open channels are 
present with the function of supplying nutrients and eliminating waste products of cell 
metabolism. (Figure 1). 
 
Figure 1. Schematic representation of the biofilm architecture is reported. 
 
The formation of biofilm is constituted by a sequence of dynamic events that can be 
divided into 3 stages (Figure 2): 
Stage 1. Initial and irreversible adhesion  
Stage 2. Maturation of biofilm architecture  
Stage 3. Detachment of single cells or cellular aggregates from the mature biofilm. 
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Figure 2: Schematic representation of the three stages involving biofilm formation. 
 
1.2.1 Initial microbial adhesion 
 
When floating planktonic cells come into the proximity of a biomaterial, the process of 
adhesion begins. This process is first reversible and then irreversible 
16
 (Figure 3).  
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Figure 3. Interactions that regulate the bacterial adhesion a substrate. 
 
Due to their small size, low density, variable degree of cell surface hydrophobicity and 
net negative charge, bacteria can be considered as living colloids. The first interactions 
occurring between bacterial cell and biomaterial surface are long-range and non-specific 
such as van der Waals forces or repulsion electrostatic forces and acid-base interactions. 
The resultant of these different non-specific interaction forces will cause bacterial 
attraction or repellence by the surface. If bacteria are attracted, short range non-specific 
interactions occur. These forces are represented by hydrophobic interactions between 
the biomaterial surface and cell membrane. In fact, many studies have shown that 
18 
 
microorganisms adhere faster on non-polar and hydrophobic surfaces such as Teflon 
compared to more hydrophilic materials such as glass or metals 
17, 18
.   
Among the short range interactions, there are also specific interactions between the 
chemical groups present on the surface of the bacterial membrane (carboxyl, hydroxyl, 
phosphate and amino groups) and biomacromoleucles adsorbed onto the biomaterial 
surface forming a so-called conditioning film. This film plays an important role in 
bacterial adhesion since can provide the biomaterial with specific bacterial receptors. 
Depending on the type of protein adsorbed on the biomaterial surface, the condition 
film can either promote or hamper bacterial adhesion. In fact, albumin is known to be a 
strong adhesion inhibitor while fibrinogen and fibronectin have shown to promote the 
adhesion of S. aureus and some strains of S. epidermidis 
19,
 
20
. 
Finally, material roughness also affects microbial adhesion. Particularly, an increase in 
surface roughness results in an increase in microbial colonization 
21
, presumably due a  
shielding effect from the shear forces present at the surface liquid interface to which 
bacteria are subject. 
 
 
1.2.2 Irreversible microbial adhesion and maturation of biofilm architecture 
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Profound physiological changes accompany the transition from reversible to permanent 
attachment onto a surface. In fact, the irreversible adhesion phase involves the secretion 
of specific bacterial adhesins and their selective binding with substratum receptors. As 
an example, S. epidermidis cells adherent to surfaces were demonstrated to be able to 
produce a polysaccharide intercellular adhesin (PIA) that binds the cells together and 
facilitates the formation of microcolonies 
22
. During the phase of irreversible adhesion, 
bacteria can not move perpendicularly to the surface but still retain the ability to move 
horizontally if endowed with extracellular organelles. 
Not only the irreversible adhesion but also the formation of biofilm complex 
architecture has been shown to be under genetic control. For example, P. aeruginosa 
changes its protein profile when growing in a biofilm than in planktonic state (Brozel et 
al., 1995) 
23
. The regulation of gene transcription during biofilm growth is possible by 
secretion and accumulation of signaling molecules that allow bacteria to communicate 
with each other. This process, called quorum sensing (QS), is activated when the 
concentration of signaling molecules exceeds a certain threshold value and enables 
bacteria to modulate the expression of genes able to coordinate the group behavior. QS 
permits bacteria to adapt to environmental changes, such as the variation in nutrient 
supply, altered levels of oxygen, pH or ionic strength. Also the formation of the 
extracellular polymeric matrix (EPS, Extracellular Polymeric Substances) in which 
bacteria are embedded is regulated by quorum sensing mechanism. 
Understanding the role of QS systems in clinically relevant strains could represent a 
new and interesting strategy to prevent biofilm formation. In fact, the ability of P. 
aeruginosa to form the characteristic mushroom-like biofilm structure has been shown 
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to be affected by quorum-sensing phenomena 
24
. Therefore, the use of quorum sensing 
inhibitors, such as halogenated and synthetic furanones, caused an attenuation of P. 
aeruginosa virulence and an increase in its susceptibility to tobramycin 
25
. 
 
1.2.3 Detachment of single cells or cellular aggregates from the mature biofilm  
 
Recently, the detachment of bacterial cells or cellular aggregates from mature biofilm 
has been demonstrated to be a physiologically regulated event. Time-lapse microscopy 
has shown that biofilms can release either single cells or visible clumps containing 
thousands of cells 
26
. 
Therefore, detachment represents a distinct process in the biofilm developmental life 
cycle. In fact, in case of lack of nutrients or high cell-density, the dispersal of cells from 
the outer biofilm layers is considered as a survival mechanism for the sessile 
community. In this way, the network of nutrient exchange channels that runs through 
the biofilm is preserved.  
Also a passive cell detachment can occur by shear forces at the liquid-surface according 
to different mechanisms such as erosion, abrasion and removal 
27
.  
While detachment has benefits for the biofilm life cycle, it is an adverse event in the 
biofilm field since the detached bacterial clumps can colonize new body sites and 
disseminate the infection.  
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1.3 Antibiotic resistance of biofilm 
 
A worrying feature of biofilm-based infections is represented by the higher resistance of 
bacterial and fungal cells growing as biofilm with respect to the planktonic ones 
28, 29
. 
The resistance to normal antibiotics that bacteria in biofilms exhibit respect to the 
planktonic counterpart can get up to 1000 times. 
This finding has been attributed to several factors. First of all, biofilms represent an 
ideal environment for plasmid exchange among cells. In fact, conjugation frequency 
appears to be higher in biofilm than in planktonic bacteria. This amplifies both naturally 
occurring and induced antibiotic-resistance phenomena. 
Other factors involved in the biofilm increased drug resistance 
30
 are:  
(1) Slow and scarce penetration of antimicrobial agents through the biofilm matrix;  
(2) Physiological response of microorganisms to the heterogeneous chemical 
environment existing in biofilms 
31
.  
In fact, the growth conditions in biofilms are quite different at lower layers, where 
nutrients and oxygen are limited, and microbial waste products can be toxic; for 
example, in the deep layers anaerobic niches are presumably present 
32
. These factors 
promote the development of different bacterial phenotypes, including drug-resistant 
ones. In addition, also nutrient depletion at lower layers by slowing bacterial growth 
rate can reduce the number of targets for antimicrobial molecules.  
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(3) Onset of subpopulations of persistent or dormant bacterial cells in a spore-like, non-
dividing state 
31, 33
. 
Therefore, once the biofilm is established, antibiotic treatments for its eradication 
usually fail. In case of medical device-related infections, the surgical removal and 
replacement of the infected device is needed. This involves serious inconvenience for 
the patient and increase in hospital costs.  
 
1.3.1 Strategies to prevent medical device-related infections 
 
In order to prevent infections associated with medical devices, many strategies have 
been adopted in the last decades.  
According to the mechanism of biofilm formation, the main strategies persuade at this 
aim are:  
1) prevention of microbial adhesion and colonization of the material surface; 
2) interference with signaling molecules to inhibit biofilm development; 
3) biofilm matrix disaggregation. 
Since the topic of this PhD thesis concerns the first strategy, a specific section will be 
focused on the detailed description of the different experimental approaches developed 
for prevention of microbial adhesion and colonization of medical device surfaces. The 
first strategy is also, doubtless, the most pursued and successful one. 
As for the second strategy, QS plays a crucial role in modulating not only the 
expression of genes associated with the production of enzymes, virulence factors and 
metabolites but also the development of biofilm. Therefore, the use of molecules 
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interfering with QS has been shown to be a promising strategy to prevent microbial 
adaptation to the host environment and the establishment of infectious processes. 
According to Rasmussen & Givskov 
34
, in gram-negative bacteria there are basically 
three possible targets: (1) signal generator, (2) signal molecule and (3) signal receptor. 
Inhibition to the receptor of binding of the signal molecule by the use of analogues of 
the signal molecules 
35, 36
 has been so far the most investigated way to interfere with 
QS.  
Potent inhibitors of gram-negative QS have been shown to be the halogenated furanones 
purified from Delisea pulchra 
37
 and a series of related synthetic derivatives. These QS 
inhibitors caused an increase of P. aeruginosa susceptibility to tobramycin. Our group 
showed that, usnic acid, a naturally occurring dibenzofuran derivative, is able to affect 
the morphology (thickness and roughness) of P. aeruginosa biofilm. This phenomenon 
is presumably associated to usnic acid (UA) ability to interfere with bacterial signaling 
pathways 
38
.  
In gram-positive bacteria, the QS inhibitor RNAIII- inhibiting peptide (RIP) resulted to 
be efficacious in preventing and treating staphylococcal medical device-related 
infections. Particularly, in a rat model, RIP-coated CVCs significantly reduced bacterial 
adhesion and increased the killing action of antibiotics versus S. aureus strains. In fact, 
when treated with RIP, biofilm growing S. aureus became as susceptible to antibiotics 
as planktonic cells 
39
.  
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RIP-loaded polymethylmethacrylate beads for orthopedic devices implanted in rats were 
able to prevent methicillin-resistant S. aureus (MRSA) biofilm formation either alone or 
combined with vancomycin 
40
.  
As far as the third strategy is concerned, the use of substances able to damage the 
biofilm matrix acting as a protective barrier for bacteria could cause a better exposition 
of sessile microbial cells to antibiotics as well as to the host immune defenses 
41
.  
In staphylococcal species, Dispersin B, a soluble b-N-acetylglucosaminidase purified 
from A. actinomycetemcomitans by Kaplan et al. 
42
, was shown to be able to 
disaggregate the exopolysaccharide matrix produced by biofilm-producing strains since 
this matrix is rich in a linear poly-N-acetyl- 1,6-b-glucosamine. In addition, our group 
showed that Dispersin B and the antibiotic cefamandole nafate synergistically prevented 
staphylococcal biofilm formation on polyurethanes 
43
.  
Depending on the nature of the biofilm constituents, the use of different enzymes can be 
necessary. In fact, Chaignon et al. 
44
 demonstrated that two successive treatments, 
consisting of Dispersin B, followed by a protease (proteinase K or trypsin), were needed 
for degradation of biofilms produced by clinical staphylococcal strains associated with 
orthopedic infections. 
Engineered bacteriophages able to express Dispersin B were also successfully tested 
against E. coli biofilms 
45
. 
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1.4 Prevention of microbial adhesion and colonization of material 
surfaces 
 
The development of antifouling or antimicrobial polymers has emerged as the most 
promising strategy to prevent microbial adhesion and biofilm formation (Figure 4). 
Such materials either repel microbes (antifouling) or kill bacteria (antimicrobial) present 
in the surface proximity. 
 
 
Figure 4. The different approaches to produce antifouling or antimicrobial polymers. 
 
 
 
 
1.5 Antifouling polymers 
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Microbial adhesion is an essential step in the pathogenesis of medical device-related 
infections. Given the hydrophobic nature of microbial surfaces 
46
, prevention of 
bacterial adhesion onto the device surfaces can be achieved by i) coating with 
hydrophilic polymers, ii) coating with negatively charged polymers. 
The development of antifouling polymers is particularly interesting since it avoids the 
use of drugs (either by systemic administration or by local release from medicated 
devices) that, when administered over long periods of time, may be associated with 
undesired side effects. 
However, the main limitation of this strategy is that its efficacy is strongly dependent on 
the bacterial species since the physico-chemical properties of microorganisms can 
largely vary among species. 
 
1.5.1 Hydrophilic polymer coatings 
 
Several polymer classes have been explored 
47
 as coating to obtain antifouling 
polymers, including polyacrylates 
48
, polyzwitterions 
49
 and poly(ethylene glycol) 
(PEG) derivates 
50, 51
.  
Among these, PEG has been the most investigated polymer due to its resistance to 
protein adsorption, non immunogenicity and antithrombogenicity. PEG antifouling 
ability is believed to be related to both hydration and steric effects 
52
. Also, the lack of 
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binding sites further hampers the adsorption of proteins and bacterial cells. However, 
the ability of PEG in reducing bacterial adhesion has had variable degrees of success, 
depending on the PEG’s molecular weight, degree of branching and surface packing 
density. Also, the bacterial species and the culture media used in the experiments seem 
to affect PEG antifouling activity.  
PEG has been grafted onto the surface of a series of materials, including glass
53
, gold 
54
, 
poly(ethylene terephthalate) 
55
 and polyurethanes 
56, 57
. 
Inhibition of Candida albicans biofilm formation on polyurethane surfaces was 
achieved by introducing a 6% polyethylene oxide 
58
.  
Also the adhesion of S. epidermidis was prevented by modification of hydrophobic 
polyurethanes with PEG 
59, 60
.  
Corneillie and colleagues 
61
 synthesized segmented polyurethanes at different PEG 
content employing in the polymer synthesis, PEG, polypropylenoxide (PPO) and 
polytetramethylenoxide (PTMO) in different ratios. Samples containing PEG/PPO or 
PEG/PTMO in 1/1 molar ratio were able to significantly reduce the adhesion of S. 
aureus and Enterococcus faecalis with respect to glass. However, these polymers 
allowed the adhesion of P. aeruginosa unless samples were incubated in urine instead 
of phosphate buffer, indicating an influence of the culture media and then of the 
conditioning film.  
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The influence of PEG end-groups on bacterial adhesion was investigated by Park K.D. 
and colleagues by using PEG possessing either -OH, -NH2 or -SO3 as chain-end groups. 
Results showed that due to a different protein adsorption on the polymer surface, the 
sulphonated PEG1000-containing polyurethane was the most repellent one. This finding 
suggests that the sulphonate groups are responsible for the antifouling features of 
heparin that will be discussed in the following section. 
 
1.5.2  Negative charged polymer coatings  
 
Heparin, a highly sulfated glycosaminoglycan, has always attracted particular attention 
in the field of hemocompatible biomaterials due to its interesting biological functions, 
such as anticoagulant activity, cell growth stimulation and antivirus ability. In fact, the 
physical adsorption or chemical grafting of heparin to artificial surfaces has been shown 
to improve device hemocompatibility 
62, 63, 64
. More recently, the ability of heparin to 
counteract microbial adhesion and colonization has been demonstrated in vitro and in 
vivo 
65
. Particularly, the heparinization of both CVCs and dialysis catheters resulted in a 
significant reduction of catheter-related infections 
66, 67
. 
An alternative strategy to the heparin coating is represented by the introduction of 
negatively charged chemical groups such as groups sulfates, sulfamates and 
carboxylates to develop heparin-like polymers
68, 69, 70
. 
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The first heparin-like polyurethanes were sulphonated PTMO-based polymers obtained 
by S.L. Cooper’s group 71. Very recently, also our group has developed segmented 
polyurethanes containing sulphate or sulphamate groups in the hard segment The 
obtained –SO3H-containing polymers showed good hemocompatibility and inhibited S. 
epidermidis adhesion, these features being related to polymer phase segregation and 
density of –SO3H groups 
72
. 
A limitation of this approach is that some bacterial strains  have specific receptors for 
heparin and therefore are able to colonize heparin coated surfaces.  
Best results were obtained by adsorption of albumin 
73
, that similarly to heparin is 
negatively charged. 
 
1.6 Antimicrobial polymers 
 
Low molecular weight antimicrobial agents have several drawbacks including toxicity, 
antimicrobial activity limited in time and potential to select resistant bacteria 
74
. To 
overcome these limitations, various efforts have been focused on the development of 
antimicrobial materials that are effective and selective towards microorganisms. The 
combined use of drugs and substances at high molecular weight, such as polymers, 
offers the advantage to better control drug release, and then to extend the residence time 
of the drug within the body, as well as to limit residual toxicity of the low molecular 
weight antimicrobial agents. Moreover, polymers are chemically stable, not volatile, 
and do not to overcome the skin barrier.  
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Mainly two strategies can be pursued to develop antimicrobial polymers: i) polymer 
impregnation with antibiotics or other biocides; ii) polymer functionalization with 
groups exerting antimicrobial activity. 
In the first approach, the polymer acts as a carrier for one or more antimicrobial agent 
that once released from the polymer exerts its action (antimicrobial agent-releasing 
polymers). In the second approach, bactericidal functionalities, such as quaternary 
amine compounds or phosphonium salts, are introduced in the polymer to obtain 
intrinsically antimicrobial polymers (biocidal polymers). Biocidal polymers do not 
release antimicrobial substances but exert their killing action when microorganisms 
contact the surface. 
 
1.6.1 Antimicrobial agent-releasing polymers 
 
To obtain antimicrobial agent-releasing polymers, antibiotics, antiseptics, surfactants or 
heavy metals can be applied to the polymer by: a) physical adsorption; b) impregnation, 
c) complexation or d) conjugation via hydrolytically labile linkages. Particularly, drug 
adsorption or impregnation are the most pursued methods since they are easy to 
perform. In addition the impregnation can permit the loading of significant drug 
amounts. 
Although such surfaces work quite efficiently, the main limitation of this strategy is the 
lack of durability of the antimicrobial activity due to the uncontrolled release of the 
absorbed antimicrobial agent in the first hours following device implantation.   
Generally, the medical device coating with antimicrobial-agent releasing polymers has 
had successful variable degrees depending on: i) implantation site of the device; ii) type 
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of antimicrobial agents used for the coatings; iii) concentration of antimicrobial agents 
on the surface of the coated device and iv) kinetics of drug release. 
A large number of antimicrobial agents have been adsorbed onto medical devices and 
tested in their ability to prevent device-related infections 
75, 76, 77
. However, systems 
based on the use of drug combinations were found to be the most interesting ones since 
they reduce the onset of antibiotic-resistant microorganisms.  
Here following, the antimicrobial-agent releasing systems that have gained more 
attention in the clinical field are described. 
 
1.6.3 Metal adsorbed/insert on/in polymers 
 
Silver is, doubtless, the most used inorganic antimicrobial agent used to provide 
polymers with antimicrobial properties. 
The antimicrobial activity of silver ions is due to its binding to microbial DNA, thus 
inhibiting bacterial replication, and to sulphydryl groups, thus provoking the 
deactivation of metabolic enzymes 
78
.  
Silver in solution has been used for almost a century as a topical antimicrobial agent for 
the regeneration of damaged tissues
 79
. 
Today, silver is used in the prevention and treatment of a wide number of diseases and 
particularly for infections. It is also able, acting local, to decrease the concentration of 
zinc present on the lesion surface, acting locally, due to its metalloproteinase activity 
80
. 
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Ions and free radicals of silver represent the active components in the bactericidal 
function and, unlike the current antibiotics, do not create problems related to the 
phenomenon of bacterial resistance 
81
. Such active species  probably destroy 
microorganisms instantly, blocking the respiratory enzyme system and causing 
structural changes in the bacterial cell wall, both in the intracellular environment and 
onto nuclear membranes. Indeed, the binding of the silver ion to bacterial DNA can 
inhibit a high number of important transport processes and can modify the processes of 
cellular oxidation.  
So, despite being one of the most powerful metal inhibitors of enzymes and 
microorganisms, it has a low toxicity to higher organism cells due to its slow adsorption 
and easy interaction with thiol groups of proteins 
82, 83
. 
Silver antibacterial activity is mainly due to high affinity of Ag
+
 ions for thiol groups 
present on the bacterial cell membrane. This activity increases with the concentration of 
the ions, although metallic silver has a slight activity against microorganisms thanks to 
the formation of traces of Ag
+
 in the biological environment 
84
. 
In order to counteract the formation of microbial biofilms, silver has been then used for 
the coating of medical devices (such as intravascular or urinary catheters). 
As for CVCs and intravenous catheters, various silver treatments method have been 
employed 
85, 86
.  
To ensure a low but constant metal dose and then to decrease the possibility of damage 
to cells and tissues, several products possessing a low silver release are available today. 
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Silver has a pronounced bactericidal effect on a wide spectrum of organisms, including 
bacteria and fungi. Indeed, it is effective against bacteria aerobic or anaerobic, Gram-
positive (S. aureus and S. epidermidis) and Gram-negative bacteria (P. aeruginosa), 
fungi (C. species) and viruses. 
Clinical studies
 87
 have shown that silver coatings were effective in the reduction of 
catheter-related infections only for urinary catheters. This finding was confirmed by a 
recent systematic review and meta analysis by Casey et al 
88
. In this study, summarizing 
data on the efficacy of marketed medicated catheters in reducing microbial colonization 
and preventing CR-BSIs ( catheter-related-blood stream infections), it has been 
demonstrated that silver-alloy-coated, silver-impregnated and silver-iontophoretic 
CVCs were not able to reduce catheter-related bloodstream infections. These findings 
are presumably due both to the poor silver antimicrobial activity against gram-positive 
bacteria, the most frequently involved species in CVC-related infections, and to the 
albumin presents in the blood that can bind silver ions, thus reducing antimicrobial 
activity.  
Different approaches have been investigated to incorporate silver in polymers. One of 
these is based on polymer impregnation with silver nanoparticles (AgNps). AgNps-
containing systems have been employed to promote wound healing 
89
 or prevent biofilm 
formation on dental materials 
90, 91
.  
Another inorganic compound employed to prepare polymer-based antimicrobial 
composites is titania. 
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Recently, antimicrobial properties of polymer composite systems containing TiO2-
anatase (Titanium oxide) nanoparticles as a biocidal agent have been tested 
92, 93
. 
Particularly, Fernández-García research group incorporated TiO2 nanoparticles into 
ethylene-vinyl alcohol copolymer (EVOH) or isotactic polypropylene via a melt 
process. These nanocomposites showed remarkable antibacterial properties against 
different bacteria strains not due to biocidal agent release in the media.  
Kubacka
 
et al. 
94
 have developed novel, highly efficient  antimicrobial nanocomposite 
films consisted of a commercially EVOH copolymer and embedded with Ag-TiO2 
nanoparticles. In these nanocomposites, different from previously studied TiO2-EVOH 
systems, through plasmonic effect, the presence of the noble metal significantly 
enhanced antimicrobial activity of the system upon UV light. Finally, novel 
nanocomposites provided with an effective germicide activity toward E. coli, P. putida, 
S. aureus bacteria/cocci and Pichia jadini yeasts, by surface doping process of anatase 
with photodepositated Ag or by addition of Cu and Zn nitrate precursors into EVOH-
based films, were also obtained by Kubacka et al. 
95
.  
 
1.6.4 Catheter coated with Chlorhexidine and Silver Sulfadiazine 
 
Chlorhexidine (CH) and silver sulfadiazine (SS) are antiseptic agents commonly used 
together in topical applications. Indeed, chlorhexidine induces alterations in the 
bacterial membrane allowing silver ions to penetrate inside the bacterial cell.  
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Catheters having the external surface coated with CH/SS have been produced 
(Arrowguard Blue® , Arrow International Inc, Reading, Pa., USA) and extensively 
studied both in vitro, ex vivo  and clinical trials 
96, 97, 98, 99
. Results of these clinical 
studies showed that CH/SS coated catheters were effective in reducing catheter-related 
infections only when catheters were implanted for a short-term (less than 7 days). The 
main reasons included the low release rate of chlorhexidine after 48 hours of elution and 
the absence of an intraluminal antimicrobial coating.  
1.6.5 Antibiotic-coated devices  
 
In the late 80s’, Sherertz et al. 100 investigated adsorption of different antibiotics onto 
catheters as a strategy to reduce device-related infections. Experiments performed, in 
vitro and in animal models, employing dicloxacillin, clindamycin, ciprofloxacin, 
cefuroxime and cefotaxime, showed a correlation between in vitro and in vivo findings. 
Particularly, antibiotic-coated catheters having in vitro zones of inhibition  10-15 mm 
were efficacious in preventing S. aureus infection when implanted in rabbits. To 
improve the loading of anionic drugs and to increase the long term protection from 
bacterial infections, coating of device surfaces with cationic surfactants (e.g. tri-
iododecylmethyl ammonium chloride, TDMAC), before antibiotic adsorption, was 
successful performed.  
                                                          
96
 Maki D.G., Stolz S.M., Wheeler S., Mermel L.A., Ann. Intern. Med., 1997, 127, 257-266. 
97
 Tennenberg S., Lieser M., McCurdy B., Boomer G., Howington E., Newman C., Wolf I., Arch. Surg., 
1997, 132, 1348-1351. 
98
 Heard S.O., Wagle M., Vijayakumar E., McLean S., Brueggemann A., Napolitano L.M., Edwards L.P., 
O'Connell F.M., Puyana J.C., Doern G.V., Arch. Intern. Med., 1998, 158, 81-87. 
99
 Schierholz J.M., Beuth J., Pulverer G., J. Hosp. Infect., 1999, 42, 163-165. 
100
 Sherertz R.J., Forman D.M., Solomon D.D., Antimicrob. Agents. Chemother., 1989, 33, 1174-1178. 
36 
 
Raad et al. 
101
 utilized TDMAC for the development of minocycline and rifampin-
coated (M/R) catheters. Such devices, tested in clinical trials, were able to reduce 
catheter colonization and catheter-related infections over a period of 7 days of 
implantation. Moreover, minocycline and rifampin-coated catheters were less colonized 
than those impregnated with CH/SS when implanted either for seven days or less (6% 
vs. 21.4%) or for more than seven days (10.8% vs. 24.4%).   
Polymers able to absorb high amount of antibiotics on their surfaces have been also 
obtained by Piozzi et al. by introducing to the side chain of urethane polymers specific 
functional groups able to interact with the drugs 
102
. This approach allowed to obtain 
high drug-polymer affinity avoiding the use and possible release of surfactants. In 
addition the loaded and release antibiotic amount could be controlled by ionic 
interactions established between drug and polymer groups.   The increase of drug 
resistant microorganisms and the occurrence of multispecies biofilm formation require a 
continuous research of innovative strategies of microbial killing. So far, the clinical 
treatment of device related infection is based on the combined use of drugs with 
different antimicrobial spectrum and modes of action.  In this regard, Raad and 
colleagues demonstrated that linezolid and vancomycin were less effective in 
decreasing the viability of S. aureus with respect to daptomycin, minocycline and 
tigecycline. However, by adding  rifampin to either linezolid or vancomycin, a biofilm 
killing activity increase was observed 
103
. 
                                                          
101
 Darouiche R.O., Smith J.A., Hanna H., Dhabuwala C.B., Steiner M.S., Babaian R.J., Boone T.B., 
Scardino P.T., Thornby J.I., Raad I. I., Urology, 1999, 54, 976-981. 
102
 Piozzi A., Francolini I., Occhiaperti L., Di Rosa R.R., Ruggeri V., Donelli G., J. Chemother., 2004, 
16, 66-72. 
103
 Raad I., Hanna H., Jiang Y., Dvorak T., Reitzel R., Chaiban G., Sherertz R. Hachem R., Antimicrob. 
Agents Chemother., 2007, 51, 1656-1660. 
37 
 
Kim and co-workers 
104
 have showed that combined and sequential treatments with 
tobramycin and silver enhanced antimicrobial efficacy of more than 200% in P. 
aeruginosa.  
Only a few investigations concerning adsorption on polymers of two antimicrobial 
agents possessing different action mechanism were performed. 
Ruggeri et al., 
105, 106
 incorporated cefamandole and rifampin in polyurethanes together 
with pore forming agents (polyethylene glycol at different molecular weight and bovine 
albumin) to increase and control drug release from polymer matrices. Indeed, it has 
been demonstrated that polyurethanes containing PEG 10000 + cefamandole + 
rifampicin were active against a rifampicin-resistant S. aureus strain up to 23 days. 
Antimicrobial-releasing polymer systems allow a more prolonged use of medical device 
but provide no solution about the onset of the phenomenon of formation of drug 
resistant strains, unless they release two antimicrobial agents having different action 
mechanism. From here arises the need for replacement the implant with a new one, 
treated with a drug able to inhibit the growth of the resistant strain. This problem has, 
therefore, prompted the search toward the synthesis of intrinsically antibacterial 
polymers, capable of inhibiting the bacterial proliferation. 
 
1.7 Biocidal Polymers 
 
Cationic and anionic polymers, widely investigated for various therapeutic applications, 
possess remarkable potential in drug delivery field. In comparison to anionic polymers, 
cationic polymers can form electrostatic complexes with anionic biomolecules, nucleic 
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acids and proteins resulting the most promising ones. In addition, since many low 
molecular weight antimicrobials are positively charged, cationic polymers appear to be 
also promising as biocidal agents, successfully employing in various areas. 
Indeed, microbial contamination is of great concern in medical devices, health care 
products, textiles, water purification systems, food packaging and storage.  
Cationic polymers (biocidal polymers, BCs) are able to kill microorganisms, acting as a 
source of sterilizing ions or molecules.  
To develop biocidal polymers, two strategies have been mainly employed: 
i. formation of a covalent bond between an antimicrobial molecule and a polymer 
matrix 
107,
 
108
. 
ii. preparation of a monomer having intrinsic antimicrobial activity to be polymerized or 
copolymerized with a second biological active or no active monomer 
109,
 
110, 111, 112
. 
As for the first strategy, the introduction of antimicrobial agents into polymers has been 
performed by different approaches. Following only some examples of this strategy will 
be reported.  
Worley and Sun covalently bonded hydantoins, oxazolidines and imidazolidines in 
nylon 6,6 and polyester fabrics
113. 114, 115
. The results concerning antimicrobial activity 
of these materials showed that they were effective without a decrease of their tensile 
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strength properties. Park et al. 
116
 attacked three different antimicrobial acids such as 4-
aminobenzoic acid, salicylic acid, 4-hydroxy bezoic acid to ethylene-co-vinyl acetate 
copolymer. It was observed that copolymer containing salicylic acid was the most 
active.   
Also antibiotics were covalently bonded to polymers. Levofloxacin, penicillin, 
ampicillin were attacked to polydimethylsiloxane
117
 and polytetrafluoroethylene 
118, 119
. 
High antimicrobial activity of the polymers was guaranteed by the antibiotic release. 
The second strategy, preparation of a monomer having intrinsic antimicrobial activity to 
be polymerized or copolymerized with a second biological active or no active monomer, 
is certainly the most promising and then the most investigated.  Most of used synthetic 
monomers and polymers are acrylic derivatives of pharmacologically active 
compounds. Among polymers, polyamides, polyurethanes, polyesters and 
polyacrylamides are more sought after for their versatile structure. As for antimicrobial 
agents, those containing reactive functional groups such as carboxyl or amino, which 
may be covalently linked to a variety of polymerizable derivatives, are mainly 
employed. Besides linear polymers, also dendrimers and hyperbranched polymers 
containing biguanide, quaternary ammonium salts, and quaternary pyridinium or 
phosphonium salts exhibit a good antimicrobial activity whose effectiveness is related 
to charge of the counterion 
120
. An intrinsically antimicrobial polymer should be 
manufactured with the following characteristics 
121
 : 
• facile and inexpensive synthesis; 
                                                          
116
 Park E.S., Kim H.K., Shim J.H., Kim M.N., Yoon J.S., J. Appl. Polym. Sci., 2004, 93,765–770. 
117
 Kugel A., Chisholm B., Ebert S., Jepperson M., Jarabek L., Stafslien S., Polym. Chem., 2010, 1, 442–
452. 
118
 Aumsuwan N., Heinhorst S., Urban M.W., Biomacromolecules, 2007, 8, 3525–3530. 
119
 Aumsuwan N., Danyus R.C., Heinhorst S., Urban M.W., Biomacromolecules, 2008, 9, 1712–1718. 
120
 Ikeda T., Hirayama H., Suzuki K., Yamaguchi H., Tazuke S., Makromol. Chem., 1986, 187, 333-340. 
121
 Kenawy E.R., Workley D., Broughton R., Biomacromolecules, 2007, 8, 1359-1383.   
40 
 
• good chemical stability, particularly in the temperature range required for the use; 
• water insolubility, in some applications such as water sterilization and medical device 
manufacturing; 
• ability to not decompose giving toxic products, in the biomedical and food packaging 
fields. 
An important feature deeply affecting the physical properties of polymers, including the 
antibacterial ones, is the molecular weight. In fact, an increase in antimicrobial activity 
has been shown with increasing polymer molecular weight, for cationic polymers 
having molecular weights less than 50,000 g mol
-1
. Otherwise, cationic polymer 
molecular weights above 120,000 g mol
-1
 negatively influence the antimicrobial activity
 
122, 123
. This dependence of antibacterial properties on molecular weight is due to poor 
polymer permeability through cell barrier of target organism. Since the antimicrobial 
adhesion occurs according to a sequence of events such as absorption on bacterial cell 
wall, diffusion through the membrane, absorption onto cytoplasmic membrane and its 
disintegration, polymer molecular weight affects both interactions between polymer and 
bacterial cell and its penetration and diffusion in cytoplasmic membrane 
124
.  
As for cationic quaternized polymers, another factor can affect their antimicrobial 
properties. It was found, indeed, a dependence of polymer antimicrobial activity on 
alkylation type, specially on the length of alkyl chain. In particular, it was observed that 
a quaternization reaction performed with compounds having long alkyl chains 
significantly enhances the biocidal properties of final polymer. However, different 
results have been obtained in literature.  
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Panarin et al. 
125
 evidenced that while the antimicrobial activity of cationic copolymers 
based on vinylamine, aminoalkyl methacrylate, and N-vinyl pyrrolidone was 
independent on the alkyl substituent length, the one of monomers considerably 
improved with chain length increasing. 
As for poly(4-vinyl-pyridium)-based polymers (PVPs), Lewis and Klibanov 
126
 
covalently attached to glass slides PVPs differently quaternized with side alkyl chains 
with length ranging from 0 and 12. They observed that a C6 chain length was needed to 
not remarkably decrease the antimicrobial activity of derivatized surfaces.  
Therefore, if on one hand, an hydrophobicity polymer increase, obtained by 
quaternization reaction with long alkyl chains, promotes interactions with cell wall, on 
the other the variation of hydrophilic/hydrophobic ratio in the polymer can lead to 
aggregation phenomena of alkyl chains decreasing its antimicrobial action. 
As for binding polymers to surfaces, different techniques including chemical grafting 
techniques 
127, 128
, layer-by-layer deposition
129,
 
130
 and plasma polymerization  
131, 132
 
have been used. 
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1.8 The cationic polymers  
 
Cationic antimicrobials, including benzalkonium chloride, chlorhexidine and polymeric 
biguanides, have been widely employed in many commercial products and in infection 
control.  
The antibacterial action of cationic antimicrobials (CAs) is due to their ability to interact 
with bacterial cell wall. Indeed, the outer bacterial cell wall is negatively charged and 
often stabilized by divalent cations such as Mg
2+
 and Ca
2+
. This negative charge is due 
to the presence of teichoic acid and polysaccharides in Gram positive bacteria cell wall 
or lipopolysaccharides and phospholipids in Gram negative bacteria outer and 
cytoplasmic membrane. In addition, the cytoplasmic membrane, possessing selective 
permeability and regulating the transfer of solutes and metabolites, is formed by a 
phospolipid bilayer. Given the different membrane composition, leading to a different 
protection of cytoplasmic membrane, CAs efficacy could be different versus Gram 
positive and Gram negative bacteria. However, a high binding affinity of cationic 
antimicrobial agents, both at low and high molecular weight, for both classes of 
bacterial cells has been demonstrated. Such affinity is presumably due to strongly 
electrostatic interactions established between CAs and bacterial cell wall and/or 
membrane.  
Thanks to wide range of obtainable properties, the use of intrinsically antimicrobial 
polymers (IAPs) is increasingly growing not only in the medical field but also in 
industrial applications. 
Although, action mechanism of IAPs is still under debate, it is generally believed that 
they can exert their action by cell wall and/or membrane disruption, causing breakdown 
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of the transmembrane potential, leakage of cytoplasmic material and finally cell death 
133, 134
.  
To better interact with the wall and cytoplasmic membrane, IAPs must possess a 
hydrophobic region and a strong positive charge as low molecular weight cationic 
antimicrobial agents. In addition, cationic polymers should be more selective towards 
bacteria than human cells, since bacterial membrane possesses a high negatively charge 
concentration due to lipid components. Then, the higher the charge density of the 
polymer, the greater its antimicrobial efficacy. Although this is true, it has been 
demonstrated that positive electrical charges are cytotoxic and hemolytic 
135
.  
For these issues, novel cationic and/or amphiphilic polymers were designed and 
synthesized by employing hydrophobic monomers or neutral macromonomers to be 
copolymerized with the cationic monomers.  
Different parameters affect cationic polymer properties including polymer chain 
flexibility, hydrogen-bond, hydrophobic and electrostatic interactions, presence of 
amino groups and pKa. 
A wide range of natural or synthetic cationic polymers have been investigated. Among 
natural polymers, generally non-toxic, biocompatible, biodegradable and with low 
immunogenicity, Chitosan 
136
 is the most extensively studied as an antimicrobial agent.  
However, the good control over properties and opportunity of easy chemical 
modifications make synthetic polymers as the best candidates to substitute the currently 
low molecular weight antimicrobial agents.  
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As for synthetic polymers, statistic and amphiphilic block copolymers showed a good 
antibacterial efficacy and low toxicity for human cells with respect to homopolymers. 
The poor toxicity of these copolymers is probably due to an increase of their selectivity 
versus bacterial cells.  
In addition, cationic copolymers are very interesting to fight the emergent risk of 
microbial resistance. Specifically, by using two different monomers one bearing 
antimicrobial hydrophobic compound and the other one a positive charge, it is possible 
to obtain copolymers possessing two different action mechanisms, thus hampering the 
development of resistant strains. Obviously, balance of hydrophobic content and a 
cationic charges is critical to achieve high activities. 
All of polymers having at least one salified or quaternized amino group in their 
repetitive unit belong to the class of cationic polymers. Generally, these polymers are 
water-soluble due to the high polarity. In polymers obtained by salification of primary, 
secondary or tertiary amines, cationic functionality is strictly dependent on pH. Indeed, 
at pH greater than their pKa occurs deprotonation of nitrogen, which returns to be 
neutral. Instead, polymers containing a quaternary ammonium salts into repetitive unit, 
prepared by reaction of tertiary amino group with an alkyl halide, maintain the positive 
charge at any pH value. The number of the protonable amino groups can vary for each 
cationic polymer. 
Cationic polymers can carry positive charges in the main chain or the side chain. In 
addition, block copolymers with polyethylene glycol as well as those having a 
polycationic backbone and grafted hydrophilic side chains have been developed and 
discussed below in the text. 
Although many cationic polymers have been synthesized and investigated for their 
antimicrobial activity, only some classes of them are reported following. 
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1.8.1 Acrylic-based polymers  
 
Examples of this polymer class are acrylic or methacrylic derivates including the most 
investigated PDMAEMA (poly[2-(N,N-dimethylamino)ethyl methacrylate]) 137, 138, 139. 
All of these materials possessed excellent antimicrobial properties. In addition, 
PDMAEMA has been used as a carrier for DNA delivery.  
The chemistry and structure of organic groups bonded to nitrogen, the number of 
nitrogen atoms as well as the counterion remarkably affect the antimicrobial activity of 
quaternary ammonium compounds 
140, 141
. Generally, organic substituents are alkyls, 
aryls, or heterocyclics. However, to better interact with the lipid bilayer of the cell wall 
at least one of the substituents should be a long alkyl chain 
142
.  
Lu et al. 
143
 synthesized novel DMAEMA-based monomers containing quaternary 
ammonium salts with different length of the alkyl group. After quaternization reaction 
of tertiary amino group with benzyl chloride (BC), butyl bromide (BB), dodecyl 
bromide (DB) or hexadecyl bromide (HB), (Figure 5). Polymers with longer alkyl 
chain showed better antimicrobial activity due to their higher affinity for the bacterial 
membrane. 
                                                          
137
 Rungsardthong U., Deshpande M., Bailey L., M. Vamvakaki , Armes S.P., Garnett M.C., Stolnika S., 
J. Control Release, 2001, 2-3, 359-380. 
138
 van de Wetering P., Cherng J.-Y., Talsma H., Crommelin D.J.A., Hennink W.E., J. Control Release, 
1997, 1-3, 145-153. 
139
 van de Wetering P., Schuurmans-Nieuwenbroek N.M.E., van Steenbergen M.J., Crommelin D.J.A., 
Hennink W.E., J. Control. Release, 2000, 1-3, 193-203. 
140
 Li G., Shen J., Zhu Y., J. Appl. Polym. Sci., 2000, 78, 668–675. 
141
 Gottenbos B., Grijpma D.W., van der Mei H.C., Feijen J., Busscher H.J., J. Antimicrob. Chemother., 
2001, 1, 7-13.. 
142
 Sauvet G., Dupond S., Kazmierski K., Chojnowski J., J. Appl. Polym. Sci., 2000, 75, 1005–1012. 
143
 Lu G., Wu D., Fu R., React. Funct. Polym., 2007, 67, 355–366. 
46 
 
 
Figure 5. Chemical structures of DMAEMA-based monomers containing quaternary 
ammonium salts with different length of the alkyl group. 
 
The same behavior was found for polymers synthesized from methacrylate monomers 
based on 1,4-diazabicyclo-[2.2.2.]-octane (DABCO) 
144
. The prepared monomers 
contained two different pendant groups, butyl and hexyl group. It was observed that 
antimicrobial activity of polymers enhanced with pendant alkyl chain length increasing. 
 
1.8.2 Polymers from monomers bearing aromatic or heterocyclic structures 
 
These polymers are characterized by the presence of aromatic or heterocyclic structures 
and by a neutral backbone. The quaternary ammonium salt is present in the side chain.  
The most studied cationic polymers derive from poly(vinylpyridine), particularly 
poly(4-vinylpyridine) (P4VP), and polystyrene (PS) and imidazole derivates 
145
. As for 
quaternized P4VP, Tiller et al. 
146, 147 
showed that polymer surfaces derivatized with 
poly(vinyl-N-hexyl-pyridium), bonded to glass slides, were more able to kill bacteria 
when the alkyl chain was longer. The intrinsically antimicrobial property of quaternized 
P4VP has been also evidenced in block and random copolymers synthesized from P4VP 
and PS 
148
. 
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The antimicrobial activity of N-hexylated P4VP as well as its biocompatibility have 
been improved by copolymerization with hydrophilic monomers as poly(ethylene 
glycol) methyl ether methacrylate (PEGMA) 
149
. 
Indeed, with increasing surface wettability, the antibacterial activity of copolymers was 
20 times higher than the quaternized homopolymer. The introduction of PEGMA also 
prevented the hemolysis of polymers 
150
.   
To obtain a suitable balance between antimicrobial activity and toxicity, Sambhy et al. 
151
 synthesized several amphiphilic pyridium-methacrylate copolymers (Figure 6) by 
varying the ratio between positive charge and alkyl chain length on the polymer. It was 
observed that for polymers having the same charge/alkyl chain ratio, the spatial 
separation enhanced both biocidal action and reduced toxicity vs cells. 
 
Figure 6. Chemical structure pyridium-methacrylate copolymers. 
Another antimicrobial polymer showing temperature-responsive behavior was obtained 
from a methacrylamide monomer containing a pyridine moiety (MAMP) 
152
. Besides 
homopolymer of MAMP, its copolymers with N-isopropylacrylamide (NIPAAm) with 
two different compositions were synthesized. Polymers with pendant pyridinium groups 
were obtained by reaction with various bromoalkanes containing 12, 14, and 16 carbon 
alkyl chains. It was observed that the neutral and quaternized copolymers with low 
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MAMP content were water-soluble and showed temperature-responsive behavior in 
aqueous solutions. In addition, the quaternized water soluble copolymers showed 
excellent antibacterial activities against S. aureus and E. coli, whereas the neutral 
polymers and quaternized water-insoluble homopolymers and copolymers were not 
active. 
 
1.8.3 Polymers with quaternary ammonium groups in the backbone  
 
Polyelectrolytes belong to this class. In these polymers the quaternary ammonium 
groups are present in the polymer backbone. Polyelectrolytes can be synthesized by 
various reaction methods including polycondensation of epichlorohydrin with bis-
tertiary or secondary ammine or benzyl amine 
153
. As an example, Wynee et al. 
154 
synthesized a new class of discrete amphiphilic quaternary ammonium compounds as 
highly effective antimicrobial additives for polyurethane films. The effectiveness of 
these additives was due to the ability to self-concentrate at the air-polymer interface 
thanks to the additive hydrophobicity obtained by varying the lengths of the n-alkyl and 
oxyethylene groups.  
 
 
1.8.4 Hyperbranched and dendritic polymers  
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Branched polyethyleneimines (PEI) represents cationic polymers having the highest 
positive charge density (Figure 7). These hyperbranched polymers generally display a 
biocidal action like other cationic polymers. However, Helander et al. 
155
 found that 
PEI, when applied alone, possessed a permeabilizing effect but no bactericidal effect on 
gram-negative bacteria. Polyethylenimine is an effective permeabilizer of gram-
negative bacteria, while a synergistic antibacterial effect of such a polymer combined 
with different antibiotics have been shown by Khalil et al. 
156
. 
To improve PEI antibacterial activity, several modifications regarding cationic and 
hydrophobic groups present in the main chain have been performed 
157, 158, 159
. 
Differently from hyperbranched PEIs, dendrimers possess unique physical and chemical 
properties including more compact structure and monodisperse molecular weights.  
Various polyethyleneglycol diacrylate (PEGDA)-based dendrimers were synthesized by 
Abid et al. 
160
 by reaction of PEGDA with ethylene diamine and diethyl amine. 
Synthesized dendrimers were copolymerized with ethyleneglycol dimethylacrylate 
(EDGMA) and then quaternized with hydrochloric acid. Quaternary dendritic 
copolymers showed broad spectrum antimicrobial properties. In addition, their 
bactericidal properties depended on the concentration of quaternary ammonium groups 
and surface porosity. 
Monodispersity of dendrimer molecular weight allowed Cooper et al. 
161
 of studying the 
structure-activity relationship of quaternary ammonium functionalized 
polypropyleneimine (PPI) dendrimers synthesized by themselves (Figure 7). These 
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quaternary ammonium dendrimers were very potent biocides. It was demonstrated that 
the antibacterial properties depended on the size of the dendrimer, the length of 
hydrophobic chains in the quaternary ammonium groups, and the counteranion 
162
.  
 
                             a)                                                                         b) 
Figure 7. Chemical structures of a generic a) PEI and b) PPI dendrimers. 
 
1.8.5 Polymers with quaternary nitrogen end group 
 
Belong to this class polyoxazolines 
163
, pseudopeptides prepared by living cationic ring 
opening polymerization. The positive charge is borne by the initiator used for opening 
the monomer. Polyoxazolines showed a good antimicrobial activity joined to a low 
toxicity. In addition, these polymers possess a wide chemical versatility of end 
functionalities thanks to the control of initiation and termination reactions of 
polymerization as well as the side chain of the monomer.  
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1.8.6 Polyzwitterions  
 
An interesting class of materials possessing positive and negative charges within the 
same monomer are polybetaines. Their peculiar ionic structure makes them 
technologically advanced polymers. Biocompatibility and antifouling features of such 
polyelectrolytes have been extensively investigated. 
Cheng et al. 
164, 165
 evidenced that zwitterionic poly(sulfobetaine methacrylate) and 
poly(2-carboxy-N,N-dimethyl-N-(2’-methycryloyoxy)ethyl)-ethanaminium efficiently 
reduced the colonization of Pseudomonas aeruginosa and Staphylococcus epidermidis. 
A new class of materials, cationic polycarboxybetaine esters, having unique properties 
when interacting with protein, DNAs and bacteria, were prepared by Zhang et co-
workers 
166
. The synthesized cationic polymers could be converted to nontoxic and 
nonfouling zwitterionic polymers upon their hydrolysis. 
In particular, three positively charged polyacrylamides bearing carboxybetaine ester 
groups as pendant groups (polyCBAA ester) were synthesized. These three polymers 
possessing different spacer groups between the quaternary ammonium and the ester 
groups were then grafted onto a gold-coated surface by atom transfer radical 
polymerization (ATRP). 
The polymer-grafted surfaces showed high protein adsorption. After hydrolysis, the 
biological surface properties changed dramatically, becoming the surface nonfouling. 
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1.8.7 Polymers mimicking natural peptides 
 
Many different organisms produce antimicrobial peptides as part of their first line of 
defense (host defense antimicrobial peptides). Generally, antimicrobial peptides 
(AMPs) possess a small molecular size (from 10 to 50 amino acids), amphiphilic 
features, with cationic and hydrophobic side chains, and are positively charged. Some of 
these peptides, such as defensins and magainins, are potent antimicrobials because of 
poor or no susceptibility to bacterial resistant mechanism. The action mechanism of 
AMPs is different with respect to conventional antibiotics. Indeed, antibiotics generally 
exert their action inhibiting enzymes and DNA replication, while AMPs attack bacterial 
cell membranes, making them more permeable with subsequently leakage cellular 
components and cell death. In addition, cationic AMPs are selective to bacteria over 
human cells due to their high binding affinity with bacterial surfaces which possess a 
great negative charge density.  
Although the considerable antimicrobial properties exhibit by AMPs, their application 
as antibiotic substitutes has been hampered by high cost of manufacturing, poorly 
understood pharmacokinetics and susceptibility to enzyme action. For these reasons, in 
recent years, an intense research activity has been addressed to development of small 
molecules and polymers known as synthetic mimics of antimicrobial peptides (SMAPs). 
 
1.8.8 Synthetic peptides 
 
Many synthetic peptides composed of L-α-amino acids (especially L-lysine) or 
including structures such as D-α-amino acids, β-peptides or peptoids have been 
obtained. Chain length of 10-30 amino acid residues by using solution-coupling or solid 
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phase synthesis can be obtained 
167
. In both cases it is possible to control precisely 
amino acid sequence. 
To better resemble AMPs, the first synthesized peptides were designed in such a way 
that a segregation of the hydrophobic and hydrophilic groups of amino acid sequence 
would occur, thus inducing helix formation, particularly α-helix.  
At this aim, analogues of idolidicin or gratisin as well as peptides composed of leucyl 
and lysyl residues with different composition and sequences were synthesized 
168, 169, 170
. 
All of these peptide-based oligomers showed selectivity and a good antimicrobial 
activities.  
Then, other β-amino acid-based SMAPs were obtained 171, 172, 173. Although these β-
peptides formed a different type of helix, they resulted active and selective.  
Successively, many investigation have demonstrated that the helicity of the molecule is 
not critical for having antimicrobial activity. Instead, it is of paramount importance that 
the molecule possess a local amphiphilicity and is able to self-organize into 
hydrophobic and hydrophilic domains on the cell interface. 
 
1.8.9 SMAPs based on synthetic polymers 
 
The main advantage in use of polymer systems over synthetic peptides for developing 
of SMAPs is that to get materials on large-scale production by few synthetic steps. This 
makes polymeric SMAPs promising candidates for therapeutical applications. 
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Understanding the influence of some parameters, such as spatial relationship between 
hydrophobic side chains and cationic groups, charge density, structure of cationic 
groups, on the biological properties of synthetic polymers, have triggered an intense 
research activity addressed to the design and development of new synthetic amphiphilic 
cationic polymers mimicking natural host-defense peptides.  
Different amphiphilic copolymers, based on a polymethacrylate or polymethacrylamide 
backbone having hydrophobic and cationic side chains have been synthesized 
174, 175, 176, 
177, 178
 (Figure 8). The hydrophobic groups and the length of the two parts have been 
changed to obtain non-hemolytic antimicrobials polymers 
175
. Primary, tertiary amino 
groups, or quaternary ammonium salts have been used as sources of cationic moieties. 
In these studies has been evidenced as the antimicrobial and hemolytic activities of  
synthesized polymers depend on the properties of amino side chains as much as the 
hydrophobic nature of the counterpart. In addition, it has also shown that reversible 
protonation of the amino groups is more appropriate to obtain non-toxic antimicrobial 
polymers. 
 
 
 
 
 
                                                          
174
 Palermo E.F., Kuroda K., Appl. Microbiol. Biotechnol., 2010, 87, 1605–1615. 
175
 Kuroda K., DeGrado W.F., J. Am. Chem. Soc., 2005, 127, 4128–4129. 
176
 Palermo E.F., Kuroda K., Biomacromolecules, 2009, 10, 1416–1428. 
177
 Kuroda K., Caputo G.A., DeGrado W.F., Chem. Eur. J., 2009,15, 1123–1133. 
178
 Palermo E.F., Sovadinova I., Kuroda K., Biomacromolecules, 2009, 10, 3098–3107. 
 
55 
 
 
 
 
 
Figure 8. Chemical structure of amphiphilic copolymers with different amine and 
hydrophobic side chains. 
 
1.8.10 Copolymers with neutral sections 
 
After extensively studying the possible applications of cationic homopolymers, searches 
are heading more and more towards the preparation and characterization of statistical, 
block or grafted copolymers having neutral hydrophilic or hydrophobic chain sections. 
Widely used for this purpose is PEG, a very hydrophilic neutral polyether (e.g. 
segmented copolymers PEG-polylysine, or triblock PEG-PBA-PDMAEMA). Numerous 
studies have shown PEG effectiveness in facilitating the action of carriers for gene 
delivery. In fact, it ensures the protection of polycation-DNA complex before its arrival 
to the cell nucleus, thus preventing the formation of aggregates with serum proteins. 
Many of the possible applications of cationic amphiphilic copolymers are related to the 
property of forming micelles. This feature is especially useful in the formation of 
complexes with DNAs. Indeed, the ability to fold in relation to the affinity with the 
nucleic acid and the surrounding environment leads to the formation of particular 
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structures to which the effectiveness of the transport and release of the genetic material 
of interest is owed 
179
. 
A stimulating approach 
180
 to give an higher biocompatibility of the quaternary 
ammonium compounds is the preparation of pegylated-copolymers. These materials are 
obtained from the copolymerization of DMAEMA and PEGMA. Then, the tertiary 
amino side chain moieties have been quaternized with different types of functional 
halides at different degrees of functionalization (Figure 9). 
 
 
Figure 9. Chemical structures of pegylated amphiphilic copolymers with different 
quaternized amine side chains. 
The resulting polymers with shorter chain have shown to possess lower MIC. In 
addition, the hemolysis resulted to be influenced by chain hydrophobicity. 
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1.8.11 Polynorborene derivatives  
 
The most of synthesized random copolymers have been obtained by employing of a 
hydrophobic and a hydrophilic comonomer. In these latter years new interesting 
polynorbornene-based SMAPs have been developed by Tew and coworkers
181, 182
.
 
These polymers contain a facially amphiphilic monomer bearing both the hydrophobic 
and hydrophilic group. The spatial arrangement of these polymers, that allows the 
charged and hydrophobic groups to be positioned on opposite sides of the polymer 
backbone, promotes the interaction with the membrane phospholipids.  
Different polynorbornene derivatives have been prepared by using ring opening 
metathesis polymerization. This synthetic strategy allowed obtaining polymers and 
copolymers with narrow polydispersity and different molecular weights (Figure 10).  
 
Figure 10. Chemical structure of a generic polynorbornene. 
By tuning the hydrophobic/hydrophilic balance, by increasing the number of amine 
groups on the most hydrophobic polymer, and molecular weight of the synthesized 
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polymers, it was possible to prepare highly selective, antibacterial and nonhemolytic 
materials 
183, 184
. 
1.9 Magnetic nanoparticles and drug targeting 
 
In the last thirty years, research in the pharmaceutical industry has been focused on the 
study of formulations capable of releasing drugs in a controlled manner 
185
.  
Currently, several pharmaceutical formulations are commercially available in which 
drug release can be either delayed or programmed in terms of rate and duration. Such 
formulations are defined controlled release therapeutic systems.  
The developed systems can be classified in i) delayed release systems; and ii) sustained, 
site-specific and targeted delivery systems.  
Drug targeting systems have the ability to concentrate drugs in organs or tissues in a 
selective and quantitative manner, regardless from the site and method of 
administration.  
Such systems are characterized by three components: a drug, a targeting unit (capable of 
selective recognition), and a carrier used to increase the number of drug molecules per 
singular targeting unit. Pharmaceutical carriers can be soluble polymers, microparticles, 
microcapsules, cells, lipoproteins, liposomes, micelles and nanoparticles
186, 187
.  
Currently, nanoparticles are strongly investigated as pharmaceutical carriers since they 
can be used for intravenous administration, being able to by-pass blood-brain barrier, 
lung airways and epithelial skin junctions that normally prevent the drugs release. 
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Four different targeting mechanisms 
188,189
 are possible for injectable formulations: i) 
Passive targeting, ii) active targeting, iii) alternative targeting, and iv) physical 
targeting. 
The passive targeting is based on pharmaceutical formulations able to avoid the removal 
of the active principle by defence mechanisms of the body such as metabolism, 
excretion and opsonization. Releasing of such systems into specific body sites occurs 
via normal physiological processes. The fate of colloidal carriers in the vascular system 
depends on two fundamental factors that are particle size and surface features. This 
targeting, however, is not always very efficient since often the injected formulation is 
incorporated by the mononuclear phagocyte system (MPS) in particular by Kupffer cells 
of liver. 
Generally, particles in the order of nanometers are more able to avoid the entrapping 
into pulmonary capillaries, but they are blocked by cells belonging to organs such liver 
or bone marrow. Particle surface features can favor or not opsonization while particle 
distribution into the body depends on the type of coating, usually based on polymers or 
surfactants 
190
. 
The active targeting consists in the use of molecules having high affinity for the target 
zone. To this aim, the surface features of nanocarriers are properly modified. 
Particularly, hydrophilic particle are less prone to be subjected to MPS attack (many 
substances naturally present in the body are hydrophilic). The active targeting can be 
also obtained by binding specific molecules on the particle surface to target the system 
to the damaged cells. These systems are cellular markers of substances such as sugars, 
antibodies or lecithins. 
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In the alternative targeting, to limit particle capture of by MPS system, macrophages are 
suppressed before particle administration by using a placebo or a suppressing agent 
such as dextran sulfate, methyl palmitate or salts of gadolino. The clinical potential of 
this system is however on debate because MPS system inactivation can have dangerous 
consequences especially in people with cancer. 
The physical targeting permits the distribution of the drug-carrier system through 
variation of parameters, such as temperature and pH, or by applying a magnetic field. 
Regions affected by presence of inflammation or tumor often show acidosis and 
hyperthermia. This makes possible the use of carriers able to release the drug at lower 
pH values or at temperatures higher than those of healthy tissues. 
The targeted delivery of a drug through the application of an external physical force, 
such as a magnetic field, can be obtained, by employing nanocarriers with 
ferromagnetic properties 
191
. 
In the context of the physical targeting, magnetic nanoparticles based on metal oxides, 
mainly magnetite (Fe3O4), in single domains of about 5-20 nm, are the carriers most 
studied for several reasons. 
Firstly, they can be obtained with controllable size, from a few nanometers to tens 
nanometers, and comparable with biological entities. Furthermore, the magnetic 
characteristics permit to direct the carrier through the application of a magnetic field. 
This possibility of a "remote control", combined with the intrinsic penetrability of the 
magnetic field in human tissue, opens many applications involving the transport and/or 
immobilization of magnetic nanoparticles and the targeting of biological substances. 
The main applications of magnetic nanoparticles are in diagnostics, as contrast agents in 
magnetic resonance imaging (they are able to influence the relaxation time of protons), 
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in cell biology, for separation and purification of cell populations, and in therapeutics, 
for cancer treatment by hyperthermia or drug targeting.  
In this latter case, nanoparticle systems based on iron oxides, in superparamagnetic 
conditions 
192
, coated with biocompatible polymers and functionalized with interest 
drug, in stabilized aqueous suspension (called ferrofluid) 
193
, are injected intravenously 
into the patient and guided up to the target with an external magnetic field , applied in 
correspondence of the interested body site. 
The effectiveness of therapy depends mainly on the strength of the applied magnetic 
field and the nanoparticle properties, namely: 
• homogeneous particle sizes and below a critical diameter; 
• high magnetic susceptibility; 
• biocompatibility; 
• surface properties specific to the application; 
• strength of drug-nanoparticle interactions and drug desorption kinetics in vivo. 
Preliminary studies, employing magnetic nanoparticles loaded with anticancer drugs, 
have been carried out in animals and men. The results obtained have been very 
encouraging. In fact, even administering low doses of anticancer agents, a decrease in 
tumor volume was observed thanks to the targeted drug release 
194, 195
. 
In the literature, several types of ceramic magnets (ferrites with the general formula 
MnFe2O3) 
196, 197
 based on Fe, Ni, Co and Cu have been studied. 
Recently, the possibility of using for this type of applications manganese ferrite 
(MnFe2O4) 
198, 199 
has been studied. This ferrite is extremely interesting for its high 
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magnetization saturation and its critical superparamagnetic size greater than that of iron 
oxides normally studied. These features allow both synthesizing particles of size greater 
than 5-10 nm and avoiding a significant reduction of magnetic properties after polymer 
coating. 
Therefore, due to considerable interest covered by such systems, several studies must be 
performed to optimize the chemical and physical properties of nanoparticles to achieve 
stabilization of the ferrofluid, biocompatibility of surfaces and to understand the 
ferrofluid action mechanism. 
Magnetic systems could be also used for biofilm fighting from device surfaces and 
surrounding tissues. By this novel promising strategy, still poorly investigated, 
nanoparticles capable of targeting antimicrobial agents, alone or possibly in 
combination with QS-interfering agents or enzymes, could be properly targeted to a 
localized area in which the drug release is planned to occur. Recently, indeed, it has 
been demonstrated that magnetic nanoparticles are able to lower in vitro the optical 
density of S. epidermidis broth cultures as well as to promote bacterial death up to 48 
hrs 
200
. 
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1.10 Antioxidants 
 
1.10.1 Role of antioxidants in fighting bacterial resistance 
 
The emergence of bacteria resistant to antibiotics used in the treatment of device-related 
infections is a critical issue in the medical field. Generally, bacterial resistance is 
mediated by the ability of microorganisms to form biofilm on device surface. 
Employment of alternative therapies using new antimicrobials depends on 
understanding of complex biological mechanisms underlying drug-mediated cell killing 
action.  
Bacterial adhesion to device and biofilm formation are remarkably affected by various 
conditions including nutrient availability, low oxygen content, and subinhibitory 
antibiotic concentration. Particularly, administration of low antibiotic doses can produce 
mutant strains susceptible to the applied antibiotic but showing cross-resistance to other 
antibiotics. Recently, it was observed that survival bacteria mechanism is due to genetic 
mutations provoked by oxidative stress. Indeed, in response to antibiotic administration 
bacteria produce reactive oxygen species (ROS). At high doses, ROS kill bacteria while 
at low doses they can lead to mutations. 
Although the ROS role in planktonic bacteria has been widely studied and their relation 
with resistant bacteria has been demonstrated, their influence on cellular stress in 
biofilm is still debated 
201
. However, to prevent microbial adhesion and biofilm 
development a potentially winning strategy could be to combine antibiotics with 
inhibitors that prevent the ROS formation.  
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1.10.2 Reactive Oxigen Species and phenolic compounds  
 
Antioxidants are substances able to counteract oxidative phenomena. According to 
Halliwell 
202
, the most widely used definition of antioxidant is: “any substance that 
when present at low concentration compared with that of an oxydizable substrate, 
significantly delays or inhibits oxidation of that substrate”.  
Reactive oxygen species (ROS) include highly reactive molecules such as superoxide 
anion, hydroxyl radical, peroxy radical and nitric oxide as well as non-radical species, 
such as hydrogen peroxide, singlet oxygen, hypochlorous acid and ozone. Hydroxyl 
radical is the most reactive and harmful ROS in biological systems. Such a radical is 
generated by the reaction of the ferrous ion (Fe
2+
) with hydrogen peroxide. In this 
process, known as Fenton reaction, the amount of produced radical is directly 
proportional to concentration of iron or copper. The endogenous production of ROS 
mainly takes place in mitochondria, where oxidative processes with electron transport 
(cellular respiration) occur. In these processes, oxygen acts as the final electron acceptor 
for energy production. Oxygen, when performing its oxidizing action, is subjected to a 
series of reduction reactions in which it subtracts electrons to other molecules, giving 
rise to a series of radical intermediates.  
ROS are also bore from arachidonic acid, by the metabolism of polyunsaturated fatty 
acids, during the production of eicosanoids (prostaglandins, thromboxanes and 
leukotrienes), molecules playing important functions at level of the vascular apparatus. 
Another case in which the production of free radicals is considered physiological and 
useful to the body is when it occurs in macrophages, in which the superoxide radical is 
used as a "killer" against bacteria and pathogenic viruses.  
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In addition to the endogenous mechanisms, factors causing the production of free 
radicals are: stress, unbalanced diet, alcohol, smoking, strenuous physical exercise, 
pollution and sunlight. An excess of cellular ROS contributes to the processes of aging 
203
 and is implicated in development of cancer and chronic diseases, neurodegenerative 
and cardiovascular diseases, such as ischemia, multiple sclerosis, atherosclerosis, 
cataracts, diabetes, hepatitis, Parkinson's disease, Alzheimer's disease, dermatitis and 
muscular dystrophy.  
Current research has highlighted the strong contribution of the polyphenols in the 
prevention of cardiovascular diseases, cancer, osteoporosis, diabetes mellitus and 
neurodegenerative disorders such as Alzheimer's and Parkinson's diseases 204. Phenolic 
compounds have remarkable importance for the role they play in foods, especially at 
nutritional level. They contribute to: i) aroma and flavor of many foods and drinks; ii) 
stabilization of natural dyes directly present in food or used as additives by food 
industry; iii) preservation of foods thanks to their antimicrobial and antioxidant features 
205
. On the other hand, phenolic compounds if present at low concentrations protect food 
from oxidative and microbial deterioration, while at high concentrations can interact 
with proteins, carbohydrates, minerals increasing their bitter taste and astringent feature 
206
. 
The biological activity of polyphenols is determined by several factors, the most 
important are: 
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- direct interaction with receptors and enzymes involved in signal transduction that can 
modify the redox state of cells 
207
, 
- interaction with estrogen receptor with consequent effects on endocrine functions. 
A main example is represented by the interaction of soy isoflavones with estrogen 
receptors, this explaining their role in preventing main manifestations of menopause 
208
, 
- well-known antioxidant activity and free radical scavenger by which they protect cells 
from oxidative damage; 
- pro-oxidant activity which can induce apoptosis of cancer cells and prevent the 
development of cancers 
209
. 
1.10.3 Antioxidant activity 
 
In every cell of human organism, biochemical processes consuming oxygen for energy 
production take place. However, these oxidation processes, which are vital for the cell, 
produce potentially harmful waste products, particularly free radicals, such as molecules 
or molecular fragments containing one or more unpaired electrons in the more external 
atomic or molecular orbital 
210
.  
The energy corresponding to this configuration provides these species with instability 
and high reactivity. As a result, autocatalytic chain reactions trigger. Free radicals are 
continually produced in human body and are controlled by endogenous enzymes 
(superoxide dismutase, glutathione peroxidase, catalase, etc.). When a high production 
of these species occurs, as a result of exposure to oxidizing substances from external 
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sources or alteration of defense mechanisms, valuable biomolecules (DNA, lipids and 
proteins) can be seriously damaged 
211
.  
Antioxidant agents with a negative reduction potential can supply electrons to free 
radicals in order to restore the chemical balance of system in which they work. To act as 
antioxidant, a substance, once oxidized, must originate a not reactive or less reactive 
species towards other molecules. 
Antioxidants exert their action at rather low concentrations. When their concentration 
increases, some of them can become pro-oxidants and promote the formation of radicals 
212
.  
In relation to mechanism of action, antioxidants can be distinguished in the following 
types:  
Type I: “chain breaker antioxidants”. They act as inactivators of free radicals through 
two basic processes: transfer of a hydrogen atom (Hydrogen Atom Transfer, HAT) or a 
single electron (Single Electron Transfer, SET) to radical species. The final result is the 
same, but kinetics and potential of reactions are different 
213
. 
The effectiveness of these antioxidant types depends on stability of radicals in which are 
transformed 
214
. Therefore, the more efficient the relocation of unpaired electrons 
produced in the reaction with free radicals, the greater their antioxidant power. Really, 
these mechanisms may also take place simultaneously. HAT reactions are independent 
on the solvent and pH of medium and, generally, take place quickly enough, finishing in 
a few minutes (Scheme 1). 
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Scheme 1. Antioxidant of type I for HAT reactions. 
Conversely, SET reactions occur more slowly. In this process, the potential antioxidant 
transfers an electron reducing compounds such as radicals, metals and carbonyls groups 
(Scheme 2) 
215
. 
 
Scheme 2. Antioxidant of type I for SET reactions. 
Type II: "scavenger antioxidants". This type of molecules prevent formation of free 
radicals, especially for coupling with another radical (Scheme 3). This reaction having a 
very low activation energy occurs with a rate close to diffusion 
216
. The scavenger 
action also includes chelation of metals. Metal traces present in food reduce the 
activation energy of the reaction in initiation phase of lipid oxidation 
 
Scheme 3. Antioxidant of type II. 
In nature, the limit between these two classes of antioxidants is not so clear. This 
because some of mechanisms by which certain antioxidants exert their action have been 
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not well defined and in addition substances as phenolic compounds can act 
simultaneously as first and second type antioxidants. 
 
1.11 Catecholic function 
 
Phenol and benzoic acid derivative polymers are biocidal agents acting into the bacteria 
membrane. Phenolic and antioxidant compounds are known to cause disruption of cell 
peptidoglycans or damage the cell membrane, or both 
217
. In addition, they can cause 
intracellular coagulation of cytoplasmic components inhibiting the cell growth or 
leading to the cell death.  
Park et al.
 218
 synthesized and tested in terms of antimicrobial properties different vinyl 
monomers bearing phenol and benzoic acid as pendant groups. They were effective 
against bacteria and fungi. However, polymerization of the monomers significantly 
decreased their antimicrobial activity. This has been explained with the extremely slow 
diffusion of glass polymer in the medium due to their molecular weight higher than 
corresponding monomers. 
Antimicrobial polymer systems were also prepared from poly(vinyl phenol) (PVP) by 
Kenawy and Abdel-Fattah 
219
. The antimicrobial activity of polymer fibers was 
examined against different test microorganisms. Generally, it was found that polymer 
morphology and molecular weight affected the activities against tested microorganisms. 
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Particularly interesting materials, possessing antioxidant and antifungal properties, have 
been obtained by Iemma et al. 
220
 by a one-pot free-radical copolymerization of ferulic 
acid (FA) and methacrylic acid (MAA) (Figure 11). After determination of disposable 
phenolic groups, the macromolecular system was tested in terms of scavenging activity 
toward hydroxyl radical and antifungal properties against A. niger. Good antioxidant 
and antifungal activities of the polymer were found. 
 
Figure 11. Ferulic acid molecular structure. 
Also polyphenols from natural sources such as green tea extracts have been found 
having antimicrobial properties 
221
. Mimicking this, Kenawy et al. 
222
 synthesized a 
copolymer of hydroxystyrene and methylmethacrylate then modified with 
ethylenediamine (EDA). The amine modified polymer was reacted with two classes of 
active compounds, particularly aldehydes and phenolic esters. The antimicrobial 
activities of the polymers and modified polymers were explored with bacteria, fungi and 
pathogenic molds. In vitro studies indicated that the start polymer did not affect the 
growth of the tested microorganisms, in contrary to its derivatives. 
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The main natural antioxidants are characterized by the presence, in their chemical 
structure, of phenolic groups, particularly, catechol, hydroquinone or gallic moieties  
(Figure 12). Such compounds exhibit high toxicity and thanks to this characteristic they 
are effective in protecting plants against insects 
223
. 
 
Figure 12. Derivatives phenolic antioxidant general structures. 
The peculiar antioxidant activity of these phenols, in particular of systems containing 
catechol structure, is due to the semiquinone formed in the first stage of the reaction 
which inactivates a second radical turning into a quinone (Scheme 4) 
224
.  
 
Scheme 4. Antioxidant action mechanism of catecholic systems. 
Examination performed on more than 8000 molecules collected in a database (called 
Comprehensive Medicinal Chemistry "CMC") has identified 78 pharmacologically 
active compounds containing one or more catecholic functions. Among them, 12 
compounds are bronchodilators, 9 are adrenergic, 7 are antiparkinsonian and other 7 are 
antihypertensives.  
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Since 1% of drugs has one or more catecholic moieties, this suggests that toxicity of this 
group is, therefore, controllable. A rigorous research, performed in the data base of the 
U.S. Food and Drug Administration (FDA), showed that there are 17 approved drugs 
still not in prescription.  
Physical-chemical calculations have recently shown that the toxicity of catechol 
compounds is related to their ability to form the quinine. In particular, the higher the 
enthalpy of dissociation of the second OH group, the less their toxicity. Obviously, the 
reduction of polyphenol toxicity often implies a reduction of the activity of radical-
scavenger. Therefore, it is often necessary to seek a good compromise.  
During the last 50 years, considerable attention has been devoted to the study of new 
antioxidants to prevent and treat various diseases. They are mostly of natural origin, 
since natural compounds are preferred by consumers because they are considered 
healthier.  
However, antioxidants can be also produced by many synthetic strategies. Contrary to 
natural antioxidants, synthetic ones are developed and produced for the exclusive 
benefit of mankind. An interesting class of antioxidants includes those chemically 
synthesized having chemical structures mimicking the natural ones. Natural mimicking 
antioxidants can be obtained at high purity degree, by reproducible and economic 
procedures.  
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1.11.1 Reactions of hydroxylation of aromatic compounds: synthesis of catechols 
 
In development of new synthesis strategies to produce synthetic or like natural 
polyphenols, the main reaction that can be considered is oxidation of aromatic 
compounds. Given the importance of obtainable products, the reaction of phenol 
hydroxylation to get catecholic structure molecules is particularly interesting. 
Direct and selective hydroxylation of aromatic compounds, especially phenols, is one of 
the main transformations in organic chemistry and has attracted particular attention in 
recent years because, as mentioned previously, the hydroxylated aromatic compounds 
are important precursors of molecules of pharmaceutical interest 
225
. 
Taking natural systems as a model, some oxidative methodologies employing isolated 
enzymes or microbial cells have been developed 
226
. Differently, chemical oxidation has 
been late to spread as an alternative to enzymatic methods. Oxidant agents such as 
Fremy’s radical, methyltrioxorhenium (MeReO3)/H2O2 catalytic system 
227
 or 
dimethyldioxirane 
228
 do not discriminate different sites in the same molecule or even 
promote the oxidation of the para position if it is free from substituents.  
However, few examples of one-pot chemical synthesis of substituted catechols from 
phenols based on the use of oxidants belonging to the family of hypervalent iodine (V) 
have been reported 
229
. These reagents represent good substitutes to the most common 
used oxidizing agents because they considerably simplify the oxidative processes, being 
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extremely active and selective at the same time, versatile, economic and easy to prepare 
in laboratory 
230
. 
 
1.12 Hydroxytyrosol  
 
Hydroxytyrosol (HTy), 4-(2-hydroxyethyl) benzene-1,2-diol, is a natural o-diphenolic 
compound found in olive oil 
231
, and in the olive processing waste, especially in olive 
oil vegetation waters (Figure 13) 
232
. It derives from hydrolysis of oleuropein glycoside 
by β-glucosidase of cell or by acid catalysis during storage or by pressing of olives 233. 
Recently, HTy has been found in some italian red and white wines 
234
. 
 
 
Figure 13. Hydroxytyrosol chemical structure. 
HTy has a discrete antioxidant capacity and scavenger action versus free radicals, due to 
o-diphenolic  functionality. In vivo studies, performed on rats, have shown that low 
doses of this compound (0.5 mg / Kg) are able to reduce the formation of lipid 
peroxidation products (isoprostanes) from an oxidative stress 
235
. Hydroxytyrosol 
possesses numerous other biological activities: it prevents some cardiovascular diseases 
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236
, platelet aggregation 
237
, diabetes, cerebral ischemia and several neurodegenerative 
disorders 
238
.  
Recently, HTy was also used in agrochemical field for controlling the growth of fungi 
and pathogenic bacteria 
239
. In vitro studies, performed on cells where a tumor process 
was induced, have evidenced that this molecule acts as a detoxifying agent against 
mutagens, increasing cell ability to repair their genetic inheritance. In addition, it has 
been shown that HTy is also involved in growth phase of tumor avoiding cell 
proliferation and mitosis, or promoting apoptosis before the neoplasm onset 
240
. For all 
these important properties, HTy is a product of large interest in pharmaceutical field. 
Different applications of hydroxytyrosol are known in cosmetic industry, as a 
component of protective creams for the skin and lipsticks 
241
, in food industry, as a food 
supplement or to stabilize and improve the quality of foods and drinks, particularly  
vegetable oils, in food packaging as a stabilizer of plastics used 
242
. Until a few years 
ago hydroxytyrosol was not commercially available. Today it is produced by some 
chemical companies with not inexpensive prices. 
Given the presence of  HTy in vegetable matrices, several protocols of extraction from 
olives, olive leaves 
243
, olive oil 
244
 and the oil mill vegetation water have been 
developed 
245
. These procedures are often laborious and require the use of significant 
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amounts of harmful and flammable organic solvents as well as appropriate extraction 
and purification equipment. Moreover, in some cases, hydroxytyrosol is not recovered 
pure but in mixture with other phenolic components, in particular with tyrosol. 
From a synthetic point of view, the procedures reported in the literature include the use, 
as starting materials, the 3,4-dimethoxyphenyl ethanol 
246
; 3,4-dimethoxyphenyl acetic 
acid
247
 and 3,4 dimethoxy-benzaldehyde 
248
. However, these syntheses require many 
steps and the final yields are not high in hydroxytyrosol. 
 
1.13 Reaction of hydroxyl insertion in phenolic compounds with IBX 
acid (2-iodoxybenzoic) 
 
In the last decade, the chemistry of hypervalent iodine (V) compounds has shown an 
intense development. Indeed, some synthetic applications based on the use of such 
compounds are reported in literature. 
One of the main reactive compound belonging to this family is the 2-iodoxybenzoic 
acid (IBX). (Figure 14)  
 
 
 
 
Figure 14. 2-iodoxybenzoic acid chemical structure. 
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IBX has the structure of cyclic benzoiodoxole oxides, as determined by X-ray analysis 
249
. It was prepared for the first time by Hartmann and Mayer in 1893 but for a long 
time its applicability has been limited by poor solubility in most organic solvents. The 
synthesis was based on the oxidation of 2-iodobenzoic acid with potassium bromate 
(KBrO3) in aqueous solution of sulfuric acid 
250
. 
This procedure resulted very dangerous because, according to the International 
Classification of toxic substances, KBrO3 is considered a carcinogenic agent (R45) and 
the reaction produced bromine vapor with the risk of personal and environmental 
contamination. Moreover, the presence of bromate and other impurities coming from 
the synthesis, provided IBX with explosive characteristics at high temperatures (> 200 
°C) or for impact. 
Therefore, subsequently other oxidants such as peracetic acid 
251
 and sodium 
hypochlorite in aqueous solution have been used 
252
. More recently, it has been 
developed an oxidation with oxone, using water as a solvent. This methodology shows 
several advantages such as employment of harmless reagents, development of sulfates 
as only reaction byproducts, high yield and a high degree of purity (NMR = 99%) 
253
. 
(Scheme 5) Currently, a stabilized formulation of IBX, called SIBX, constituted by a 
mixture of benzoic acid (22%), isophthalic acid (29%) and 2-iodoxybenzoic (49%) is 
also commercially available 
254
. 
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Scheme 5. IBX synthesis. 
 
1.13.1 Iodobenzoic acid reactivity 
 
The first applications of IBX involved the oxidation of alcohols to aldehydes and 
ketones. With the progress of research on this reagent, other oxidative potentialities of 
the IBX have been evidenced. An interesting example is hydroxylation of phenols in 
ortho position. The reaction mechanism, described in the literature, is following 
reported (Scheme 6): 
 
Scheme 6.Reaction mechanism of ortho phenol oxidation. 
Initially, a coordination between the substrate and IBX occurs. Formation of the 
intermediate A with pentavalent iodine promotes the shift of oxygen to more 
I
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nucleophilic and less hindered intramolecular ortho position of the initial phenol 
(intermediate B). During this step, iodine is reduced from V to III with subsequent 
tautomerization (intermediate C). Then, the oxidation of catechol leads to ortho-quinone 
with reduction of iodine to valence I. Finally, by one-pot mild reduction, catechol is 
obtained. 
 
1.14 Chelating properties of cathecol antioxidants 
 
Another important application in the medical field of antioxidant substances bearing 
cathecol moieties is in chelation therapy. In this case, their ability to form complexes 
with metals is exploited. An example is the study of L-DOPA complexes with some 
metals 
255
.  
Catechols are well known for their chelating properties towards some metals such as 
iron (III), cadmium (II), copper (II) etc. with high complexation constants 
256
. 
Different chelating ability of catechol group found for Fe (III), Cu (II) and Ni (II) has 
been explained with an adsorption of these metals including two aspects 
257
: 
• Existence of 3d orbital not occupied, interacting with a lone pair of the catechol 
oxygen forming a coordination bond with the compound; 
• catechol OH groups can form with metal ions hydrogen bonds stronger than those 
formed between water and these ions. 
                                                          
255
 Hamada Y., Rogers C., J. Coord. Chem., 2007, 60, 2149-2163.  
256
 Sillén L.G., Martell A.E., Stability Constants of Metal-Ion Complexes, The Chemical Society, 
Burlington House London, 1964. 
257
 Li L., Li Y., Luo X., Deng J., Yang W., React. Funct. Polym., 2010, 70, 938-943. 
80 
 
Taking this as a cue, a line of research in the environmental field concerning adsorption 
of metals by catechol has been developed for a long time 
258, 259
. Numerous polymer 
materials have been provided with a side chain containing the catechol group 
260
. 
Chelation therapy could be a promising therapeutic approach since metals are 
considered to be a pharmacological target for development of new therapeutic agents 
for neurodegeneration or cancer treatment. 
Indeed, while many neurodegenerative diseases as well as multiple sclerosis are 
associated with iron elevated levels, cancer patients show significantly high copper 
levels.  Iron under oxidative stress passes from the ferrous state to the ferric one, while 
copper during the process of cellular copper uptake, being a potent oxidant, is reduced 
from Cu (II) to Cu (I). 
Oxygen is absolutely essential for life. Under certain circumstances, however, the 
oxygen can also act as a toxic substance. In fact, oxidant events cause the formation of 
highly reactive species, ROS.  
Oxygen circulates in our body in two forms, unstable and stable oxygen molecules. 
ROS are unstable oxygen molecules, highly reactive produced in the body by several 
environmental factors and hygienic habits only apparently healthy.  ROS react rapidly 
and indiscriminately with surrounding molecules to capture their missing electrons. 
Transition metals promote the production of ROS. In biological systems, iron and 
copper catalysts are particularly important in the production of ROS. 
ROS damage proteins, oxidize the bases of the genetic material and cause lipid 
peroxidation. However, ROS are also useful to fight infection, to kill bacteria and to 
control the smooth muscle tone, which regulates the functioning of the internal organs 
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and blood vessels. Oxidative stress can be defined as an imbalance between ROS and 
endogenous antioxidants produced by cells as defense mechanism. When this imbalance 
occurs, oxidatively modified molecules accumulate in the cells causing dysfunction.  
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CHAPTER II 
 
WATER SOLUBLE USNIC ACID-POLYACRYLAMIDE 
COMPLEXES WITH ENHANCED ANTIMICROBIAL ACTIVITY 
AGAINST STAPHYLOCOCCUS EPIDERMIDIS 
 
2.1 Introduction 
 
Drug oral bioavailability can be reduced by several physiological factors such as 
metabolic degradation prior to absorption, poor absorption from gastrointestinal tract or 
first-pass metabolism 
1
.
 
Low solubility and subsequent unsatisfactory dissolution rate 
often compromise the development of new active molecules hindering their usage in 
clinics.  
In an attempt to improve drug oral bioavailability, various pharmaceutical formulation 
technologies have been developed, including particle size reduction, use of surfactants 
or complexes formation. 
Usnic acid, one of the most extensively studied lichen derivates, is known to possess 
several interesting biological properties 
2
. It has a good antimicrobial activity against 
planktonic Gram-positive bacteria 
3, 4
, such as Staphylococcus epidermidis, S. aureus, 
Enterococcus faecalis, Mycobacterium tuberculosis, and some pathogenic fungi. 
5
 
 
Usnic acid was also recently shown to be able to prevent biofilm formation by 
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Staphylococcus spp. when incorporated in polyurethanes 
6, 7
 or in bone cements 
8
. 
Therefore, this drug is under investigation for the prevention of medical device-related 
infections as antimicrobial agent to be adsorbed on the surface of medical devices in 
alternative to conventional antibiotics 
9
. 
Besides the antimicrobial activity, usnic acid also possesses anticancer properties. Its 
antiproliferative activity was first reported against lung carcinoma 
10
 and then 
demonstrated against a wide variety of human cancer cell lines 
11, 12
.
 
A recent study 
showed that usnic acid works in a p53-independent manner 
13
,
 
making it a potential 
candidate for novel therapies. 
Despite these recognised features, usnic acid therapeutic application has not yet been 
introduced due to its low water solubility 
10
 and high hepatotoxicity
14, 15
.
 
Thus, its use in 
a safe and efficient manner requires the development of suitable dosage forms able to 
improve its therapeutic index.  
Natural or synthetic water-soluble polymers have been extensively investigated as 
carriers either to solubilise drugs 
16
 or to control and target their release to specific cells 
17, 18 
. The potential advantage of the use of synthetic polymers over the natural ones 
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relies on the versatility of the macromolecular chemistry which allows to tailor the 
polymer molecular weight, to control its composition and to introduce specific 
functional groups or bioresponsive elements. 
A number of polymer/anticancer drug conjugates are being tested clinically, most of 
which has N-(2-hydroxypropyl)methacrylamide copolymers as carriers 
19
. So far, only a 
few studies concern the development of usnic acid/polymer systems. Particularly, PEG 
400 or polypropylene glycol were used as co-solvents to increase usnic acid solubility 
20
. However, only a poor or no effect on drug effectiveness was achieved. Better results 
were instead obtained by drug complexation with 2-hydroxypropyl--cyclodextrin in 
terms of both solubility and anti-proliferative activity 
20
. The entrapping of a usnic 
acid/-cyclodextrin complex in liposomes allowed the development of a long-term 
controlled-release system 
21
. However, this system did not show better antimicrobial 
activity with respect to the free usnic acid when tested against Gram-positive bacteria. 
The injection of usnic acid-loaded poly(D,L-lactic acid-co-glycolic acid) nanoparticles 
in Swiss mice produced a 26% increase in tumour inhibition and a reduction in drug 
hepatotoxicity 
22
, as a consequence of drug targeting. 
In a more recent study 
23
, usnic acid was derivatized with various amine moieties, 
including the three natural low molecular weight polyamines putrescine, spermidine and 
spermine, in order to improve drug cellular uptake by targeting the polyamine transport 
system (PTS). Although results showed an increase in drug cytotoxicity against human 
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cancer cell lines, drug targeting to the PTS was unsuccessful. The authors explained the 
failure by an unfavourable architecture of the conjugates. 
Therefore, since the encapsulation or conjugation of the usnic acid with polymers can 
enhance its bioavalaibility reducing its toxicity, we wanted to develop water soluble 
cationic polymers as drug carriers possessing a high affinity with the drug thanks to 
acidic-base interactions. 
It is known that cationic polymers have good antimicrobial features thanks to the 
presence of pendent charged groups such as phosphonium, biguanide or nitrogen 
groups. Different factors affect their activity such as polymer molecular weight, the type 
of counterion and the alkyl chain length attached to charged group 
24, 25
. Although 
synthetic cationic polymers can be an alternative to the use of low molecular weight 
antimicrobials, they suffer from their cytotoxicity if considered for therapeutic 
applications 
26
. 
In fact, in spite of the positive charges facilitate the polymer cellular internalization, the 
non-specific electrostatic interactions with blood components lead undesired side 
effects. It was seen that the complexation of cationic polymers with biomolecules such 
as DNA, leading to the partial neutralization of charges, reduces the toxicity of such 
polymers 
27
. 
A widely investigated polyacrylamide in the literature is the poly-N-[2-(N,N- 
dimethylamino)ethyl]acrylamide containing charged tertiary amine groups bearing 
methyl residues 
24, 
 
28
. 
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In this work, an ethylacrylic amide containing charged tertiary amine groups bearing 
ethyl residues was first synthesized. We chose to introduce longer alkyl residues to 
enhance the polymer hydrophobicity and then improve its interaction with bacterial 
membrane. Pursuing this strategy, propyl and butylacryl amides always bearing ethyl 
residues on the charged amine groups were also synthesized. 
The water-soluble monomers were used for radical polymerization in order to obtain 
polymers to be employed as carriers for usnic acid. Differently from the other systems 
developed in literature, such cationic polymers can establish multipoint acid-base 
interactions with the drug phenolic groups. These interactions could improve not only 
the drug bioavalaibility but also polymer antimicrobial activity as well as lower polymer 
toxicity by decreasing charge density.    
Finally, since one of the main issue related to the use of antimicrobial agents is the 
development of drug resistant bacteria, the employment of an intrinsically antimicrobial 
carrier rather than an inert polymer could address this problem by exerting a synergistic 
effect in bacterial killing. Indeed, the most pursued strategy to reduce the drug 
resistance is the combined use of antimicrobial agents having different mechanisms of 
action. In our case, the cationic polymers adsorb on the negative charged bacterial 
membrane provoking cell disruption while the usnic acid inhibits bacterial metabolic 
functions. The developed polymer/usnic acid systems were characterized by thermal 
and spectroscopic analysis and tested against Staphylococcus epidermidis. 
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2.2 Experimental methods 
 
2.2.1 Monomer and polymer synthesis 
 
Three acrylic monomers were synthesized by reaction between acryloyl chloride (Ac, 
Fluka) and N,N-diethylethylendiamine (DED, Sigma Aldrich) or N,N 
dipropylethylendiamine (PED, Santa Cruz Biotechnology, Inc.) or N,N 
dibutylethylendiamine (BED, Fluka). The obtained monomers were called AcDED, 
AcPED and AcBED respectively. The synthesis procedure was: 0.029 moles of each 
diamine was added to a solution of Ac (0.038 moles) in dimethylcarbonate (DMC, 75 
ml, Sigma Aldrich) containing K2HPO4 (0.08 moles, Carlo Erba), used as base. The 
reaction was carried out for 4 h at room temperature. In all reactions no side product 
was found. After reaction, the solution was filtered to remove the inorganic and organic 
salt and the monomer recovered by solvent evaporation (yield ranging from 85 to 90%). 
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Scheme 1. Structure formula of pAcDED (a) and usnic acid (b). 
 
Differently from AcDED monomer, AcPED and AcBED resulted no water soluble. 
Since the object of our work was to develop water soluble antimicrobial polymers to be 
employed as carriers for hydrophobic drugs, only AcDED monomer was used for 
radical polymerization.  
Polymer synthesis was carried out at 25 °C for 24 h by using a 1 M water solution of 
AcDED (5 ml) and K2S2O8 (2.8x10
-4
 mmoles, Carlo Erba) plus FeSO4 (2.4x10
-4
 
mmoles, Carlo Erba) as radical initiators. The resulting polyacrylamide (Scheme 1a) 
was called pAcDED (pKb=8.61).  
To evaluate the effect of polymer molecular weight on usnic acid dissolution in water, 
polymers at different chain length were obtained by adding in the synthesis sodium 
metabisulfite (Na2S2O5, Carlo Erba) as chain transfer agent (T). The following chain 
transfer agent/monomer molar ratios were employed: [T]/[AcDED] = 0, 0.05, 0.1, 0.3 
and 0.5. Resulting polymers were called pAcDEDT=0, pAcDEDT=0.05, pAcDEDT=0.1, 
pAcDEDT=0.3 and pAcDEDT=0.5.  
 
2.2.2 Polymer characterization 
 
1
H-NMR spectra were performed employing a Varian XL 300 instrument and 
Chloroform (CDCl3) or water (D2O)  as solvents. The obtainment of AcDED monomer 
and the respective polymer (Figure 1a) was confirmed by 
1
H-NMR (300MHz, CDCl3 
and D2O): AcDED δ= 0.95 (t, J =7.2 Hz, 6H, N(CH2CH3)2), 2.56-2.47 (m, 6H, 
CH2N(CH2CH3)2), 3.34-3.28 (m, CONHCH2), 5.52 (dd, J1=9.9 Hz, J2=2.1 Hz, 1H, 
CHH=CH), 6.07 (dd, J1 = 9.9 Hz, J3 = 16.8 Hz, 1H, CHH=CH), 5.52 (dd, J3=16.8 Hz, 
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J2=2.1 Hz, 1H, CHH=CH), 6.70 (s, 1H, CONH); pAcDEDT=0 δ= 0.76 (s, 6H, 
N(CH2CH3)2), 1.64-1.20 (m, 3H, CH2CH), 2.47 (s,  6H, CH2N(CH2CH3)2), 2.99 (s,2H, 
CONHCH2). 
Molecular weight measurements were carried out at 25°C using a gel permeation 
chromatography (GPC) system equipped with a Shimadzu RID-10A differential 
refractive index detector and Tosoh TSK polyacrylamide gel columns. The calibration 
curve was obtained by using polyethylene oxide standards. Aqueous sample solutions 
containing 0,1 M NaCl were injected by an autosampler Hitachi AS-2000 at a flow rate 
of 0.8 mL min
-1
.  
pAcDEDT=0 possessed a Mn of 120x10
3
 g/mol and 1.35 polydispersity index. By 
increasing the [T]/[AcDED] molar ratio the polymer molecular weight decreased, 
reaching a Mn value of 69x10
3
 g/mol for a 0.5 molar ratio (Table 1). 
The size of polymers was evaluated by dynamic light scattering analysis (Coulter LS-
13320) employing water solutions at 0.1 mg/ml concentration. 
Differential scanning calorimetry (DSC) measurements were carried out by a 
METTLER TA 3000 calorimeter provided with a TC 10 A processor, by keeping the 
cell (DSC30) under N2 flow. The explored temperature range was  -100-250° C and the 
employed heating rate was 10 °C/min. For each sample two scans were performed. 
 
2.2.3 Preparation of pAcDED/UA complexes and their characterization 
 
Polyacrylamide/Usnic acid (UA, Sigma Aldrich, M=344 g/mol, pKa3=4.4, pKa9=8.8, 
pKa7=10.7, (Scheme 1b) complexes were prepared by dissolving in water the pAcDEDs 
having different molecular weights with the drug at the following polymer/UA weight 
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ratios, 70/30, 60/40, 50/50 and 30/70. In particular, 50 mg of UA were added to 5 ml 
polymer solutions containing different amounts of polymer ranging from 116 to 22 mg. 
Considering that pAcDEDs have one basic group per repetitive unit while the drug has 
three acidic groups, the employed weight ratios correspond to equiv(basic group)/equiv(acidic 
group) ratio of 1/0.5, 1/1, 1/2 and 1/3. After water evaporation under vacuum, powders 
were recovered and stored at 4 °C. 
1
H-NMR measurements were carried out dissolving the complexes in dimethyl 
sulfoxide (DMSO-d6). 
Thermal and DLS analyses were performed on the polymer/UA complexes by 
employing the same conditions used for the polymers. 
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Figure 1: 
1
H-NMR spectra of pAcDEDT=0 (a), usnic acid (b) and pAcDEDT=0/UA 70/30 
complex (c). 
  
To evaluate UA dissolution in water, tablets containing 50 mg of drug and variable 
amount of pAcDEDs were prepared and kept in water up to complete dissolution. At 
specified time frame, aliquots of the solutions were collected and tested by UV-
spectroscopy (290 nm). 
The antibacterial activity of samples was assessed against Staphylococcus epidermidis 
(ATCC 35984) by the disk diffusion test and broth microdilution assay. The former test 
was carried out on cellulose disks embedded with 20 µL of a 1 mg/mL polymer alone or 
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polymer/UA solution and placed in Petri plates previously seeded with 10
8
 CFU/mL 
bacterial concentration. Following incubation at 37°C for 24 h, diameters of inhibition 
zones of bacterial growth were measured.  
The broth microdilution assay allowed instead to determine the minimum inhibitory 
concentration (MIC) of UA, pAcDEDs and polymer/UA complexes. As for UA, 
because of its limited water solubility, dimethylsulfoxide (2% wt) was used as solvent 
mediator for the antimicrobial agent, after ruling out any intrinsic activity of 
dimethylsulfoxide by plating viability 
6
. As for polymer/UA complexes, tablets 
containing a fixed amount of drug (500 µg) and variable amounts of polymer to obtain 
70/30, 60/40, 50/50 or 30/70 pAcDED/UA weight ratios were prepared and dissolved in 
water (1 mL). Then, a series of dilutions was prepared and inoculated with a 10
6
 
CFU/mL bacterial concentration. After 24 h-incubation at 37 °C, bacterial growth was 
determined by measuring the adsorbance at 600 nm. All the experiments were done in 
triplicate. Analysis of variance was performed using MiniTab. Differences were 
considered significant for P <0.05.  
 
 
 
2.3 Results and Discussion 
 
Infectious disease is a critically important healthcare issue. The extensive use of 
antibiotics to eradicate the infections has contributed to the emergence of multidrug-
resistant pathogens 
29, 30
. In the last years, the need of suitable alternatives to replace or 
support systemic therapies has promoted both the use of antibiotic combinations and the 
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development of new classes of antimicrobial compounds 
24, 25,
 
31
. In this regard, 
antimicrobial polymers offer the promise for enhancing the efficacy of existing 
antimicrobial agents by increasing their efficiency and selectivity 
24
. 
Cationic polymers based on ammonium salts are undoubtedly the most investigated 
macromolecular antimicrobial compounds. Similarly to host defense peptides 
25
, 
cationic polymers accumulate at the level of the polyanionic bacterial cell surface. They 
have a broad-spectrum of activity since both Gram-negative and Gram-positive bacteria 
display on their surfaces anionic charges.  
In this study, a hydrophilic polyacrylamide (pAcDED) was obtained by polymerization 
of a novel acrylic monomer that resulted water soluble thanks to the short alkyl chain 
(ethyl chain) bearing the cationic amine group.  Therefore, this polymer was employed 
as carrier for usnic acid.  
The use of a chain transfer agent in the synthesis controlled polymer molecular weight 
as demonstrated by the data reported in Table 1.  
In the same table, DLS data show that pAcDEDT=0 and pAcDEDT=0.5 in water possessed 
a remarkable size of  920 and 500 nm respectively. These values suggest that the 
polymer chains interact each other leading to large aggregates. In GPC analysis, these 
aggregation phenomena were avoided by adding NaCl in the eluent. 
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POLYMER 
Mn    (10
3
 
g/mol) 
I=Mw/Mn Size (nm)* 
pAcDED T=0 120 1.35 920±40 
pAcDED T=0.05 100 1.30 880±80 
pAcDED T=0.1 94 1.32 780±50 
pAcDED T=0.3 78 1.29 680±70 
pAcDED T=0.5 69 1.31 500±70 
 
* The data, representative of at least six measurements, are reported as arithmetic mean  standard deviation. 
 
Table 1. Molecular weight, polydispersity index and DLS size of synthesized polymers. 
The data, representative of at least six measurements, are reported as arithmetic mean 
 standard deviation. 
  
 
In Figure 2, the size of inhibition zone of bacterial growth for the polymers synthesized 
with different amount of chain transfer agent is reported. As can be observed, all of 
polymers showed small inhibition zones indicating a poor diffusion ability probably due 
to their large molecular size and possible interaction with ionic components of the agar 
medium. The lowest molecular weight polymer (pAcDEDT=0.5) displayed the largest 
inhibition zone (4 mm).  
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Figure 2: Inhibition zones of bacterial growth of polymers synthesized with different 
amount of chain transfer agent (T). 
 
For all pAcDED polymers a MIC value of 100 µg/mL was found. This minimum 
inhibitory concentration is comparable to those reported in literature for polymers based 
on ammonium salts 
32
. 
Differential scanning calorimetry evidenced that pAcDEDs were amorphous polymers. 
As an example, the thermogram of pAcDEDT=0 is reported in Figure 3a. In the first 
scan, a wide endothermic peak related to the adsorbed water can be observed. This peak 
in the second scan disappeared. To evidence if any transition was present, the first 
derivative of the curves was done. A glass transition temperature at 86 °C was found.  
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Figure 3:  pAcDEDT=0 thermograms related to the first and second heating cycle (a); 
dependence of polymer glass transition temperature (Tg) on the chain transfer 
agent/monomer [T]/[AcDED] ratio (b). The Tg values were determined by the first 
derivative of the curve obtained in the second heating cycle. 
 
This transition remained unchanged in third scan. With increasing of [T]/[AcDED] 
molar ratio employed in the synthesis a decrease in glass transition temperature (Figure 
3b) was observed indicating a higher chain flexibility of the lower molecular weight 
pAcDEDs. This was presumably due to the higher concentration of the chain-ends. 
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Figure 4: DSC curves of usnic acid and pAcDEDT=0/UA complexes (a); dependence of 
polymer glass transition temperature on usnic acid content for pAcDEDT=0 and 
pAcDEDT=0.5 (b). The Tg values were determined by the first derivative of the curve 
obtained in the first heating cycle. 
 
DSC also allowed to assess the establishment of polymer/drug interactions. In fact, the 
disappearance or shifting of exothermic or endothermic peaks as well as variation of 
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enthalpy values can give information on the compatibility/incompatibility of the 
components in the formulation. In Figure 4a, DSC curves of UA, pAcDEDT=0/UA 
30/70, 50/50 and 70/30 are reported.  
As can be observed, UA is a crystalline drug with a melting temperature of 203 °C 
(melting enthalpy = 98 J/g). When UA was dispersed in pAcDED, the absence of the 
melting peak in all the tested formulations indicates that UA was in an amorphous state. 
This is probably due to the establishment of polymer/drug acidic-base interactions 
hindering UA crystallization. These interactions also caused a stiffening of polymer 
chains as demonstrated by the increase in polymer Tg (Figure 4b). This stiffening 
occurs at a 30% UA content for the lower molecular weight polymer (pAcDEDT=0.5) and 
only at high UA content (70%) for pAcDEDT=0. Thus, due to its basic and amorphous 
features, pAcDED seems a good carrier for UA since a molecular dispersion of the drug 
and a complete drug/polymer miscibility in the amorphous phase was achieved. 
A further confirm of the polymer/drug interactions was given by 
1
H-NMR 
measurements. 
1
H-NMR spectra of usnic acid and the pAcDEDT=0 /UA 70/30 complex 
(equiv(basic group)/equiv(acidic group) ratio =1/0.5) are reported in Figure 4b and 4c 
respectively.  
The UA spectrum showed a resonance at 11.3 ppm related to the protons of the 
hydroxyl groups in 3, 7 and 9 position (Figure 1b). The signal at 6.2 ppm was attributed 
to the proton in position 4 while the resonances at 2.65, 2.57, 1.98 and 1.71 ppm to the 
methyl groups in 12, 14, 15 and 10 position, respectively. In the spectrum of the 
pAcDEDT=0 /UA 70/30 complex, the disappearance of the signal at 11.3 ppm indicated 
the establishment of acid-base interactions between UA and pAcDED (Figure 1c). 
These interactions also caused shifts of the signals attributed to the CH in position 4 
(from 6.2 to 5.4 ppm) and to the CH3 in  position 12 (from 2.65 to 2.20 ppm). Similar 
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results were found for the other complexes where the equiv(basic group)/equiv(acidic group) 
ratio was ≥1/1 (data not shown).  
Also experiments of drug water dissolution showed the strong polymer/drug 
interactions. Indeed, differently from the free UA, a complete tablet dissolution was 
achieved after 30 min of immersion in water for all the tested formulations. This 
indicates that the polymer promotes UA solubilization in water. However, since a 
significant variation of the UV spectrum was observed after tablet dissolution, it was 
not possible to determine the increase in UA water solubility. In fact, other than the 
adsorption band of the free drug (290 nm), a new band, strongly dependent on the 
polymer/drug ratio, appeared at 240 nm (data not shown). This suggests the formation 
of a stable polymer/UA complex both at low and high drug concentrations.  
As for the size of complexes in solution, DLS analysis showed a decrease in complex 
sizes with respect to those of polymers alone due to the ability of usnic acid to shield 
polymer positive charges breaking the inter-chain interactions (Table 2). Indeed, the 
drug can establish multipoint interactions  with polymer chains promoting the formation 
of small structures. 
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Table 2. DLS size of polymer/UA complexes.The data, representative of at least six 
measurements, are reported as arithmetic mean  standard deviation. 
 
Such size decrease was higher for the polymers at lower molecular weight 
(pAcDEDT=0.1 and pAcDEDT=0.5) than the polymer obtained without chain transfer 
agent. This finding can be attributed to the large initial size of pAcDEDT=0 aggregates 
that did not allow UA to interact efficiently polymer cationic groups.  The greater size 
of pAcDEDT=0 with respect to other polymers is due to not only the higher length of the 
polymer chains but also probably to the lower concentration of chain ends that 
involving a minor excluded volume allows each chain to interact with nearby chains.  
Moreover, the complex size depended also on usnic acid content (Table 2). Generally, a 
slightly increase of the complex size was observed with increasing of drug amount. The 
size of the pAcDEDT=0.1/UA and pAcDEDT=0.5/UA complexes could be suitable for a 
good cellular uptake 
22
. 
  Size (nm)  
pAcDED/UA [T]/[AcDED]=0 [T]/[AcDED]=0.1 [T]/[AcDED]=0.5 
100/0 920±40 780±50 500±70 
70/30 530±40 70±7 60±10 
60/40 600±30 90±8 80±10 
50/50 580±50 95±15 90±9 
30/70 610±70 100±15 100±10 
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To verify the effect of polymer charge density on the antibacterial properties of 
complexes, the pAcDEDT=0/UA and pAcDEDT=0.5/UA samples at different polymer/UA 
ratio were submitted to the disk diffusion tests. The pAcDEDT=0/UA complexes showed 
a diameter of inhibition zone ranging from 4 mm for polymer/UA 70/30 to 2 mm for 
polymer/UA 30/70, values comparable to that of UA (2 mm). This finding indicates a 
poor diffusion ability of pAcDEDT=0 /UA complexes due to their remarkable size 
(Table 2). 
On the contrary, as shown in Table 3, the antibacterial activity of pAcDEDT=0.5/UA 
complexes resulted improved with respect to both UA and polymer alone, particularly 
for the pAcDEDT=0.5/UA 70/30. This result confirms that the inhibition zone depends 
mainly on size of the complexes rather than drug amount. Therefore, UA, being 
strongly linked to the polymer, cannot directly act against bacteria but can potentiate 
polymer activity by reducing the size of aggregates.  
The broth microdilution assay was performed on UA, after its solubilisation with 
dimethylsulfoxide (2% wt), pAcDEDs and on pAcDEDT=0.5/UA complexes, these latter 
being chosen for the better antimicrobial activity showed in the disk diffusion tests. For 
all pAcDED polymers a MIC value of 100 µg/mL was found. This minimum inhibitory 
concentration is comparable to those reported in literature for polymers based on 
ammonium salts 
32
. In Table 3 the MIC values of UA, pAcDEDT=0.5 and 
pAcDEDT=0.5/UA complexes against S. epidermidis are reported. All pAcDEDT=0.5/UA 
complexes possessed a lower MIC with respect to UA (P<0.01). 
Also in this case, the good activity of the complexes can be attributed to their reduced 
size. Indeed, the killing effect extent seems to be not significantly dependent on UA 
content in the samples (Table 3).  
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Sample 
Inhibition 
zone 
(mm) 
MIC  
(µg/ml) 
Usnic acid 2 ± 0.5 16 ± 4 
pAcDED T=0.5 4 ± 1 100 ± 3 
pAcDED T=0.5/UA 70/30 15 ± 2 5 ± 1 
pAcDED T=0.5/UA 60/40 9 ± 1 7 ± 1 
pAcDED T=0.5/UA 50/50 9 ± 2 8 ± 1 
pAcDED T=0.5/UA 30/70 9 ± 2 10 ± 2 
 
Table 3. Inhibition zones of bacterial growth and MICs of usnic acid, pAcDEDT=0.5 and 
pAcDEDT=0.5/UA complexes. 
 
Then, the UA complexation with a cationic amorphous polymer at low molecular 
weight allowed not only a successful drug solubilization but also an improvement of the 
polymer activity thanks to the reduction of the aggregate size. Since the best results 
were obtained for the complex at a low drug content (pAcDEDT=0.5/UA 70/30), this 
strategy is particularly winning given the known UA toxicity. Also the polymer toxicity 
could be reduced since the interaction with the drug partially neutralizes its positive 
charges. In addition, the combined use of two antimicrobial agents at different 
mechanism of action reducing the risk of emergence of drug-resistant microorganisms 
makes these systems particularly interesting for clinical application. 
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2.4 Conclusions 
 
To increase the bioavalaibility of water insoluble drugs novel basic polyacrylamides 
(pAcDEDs) at different molecular weight were synthesized and used as carriers. All 
obtained polymers were amorphous, water-soluble and able to complex usnic acid, 
chosen as model drug.  
DSC and 
1
H-NMR measurements showed that the polymers established multipoint acid-
base interactions with the drug phenolic groups. The shielding of polymer positive 
charges by usnic acid allowed the obtainment of polymer/UA complexes smaller in size 
than the polymers alone particularly for polymers with lower molecular weight. The 
drug-polymer multipoint interactions were more favored in the polymers with a higher 
concentration of chain ends. Indeed, a complex size of about 60 nm was obtained with 
the lowest molecular weight polymer at low usnic acid content (pAcDEDT=0.5/UA 
70/30).  
The polymer molecular weight affected also the antimicrobial activity against S. 
epidermidis of both the polymer alone and polymer/UA complexes. Indeed, 
pAcDEDT=0.5 displayed the largest inhibition zone of bacterial growth both alone and 
when combined with UA.  
The good activity of the complexes is probably due to their reduced size that allows an 
efficient cellular uptake of the antimicrobial complexes. The killing effect extent seems 
to be not significantly dependent on UA content in the samples. 
Novel polymers here reported could be used as carrier for different types of molecules 
(drugs, DNA, vaccines) that similarly to usnic acid have toxicity issues or need a 
targeted release. Further investigations are needed to determine whether this 
complexation allows a safer use of the cationic polymer and usnic acid in therapeutics. 
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CHAPTER III 
USNIC ACID LOADED CORE-SHELL MANGANESE FERRITE 
NANOCOMPOSITE 
  
3.1  Introduction 
 
Magnetic nanoparticles (MNPs) are interesting materials for many applications in 
different fields such as the environment, medical and electronic one. In particular, in the 
medical field MNPs can be used for drug delivery
1, 2
, magnetic resonance imaging 
(MRI)
1, 3
, cell labeling
 1, 3 
 and hyperthermia 
4
. 
In fact, development of magnetic particles with a mean diameter of few nanometers is a 
subject of intense research in the biomedical field since they can be alternatively used in 
magnetically targeted therapy or diagnostics
 1, 3
 . 
Using magnetic nanoparticles in drug targeting requires not only production of particles 
with a narrow size distribution and superparamagnetic properties but also with 
engineered surfaces such to ensure the adsorption and release of active molecules at a 
specific body site. However, because of their large surface area/volume ratio, the 
nanometer-sized iron oxide particles tend to agglomerate into large clusters and loose 
the specific properties associated with their initial nanometer dimensions
 5
 . Therefore, 
an appropriate surface modification and particle stabilization have become critical 
challenges for extending the utility of magnetic nanoparticles into biomedical field  
5
. In 
                                                          
1
 Laurent S., Forge D., Port M., Roch A., Robic C., Vander Elst L., Muller R. N., Chem. Rev., 2008, 108, 
2064–2110. 
2
 Dobson J., Nanomedicine, 2006, 1, 31–37. 
3
 Veiseh O., Gunn J. W., Zhang M., Adv. Drug Delivery Rev., 2010, 62, 284–304. 
4
 Barakat N. S., Nanomedicine, 2009, 4, 799–812. 
5
 Dong H., Huang J., Koepsel R. R., Ye P., Russell A. J., Matyjaszewski K., Biomacromolecules, 2011, 
12, 1305–1311. 
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fact, despite natural accumulation in target tissues (tropism of host cell), surface 
engineering of magnetic particles with proteins, target ligands or polymers can improve 
nanoparticle  selectivity towards tissues or organs. 
In particular, the ability of hydrophilic polymers of increasing the uptake of micro-and 
nano-particles into lipid bilayer of cell membrane has already been demonstrated 
6
 . 
Indeed, nanoparticle coating with hydrophilic materials such as PEG
7
 has been able to 
increase the uptake of nanoparticles in cancer cells compared to the uncoated system. 
In recent years, many efforts have been directed towards surface modification of various 
nanostructured carriers with hydrophilic polymers to increase their biocompatibility, 
circulation time in bloodstream, resistance to protein absorption (which would allow 
system recognition by the reticuloendothelial system (RES )) and efficiency in cellular 
internalization 
7
 . 
A common strategy employed to prepare a ferrofluid is to coat magnetic nanoparticles 
with either a surfactant, inorganic material or polymer 
8
. Surface coating may be also 
useful to improve nanoparticle biocompatibility as well as to permit a better drug 
conjugation and delivery to the target area. 
Magnetic particles offer a high potential for developing effective drug delivery systems. 
In general, when drugs are systemically administered only a part of the active principle 
reaches the desired site owing to poor absorption and loss in metabolism. In addition, 
the drug dosage is critical in all therapies since the drug concentration must be included 
between the toxic and ineffective levels. The development of targeted release (TR) 
systems solves these drawbacks since the drug is release directly at the target site. 
                                                          
6
 Romberg B., Hennink W.E., Storm G., Pharm. Res., 2008, 25, 55–71. 
7
 Francolini I., Palombo M., Casini G., D'Ilario L., Martinelli A., Rinaldelli V., Piozzi A., J. Control. 
Release, 2012, 148, e57- e59 
8
 Raj K., Moskowitz B., Casciari R., J. Magn. Magn. Mater., 1995, 1-2, 174-180. 
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TR systems can be extremely useful for the treatment of diseases localized in specific 
body areas such as tumors 
9
 . Recently, magnetic nanoparticles have been also proposed 
for the treatment of microbial infections related to implantable medical devices 
10, 11
. 
These infections are caused by the formation of a sessile bacterial community, known as 
biofilm 
12
, on the device surfaces . Microbial biofilms are difficultly eradicable due to 
their high antibiotic resistance 
13
. The resistance to normal antibiotics that bacteria in 
biofilms exhibit respect to the planktonic counterpart can get up to 1000 times. 
This finding has been attributed to several factors. First of all, biofilms represent an 
ideal environment for plasmid exchange among cells. In fact, conjugation frequency 
appears to be higher in biofilm than in planktonic bacteria. This amplifies both naturally 
occurring and induced antibiotic-resistance phenomena. 
Other factors involved in the biofilm increased drug resistance 
14
 are i) slow and scarce 
penetration of antimicrobial agents through the biofilm matrix; ii) physiological 
response of microorganisms to the heterogeneous chemical environment existing in 
biofilms 
15
. In fact, the growth conditions in biofilms are quite different at lower layers, 
where nutrients and oxygen are limited, and microbial waste products can be toxic; for 
example, in the deep layers anaerobic niches are presumably present 
16
. These factors 
promote the development of different bacterial phenotypes, including drug-resistant 
ones. In addition, also nutrient depletion at lower layers by slowing bacterial growth 
rate can reduce the number of targets for antimicrobial molecules; iii) onset of 
                                                          
9 Alexiou C., Schmid R.J., Jurgons R., Kremer M., Wanner G., Bergemann C., Huenges V, Nawroth T., 
Arnold W., Parak F.G., Eur. Biophys J. , 2006, 35, 446–450. 
10
 Taylor E.N., Webster T.J., Int. J. Nanomed., 2009, 4, 145–152. 
11
 Taylor E., Webster T.J., Int. J. Nanomed., 2011; 6, 1463–1473. 
12
 Stoodley P., Sauer K., Davies D.G., Costerton J.W., Annu. Rev. Microbiol., 2002, 56,187-209. 
13 Ramage G., Mowat E., Jones B., Williams C., Lopez-Ribot J., Crit. Rev. Microbiol., 2009, 35, 340-355. 
14
 Lewis K., Curr. Top. Microbiol. Immunol., 2008, 322, 107-131. 
15
 Stewart P.S., Franklin M.J., Nat. Rev. Microbiol., 2008, 6, 199–210. 
16
 Borriello G., Werner E., Roe F., Kim A.M., Ehrlich G.D., Stewart P.S., Antimicrob. Agents Chemoter., 
2004, 48, 2659–2664. 
107 
 
subpopulations of persistent or dormant bacterial cells in a spore-like, non-dividing state
 
17
. 
Therefore, once the biofilm is established, antibiotic treatments for its eradication 
usually fail. In case of medical device-related infections, the surgical removal and 
replacement of the infected device is needed. This involves serious inconvenience for 
the patient and increases in hospital costs.  
The localization of magnetic nanoparticles releasing antimicrobial agents (alone or in 
combination with quorum sesing-interfering agents and biofilm-matrix disaggregating 
enzymes) at the infected area surrounding the implanted medical device has emerged as 
a novel promising strategy to potentiate the activity of the employed antimicrobial 
agents against the biofilm.  
In this study, manganese ferrite nanoparticles were obtained by coprecipitation of Fe
3+
 
and Mn
2+
 from water-in-toluene micelle system. Magnetic nanoparticles were coated 
with pAcDED an amorphous and water-soluble polymer, bearing tertiary amino groups 
18
. These groups, besides providing the polymer with intrinsic antimicrobial activity, 
can be employed for the adsorption of drugs with acidic properties by establishing acid-
basic interactions. In addition, the pAcDED  hydrophilic shell attached to the MNPs can 
contribute to avoiding MNPs recognition by mononuclear phagocyte system, thus 
prolonging their circulation time into the bloodstream. 
To evaluate the ability of pAcDED-coated MNPs to adsorb and release drugs, usnic 
acid was chosen as a model drug due to both its chemical features, enabling it to 
establish acid-base interactions with pAcDED, and its antimicrobial and antitumoral 
activity. In fact, usnic acid has a good activity against planktonic Gram-positive 
                                                          
17
 Lewis K., Nat. Rev. Microbiol., 2007, 5, 48–56. 
18
  Francolini I., Taresco V., Crisante F., Martinelli A., D’Ilario L., Piozzi A., Int J Mol Sci., 2013; 14(4), 
7356-7369. 
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bacteria, 
19, 20
 such as Staphylococcus epidermidis, S. aureus, Enterococcus faecalis, 
Mycobacterium tuberculosis, and some pathogenic fungi 
21
 .
 
This drug was also recently 
shown to be able to prevent biofilm formation by Staphylococcus spp. when 
incorporated in polyurethanes 
22, 23
 or in bone cements 
24
. Therefore, usnic acid is under 
investigation for the prevention of medical device-related infections as an antimicrobial 
agent to be adsorbed on the surface of medical devices in alternative to conventional 
antibiotics 
25
. 
Besides antimicrobial activity, usnic acid also possesses anticancer properties. Its 
antiproliferative activity was first reported against lung carcinoma 
26
 and then 
demonstrated against a wide variety of human cancer cell lines 
27, 28
. 
Despite these recognised features, usnic acid therapeutic application has not yet been 
introduced due to its low water solubility and high hepatotoxicity
29, 30
.
 
Thus, its use in a 
safe and efficient manner requires the development of suitable dosage forms able to 
improve its therapeutic index.  
Moreover, since one of the main issue related to the use of antimicrobial agents is the 
development of drug resistant bacteria, employing pAcDED-coated core-shell MNPs 
loaded with usnic acid could overcome this problem by exerting a synergistic effect in 
                                                          
19
  Lauterwein M., Oethinger M., Belsner K., Peters T., Marre R, Antimicrob. Agents Chemother. 1995, 
39, 2541-2543. 
20
  Ramos D.F. and Almeida da Silva P.E., Pharm. Biol. 2010, 48, 260-263. 
21
  Pires R.H., Lucarini R., Mendes-Giannini M.J., Antimicrob. Agents Chemother. 2012, 56, 595-597. 
22
  Francolini I., Norris P., Piozzi A., Donelli G., Stoodley P., Antimicrob. Agents Chemother. 2004, 48, 
4360-4365. 
23
  Labib M.E., Brumlik C.J., Stoodley P., Dukhin S.S., Davidson T., Tabani Y., Colloids Surf. A 
Physicochem. Eng Asp. 2010, 254, 331-337. 
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 Kim S., Greenleaf R., Miller M.C., Satish L., Kathju S., Ehrlich G., Post J.C., Sotereanos N.G., 
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452. 
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27  Song Y., Dai F., Zhai D., Dong Y., Zhang J., Lu B., Luo,J., Liu M., Yi Z., Angiogenesis. 2012,  
28
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bacterial killing. Indeed, the most pursued strategy to reduce the drug resistance is the 
combined use of antimicrobial agents having different mechanisms of action. In our 
case, the positively charge polymer can adsorb on the negative charged bacterial 
membrane provoking cell disruption while usnic acid can inhibit bacterial metabolic 
functions. 
The activity of usnic acid-loaded, pAcDED-coated MNPs was evaluated against 
Staphyloccoccus epidermidis. The results were compared to those obtained by the use of 
MNPs coated with a star branched hydrophobic polymer based on polycaprolactone 
31
. 
 
3.2 Materials and Methods 
3.2.1 Preparation of magnetic manganese ferrite nanoparticles (MnFe2O4) 
 
Manganese ferrite nanoparticles were synthesized by coprecipitation of Fe
3+
 and Mn
2+
 
from a water-in-toluene micro-emulsion system followed by thermal treatment as 
previously described 
27
. Briefly, 12.5 mL of a 0.4 M sodium dodecyl benzene sulfonate 
(NaDBS, Aldrich) solution were added to 11.5 mL of a water solution containing 0.4 M 
Fe(NO3)3 (Fluka) and 0.2 M Mn(NO3)2 (Fluka). Later, excess toluene (1:20 
water:toluene volume ratio) was added to the mixture and the resulting microemulsion 
was stabilized by stirring for 24 h. Finally, 20 mL of 1 M NaOH solution (in 
stoichiometric amount to obtain MnFe2O4) were added to the microemulsion under 
nitrogen flow to avoid Mn
2+
 oxidation. After 2 h stirring, the microsuspension was kept 
at 100 °C for 90 min under nitrogen flow (digestion process). Then, the precipitated 
powder was collected by centrifugation and repeatedly washed with a 1:1 water/ethanol 
                                                          
31 Yanga J., Parkb S.B., Yoonc H.G., Huhd Y.M., Haama S., International Journal of Pharmaceutics, 
2006, 324, 185-190. 
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solution. The obtained dark brown powder was first dried at 40 °C and then submitted 
to a thermal treatment in oven at 600 °C. The employed procedure allowed the 
obtainment of magnetic nanoparticles (MnFe2O4) with a mean size of 6 nm and a 
saturation magnetization of 29 emu/g 
32
. 
 
3.2.2 Polymer synthesis 
 
To obtain magnetic nanoparticles with different surface properties, MnFe2O4 were 
coated with either a hydrophilic basic polyacrylamide (pAcDED) or a hydrophobic star-
branched poly--caprolactone (sbPCL).  
The polyacrylamide pAcDED was synthesized as previously described 
18 
. The polymer 
was obtained by radical polymerization of the monomer AcDED obtained by reaction 
between acryloyl chloride (Ac, Sigma) and N,N-diethylethylendiamine (DED, Sigma), 
as described elsewhere.  Briefly, for monomer synthesis DED (0.029 moles) was added 
to a solution of Ac (0.038 moles) in dimethylcarbonate (DMC, 75 ml) containing 
K2HPO4 (0.08 moles). The reaction was carried out for 4 h at room temperature. After 
reaction, the solution was filtered and AcDED recovered by solvent evaporation. 
The polymerization was carried out at 25 °C for 24 h by using a 1 M water solution of 
AcDED and K2S2O8 (2.8x10
-4
 mmoles) plus FeSO4 (2.4x10
-4
 mmoles) as radical 
initiators. The polymer was purified by dialysis and recovered after lyophilization. The 
obtained polymer possessed Mw = 120000 g/mol 
18
. 
The star-branched poly--caprolactone was obtained by ring opening polymerization 
(ROP) of -caprolactone (CL, Sigma) by using tetraethylenepentamine (TEPA, Fluka) 
                                                          
32  Bellusci M., Canepari S., Ennas G., La Barbera A. Padella F., Santini A., Scano A., Seralessandri L., 
Varsano F., J. Am. Ceram. Soc., 2007,  90, 3977-3983. 
 
111 
 
as a polyfunctional initiator (5 reactive functionality) and Sn(Oct)2 as a catalyst (0.1% 
with respect to monomer). The length of polymer arms was varied by employing 
different [CL]/[TEPA] molar ratios ranging from 2 to 100. ROP reaction was carried 
out at 110 °C for 24 h, under stirring and nitrogen flow. Nitrogen flow was needed to 
have the anhydrous environment and avoid the water to act as an initiator of 
polymerization. Acronym of the synthesized polymers was sbPCLn, where n the 
obtained arm length. In this work, only the most hydrophobic polymer (sbPCL50) 
having longer arms with the same length was chosen. 
 
3.2.3 MNPs coated with pAcDED 
 
Nanoparticle coating with pAcDED was carried out by employing two methodologies: 
i) physical adsorption and ii) in situ microemulsion-polymerization and cross-linking. 
As for the first method, nanoparticles (50 mg) were put in contact with a pAcDED 
water solution (1x10
-3
 M) for 24 h under sonication. Then, the coated nanoparticles 
were recovered by centrifugation, repeatedly washed in water and dried. The 
nanocomposite was called pAcDED-MnFe2O4. 
As for the second coating procedure, the monomer AcDED was first physically 
adsorbed onto the nanoparticle surface and then polymerized and cross-linked by N,N 
methylenebisacrylamide (Bis-A, Sigma). Particularly, 50 mg of nanoparticles were 
suspended by sonication in 1 mL of AcDED water solution (10 mg/mL) and kept in 
aqueous environment for 6 hr. This suspension was added to a solution of sorbitan 
monoleate (SPAN80 2 mg) in 40 ml of ciclohexane. Once reached a stable emulsion 
under stirring at 15000 rpm, Bis-A (1 mg) and K2S2O8 (1 mg) were added. 
Polymerization and cross-linking was carried out at room temperature under stirring for 
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15 min, till disappearance of double bond absorbance in ATR-IR (Attenuated total 
reflection infrared spectroscopy) spectrum.  
The coated nanoparticles were recovered by centrifugation and washed with water to 
eliminate the unreacted monomer and the not-physically adsorbed polymer. This 
nanocomposite containing pAcDED cross linked was called pAcDEDCL-MnFe2O4. 
 
3.2.4 MNPs coated with sbPCL 
 
The adsorption of the hydrophobic polymer sbPCL50 on ferrite surface was carried out 
by suspending 50 mg of nanoparticles in THF and by adding a 1x10
-3
 M sbPCL50 
solution in THF. After 24 hr under sonication, the coated nanoparticles were recovered 
by centrifugation and submitted to repeated washings in THF and water to eliminate the 
unbound polymer. Finally, the sbPCL50 coated nanoparticles were dried under vacuum 
at 40 °C. The nanocomposite was called sbPCL50-MnFe2O4. 
 
3.2.5 Characterization of the core-shell nanocomposites 
 
Attenuated total reflection infrared spectroscopy (ATR-IR) was accomplished by using 
a Thermo Nicolet 6700 instrument equipped with a Golden Gate diamond single 
reflection device (Specac). Spectra were acquired with a resolution of 2 cm
-1
, in the 
range 4000-650 cm
-1
. 
Thermogravimetric analysis was carried out employing a Mettler TG 50 thermobalance, 
provided with the same TC 10 A processor. The explored temperature range was 25 - 
600 °C, and the heating rate 10 K/min, under N2 flow.  
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Size distribution of nanoparticles was assessed by a Laser Diffraction Particle Size 
Analyzer (LS 13320, Beckman Coulter) while their morphology was investigated by 
scanning electron microscopy (SEM, Assing LEO1450VP). 
 
3.2.6 Usnic acid loading and release 
 
Due to the poor solubility of usnic acid (UA, 344.315 g/mol) in water, a sodium salt of 
the drug was prepared by adding NaOH (0.1 N) to a UA solution in a 3.5/1 NaOH/UA 
molar ratio. 
For UA adsorption, either uncoated or coated MNPs were kept in contact for 24 h with a 
0.015 M drug solution under moderate stirring. Later, UA not adsorbed to the 
nanoparticles was rinsed out with water, lefting it in contact with the nanoparticles for 2 
h. The amount of adsorbed drug was determined as the difference of drug concentration 
in the solution before and after the adsorption plus washings. Drug amount in solution 
was determined by UV-Vis spectroscopy (290 nm). The kinetics of drug release was 
studied by keeping drug-loaded nanoparticles in water for increasing times. At defined 
times, aliquots of solution were collected and analyzed by UV-Vis spectroscopy.  
 
3.2.7 Evaluation of antimicrobial activity of UA-loaded MNPs 
 
For biological assay, Staphylococcus epidermidis ATCC 35984 was grown in Triptic 
Soy Agar (TSA) and Tryptic Soy Broth (TSB). The antimicrobial activity of 
nanocomposites was assessed by the Kirby Bauer test. MH agar plates were seeded with 
10
8
 CFU/ml of S. epidermidis, cellulose discs were loaded with different concentrations 
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of various drug loaded MNPs and then  placed in these Petri plates. Following 
incubation at 37 °C for 24 h, the diameters of inhibition zones of bacterial growth 
around the discs were measured. All the experiments were done in triplicate. Analysis 
of variance was performed using MiniTab. Differences were considered significant for 
P <0.05.  
 
3.3 Results and Discussion 
 
The coating of MNPs with a polymer shell does not only decrease MNPs aggregation 
and flocculation, but can be also exploited for functionalization with specific 
components, such as other functional groups, specific binding sites, or various drugs 
33
.  
To limit MNPs interaction with host-immune defences, different surface engineering 
have been proposed. Particularly, surface modification with hydrophilic molecules such 
as polyethylene glycol (PEG) 
34
, hyaluronic acid, polyvinyl alchool
35
, 
polyethyleneimine 
36
, dextran
37
 and chitosan
38
 have been shown to reduce MNPs 
opsonization through steric repulsion, thus prolonging circulation time. 
Hydrophobic/hydrophilic interactions have been proved to be useful when adsorbing 
hydrophobic drugs onto MNPs. For this application, MNPs have been engineered with 
hydrophobic layers, such as oleic acid
39
, to adsorb hydrophobic drugs 
39,40
. This strategy 
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has some drawbacks such as MNPs sensitivity to environmental conditions and low 
control over molecular orientation of bound ligands. 
In this study, MnFe2O4 were coated with either a hydrophilic basic polyacrylamide 
(pAcDED) or a hydrophobic star-branched poly--caprolactone (sbPCL50).  
Poly--caprolactone was chosen because it has good characteristics of biocompatibility 
and high thermal stability and is widely used in biomedical applications 
41, 42
. 
Additionally, the use of a hydrophobic polymer such as the PCL for covering MNPs 
could ensure a good affinity of UA for the nanostructured system, due to high drug 
hydrophobicity. 
A star branched PCL was obtained by ROP of of -caprolactone by using TEPA as 
polyfunctional initiator. Among the different experimented [CL]/[TEPA] molar ratios, 
the [CL]/[TEPA]=50 allowed obtaining a polymer with 5 arms and an experimental 
number-average degree of polymerization (DPn,exp) of 50 each. The use of lower molar 
ratios resulted in polymers with lower degree of branching (data not shown). Instead, 
when higher molar ratios were employed, a decrease in the DPn,exp was evidenced 
presumably due to possible degradation phenomena occurring during the synthesis (data 
not shown).  
The [CL]/[TEPA]=50 molar ratio permitted the obtainment of the best fitting between 
the experimental number-average molecular weight, determined by 
1
H-NMR (Mn-
NMR=27.600 Da), and the theoretical one calculated from the used [CL]/[TEPA] molar 
ratio (Mn- theoretical=28.700 Da). The occurred reaction was also confirmed by ATR-IR 
analysis. In addition, thermal analysis performed by differential scanning calorimetry 
                                                          
41 Hutmacher D., Hürzeler M.B., Schliephake H., Int. J. Oral. Maxillofac. Implants, 1996, 11, 667-678. 
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evidenced the semicrystalline features of sbPCL50. In particular, a melting peak with a 
temperature of 54°C was observed (thermogram not shown). 
pAcDED-coating was chosen both for its hydrophilicity and intrinsic antimicrobial 
activity displayed against S. epidermidis. In fact in a previously work 
18
, a MIC value of 
100 µg/ml was found for pAcDED against this strain. Furthermore in the same work,
 
it 
was highlighted as pAcDED was able to complex usnic acid by establishing polymer-
drug multipoint interactions thus promoting drug solubilization in water and increasing 
antimicrobial activity. 
To evaluate the success of MNPs coating, ATR-IR analysis was used. As can be 
observed in Figure 1, the uncoated magnetic nanoparticles show a strong peak in the 
range 850 cm
-1
 and 1000 cm
-1
 attributed to the metal-OH bond of the iron and 
manganese oxide skeleton, a peak between 1340 and 1650 cm
-1
 attributed to the H-O-H 
bending of the water adsorbed or entrapped in the structure, and a wide band between 
2500 and 3650 cm
-1
 attributed to the O-H stretching. 
The sbPCL50-coated MNPs spectrum showed, besides the ferrite signals, also the signals 
related to the polymer. Particularly, it can be observed the absorbance related to the 
stretching of polymer C=O groups (1720 cm
-1
) and the stretching (2800-3000 cm
-1
) and 
bending (1450-1100 cm
-1
) of the polymer CH2 groups (Figure 1A). 
ATR-IR spectrum of the pAcDED-MnFe2O4 sample displayed the peak relative to the 
stretching of the amide C=O at 1650 cm
-1
, the absorption at 1550 cm
-1
 related to the 
stretching and bending of amide C-N,  and the peak at 1100-1450 cm
-1
, related to the 
bending of the CH2 (Figure 1B). 
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Figure 1. ATR-IR spectra of uncoated MnFe2O4 nanoparticles, sbPCL50 polymer and 
sbPCL50-MnFe2O4 nanocomposite (A); uncoated MnFe2O4 nanoparticles, pAcDED 
polymer and pAcDED-MnFe2O4 nanocomposite (B). 
 
SEM analysis showed that MNPs were spherical, with a narrow size distribution and a 
average size of about 30 nm, but arranged in aggregates (Figure 2A). SEM micrographs 
of nanocomposites (Figure 2B and C made at 15k magnification) showed that the 
polymer coating increased the size of the nanoparticles up to about 50-60 nm. Also, it 
could be observed that the coated-nanoparticles appeared more separated than the ferrite 
alone 
43
. This latter finding confirms the ability of positively charged polymers to de-
aggregate MNPs already reported in the literature for polyetylenimmine (PEI) that, 
when used for MNPs coating, was able to de-aggregate MNPs without re-aggregation in 
any pH conditions 
43
. The further advantage of using positively charged polymers for 
MNPs coating is that the net negative charge of MNPs can be neutralized thus 
permitting the loading of negative molecules, such as DNA and proteins.  
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 Wang X., Zhou L., Ma Y., Li X., Gu H., Nano Res., 2009, 2, 365-372.9 
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Figure 2. SEM micrographs of uncoated MNPs (A), sbPCL50-MnFe2O4 (B) and 
pAcDED-MnFe2O4 (C). 
 
In order to evaluate the coating content, Thermogravimetric Analysis (TGA) and 
Derivative Thermogravimetric Analysis (DTGA) were used, given that these techniques 
have been reported to be suitable for assessing presence of polymer coating 
44, 45
. In 
Figure 3 the TGA and DTGA curves of uncoated MnFe2O4 are reported. As it can be 
observed, the uncoated magnetic nanoparticles present a slight loss (10%) between 25 ° 
and 250 ° C corresponding to water either weakly adsorbed or strongly linked to oxide 
structure. This loss in weight is gradual and continues up to 600 ° C (Figure 3). 
                                                          
44
 Osuna Y., Jauregui K.M.G., Gaona-Lozano J.G., de la Garza-Rodríguez I.M., Ilyna A., Díaz Barriga-
Castro E., Saade H., López R.G., Journal of Nanomaterials, 2012, 2012, 1-7. 
45
 Juríková A., Csach K., Mikuf J., Koneracká M., Záviová V., Kubovíková M., Kopanský P., ACTA 
PHYS. POL. A, 2012, 121, 1296-1299. 
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As for the nanocomposite sbPCL50-MnFe2O4 (Figure 4), the loss in weight in the 
temperature range of 30-110 ° C (about 13%) was attributed to weakly bound water, 
while the second gradual loss in the range of 150-300 ° C to polymer degradation. This 
latter loss in weight was of about 20 %. 
Also for the pAcDED-MnFe2O4 sample (Figure 5), having the first weight loss related 
to bound water (about 13%) at about 100 °C, a more complex polymer degradation 
between 130 ° C to 550 ° C corresponding to about 20% was observed. The 
nanocomposite with cross linked pAcDED (pAcDEDCL-MnFe2O4) showed the same 
percentage losses of the pAcDED-MnFe2O4 (thermogram not shown). 
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Figure 3. Uncoated MnFe2O4 TGA and DTGA curves. 
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Figure 4. sbPCL50-MnFe2O4 TGA and DTGA curves. 
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Figure 5. pAcDED-MnFe2O4 TGA and DTGA curves. 
 
After physical characterization, the MNPs were subjected to drug adsorption. Generally, 
drug stability in vivo as well as adsorption by target tissues can be greatly improved by 
the use of targeted-release systems. In fact, these delivery systems can permit efficient 
pharmacokinetics and offer protection for easily degradable molecules, such as 
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peptides, proteins and nucleic acids that usually have short in vivo half-lives 
46
. In 
addition, an appropriate nanoparticle coating can permit a higher drug loading with 
respect to uncoated nanoparticles and a suitable drug release. In particular, hydrophilic 
coatings can enhance drug loading thanks to their good swelling in water and ability to 
establish hydrogen bonds with drugs 
47
. Moreover, by introducing a polymer shell with 
functional groups, such as amino groups, it is possible to conjugate targeting ligands 
thus providing a controlled and persistent release 
46
. 
 
Sample (mgUA/mgMNPs) 
 
uncoated-MnFe2O4 
 
0.22± 0.04 
sbPCL50- MnFe2O4 0.49 ± 0.07 
pAcDEDCL- MnFe2O4 0.48 ± 0.05 
pAcDED- MnFe2O4 0.62 ± 0.02 
  
 
Table 1. Usnic acid loaded amount. 
 
Usnic acid was loaded on both the uncoated and coated MNPs. Usnic acid loaded 
amount was expressed as mgdrug / mgMNPs ratio. The values are the result of arithmetic 
averages performed on at least four loading experiments. 
As can be observed from data reported in Table 1, uncoated MNPs absorbed a small 
amount of drug compared to coated MNPs. Particularly, pAcDED-MnFe2O4 sample 
                                                          
46
 Chronopoulou L., Massimi M., Giardi M.F., Cametti C., Devirgiliis L.C., Dentini M., Palocci C., 
Colloids Surf. B, 2013, 103, 310-317. 
47
 Francolini I., Palombo M., Casini G., D'Ilario L., Martinelli A., Rinaldelli V., Piozzi A., J. Control. 
Release, 2012, 148, e57- e59. 
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showed greater loading of drug. In this case, probably, the drug can also penetrate from 
the surface up to the inner layers due to the significant swelling of the polymer. This 
hypothesis can be confirmed by comparing the data of pAcDED-MnFe2O4 which those 
of pAcDEDCL-MnFe2O4. The less amount of drug adsorbed by the latter system is 
probably due to the formation of a more compact structure that prevented drug diffusion 
into the underlying polymer layers thus allowing a more superficial drug adsorption (as 
shown by TGA data the amount of polymer in the two nanocomposites was the same). 
As for sbPCL50-MnFe2O4, the discrete absorbed drug amount can be ascribed to the 
high drug affinity for this hydrophobic material. 
In general, drugs to perform their action must be released into biological fluids. In our 
case such release is ensured by the lack of a covalent bond between the nanocomposite 
and the sodium usniate.  
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Figure 6. Usnic acid release kinetics of each nanostructured sample. 
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From the kinetics (Figure 6), it can be observed that the nanocomposite pAcDEDCL-
MnFe2O4 released more than 90% of drug in 24 h as a demonstration of a drug 
absorption on the surface polymer layers. 
In the case of pAcDED-MnFe2O4, the lower quantity of released drug in 24 h (about 
65%) is probably due to a diffusion controlled release exerted by acid-base interactions 
established between the tertiary amine groups of the polymer and the acidic OH groups 
of the drug. Among the nanocomposites, sbPCL50-MnFe2O4 showed the minor release 
probably due to the poor hydrophilicity of the polymer matrix. However, all systems 
reached the plateau in 24 h. 
To confirm that the interaction forces between nanocomposites and usnic acid 
controlled the drug diffusion and release, a defined amount of nanoparticles were 
embedded on cellulose disks in order to have an equal content of usnic acid (1 mg) for 
all systems. Such systems were then subjected to Kirby-Bauer assay. In this test, the 
size of inhibition zone is due to the diffusion of drug released amount. This amount 
depends on drug-nanocomposite interactions. 
 
     Sample Inhibition zone (mm)   
 
      uncoated- MnFe2O4 
 
22 ± 3 
  
      sbPCL -MnFe2O4 18 ± 3   
      pAcDEDCL-MnFe2O4 11 ± 4   
      pAcDED-MnFe2O4   6 ± 2   
 
 
Table 2. Inhibition zones of uncoated and coated MNPs before release kinetics. 
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In Table 2, the inhibition zones of nanocomposites and uncoated-MnFe2O4 are reported. 
The high zones of inhibition observed for MNPs and sbPCL50-MnFe2O4 indicated a 
poor interaction between the matrices and the drug. On the contrary, the lower 
inhibition zones observed for the two nanocomposites based on pAcDED demonstrated 
strong ionic interactions between UA acid groups and polymer tertiary amine groups. In 
addition, the higher inhibition zone measured around pAcDEDCL-MnFe2O4 confirmed 
the hypothesis of drug adsorption only on surface polymer layers, then more superficial 
with respect to the pAcDED-MnFe2O4. 
To verify the potential use of these systems in vivo, it must be considered that when 
drug-loaded ferrofluids are administered in patients, in order to allow nanoparticles 
achieving the target site a magnetic field is externally applied for a sufficiently long 
period of time, generally ranging from 30 to 60 min 
48
. Once the drug is released, 
nanoparticles are degraded and excreted by the body. At this aim, evaluations of the 
drug released from the systems at 30 and 60 minutes were performed (Table 3).  
 
 
 
 
 
 
 
                                                          
48  Alexiou C., Schmid R.J., Jurgons R., Kremer M., Wanner G., Bergemann C., Huenges V, Nawroth T., 
Arnold W., Parak F.G., Eur. Biophys J. , 2006, 35, 446–450. 
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Sample 
mgUA/mgMNPs 
30 min 
mgUA/mgMNPs 
60 min 
 
 
Uncoated- MnFe2O4 
         
        0.04 ± 0.01 
       
      0.05 ± 0.005 
 
sbPCL - MnFe2O4         0.09 ± 0.01       0.12 ± 0.04  
pAcDEDCL-MnFe2O4         0.11 ± 0.04       0.21 ± 0.02  
pAcDED-MnFe2O4         0.11 ± 0.03       0.14 ± 0.02 
 
Table 3.  Drug release after 30 and 60 minutes. 
 
As it can be observed the nanocomposites based on pAcDED released drug amounts 
higher than uncoated and sbPCL50-coated MNPs. In addition, since at 60 min 
pAcDEDCL-MnFe2O4 released the highest drug quantity (0.21 ± 0.07 mgUA/mgMNPs), 
this system seemed to be the most suitable for drug targeting.  
In particular, these drug-loaded MNPs could be used either for the prevention or for the 
treatment of medical device-related infections. In fact, they could be injected in the 
patient soon after device implantation, to prevent biofilm formation, or, later, in 
presence of signs of infection, to kill the biofilm grown on the device surfaces.  
The significant drug amount released in 60 minutes by pAcDEDCL-MnFe2O4 is 
encouraging for a successful biofilm eradication. In fact, the treatment protocol adopted 
in clinical studies for cancer patients 
49, 50, 51, 52
 consists in the injection of about 50 ml of 
ferrofluid (0.5-1% total blood volume), at a concentration of 10-20 mg/ml, containing 1-
3 mg of drug / kg of patient. If we hypothesize a similar treatment protocol for patients 
                                                          
49
 Lubbe A.S., Alexiou C., Bergemann C., J Surgical Res., 2001, 95, 200-206. 
50
 Bjornerud A., Johansson L.O., Ahlstrom H.K., Magn. Reson. Mater. Phy, 2001, 12, 99-103. 
51
 Lubbe A.S., Bergemann C., Brock J., McClure D.G., J Magn. Magn. Materi., 1999, 194, 149-155. 
52
 Lubbe A.S., Bergemann C., Cancer Res., 1996; 56, 4686-4693. 
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suffering from a localized infection caused by staphylococci, an extremely high dose of 
antimicrobial agent, approximately 1000 times higher than the usnic acid MIC (16 
μg/ml), can be concentrated in the infected area surrounding the medical device. This 
opens interesting perspective for a potential future in vivo application of the developed 
UA-loaded pAcDEDCL-MnFe2O4 system. 
 
 
3.4 Conclusions 
 
In order to increase MNPs biocompatibility and circulation time in blood as well as to 
provide them with functional groups able to interact with biologically active substances, 
manganese ferrites were coated with hydrophilic and hydrophobic polymers. The 
hydrophilic and water-soluble polymer pAcDED, bearing tertiary amino groups, should 
have allowed nanostructured systems exerting antimicrobial action and binding an 
antimicrobial drug by ionic interactions (usnic acid). The combination of two 
antimicrobial agents should contribute to prevent the development of drug resistant 
bacteria. MNPs coating with a novel star-branched polymer based on poly--
caprolactone should have only increased UA loading thanks to its hydrophobic features.  
To demonstrate that nanocomposites could be potentially used to target a drug at a 
specific body site, usnic acid was adsorbed on the surface of uncoated and coated 
MNPs. The amount of drug adsorbed on nanocomposite was higher than uncoated 
MNPs. This phenomenon was accentuated in presence of hydrophilic matrices. The 
hydrophilic features also affected the release kinetics of nanostructured systems. Indeed, 
MNPs coating with polymers based on pAcDED, either crosslinked or not, besides 
increasing the amount of released drug, controlled drug release by establishing strong 
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ionic interactions between UA acid groups and polymer tertiary amine groups, as 
evidenced by Kirby-Bauer assay. In addition, findings regarding the UA release 
indicated that pAcDEDCL-MnFe2O4 could be the most suitable system for drug targeting 
thanks to the greater presence of the drug on the polymer surface.
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CHAPTER IV 
 
SYNTHESIS OF AN ACRYLIC-BASED POLYESTER BEARING 
CATECHOLIC MOIETIES WITH ANTIOXIDANT AND 
ANTIMICROBIAL PROPERTIES. 
 
4.1. Introduction 
Implanted biomedical devices are of increasing importance in modern medical care. 
Different materials, generally inert and non-toxic, including metals, ceramics and 
polymers are used for manufacturing of these devices. However, since the biological 
response to material is related to its surface features, to avoid the device failure the 
chemical, physical, and morphological properties of biomaterial must be carefully 
considered 
1, 2, 3
 . 
The foreign body reaction includes a cascade of cellular events such as protein 
adsorption, adhesion and activation of immune cells, fibrosis and infection
4
. In 
particular, material-mediated inflammatory responses induce the production of reactive 
oxygen species (ROS) which besides contribute to oxidative degradation of material 
itself  
5
.  
ROS including hydroperoxide, hypochloride, hydrogen peroxide and hydroxyl anions, 
are released by activated phagocytes together with other molecules having killing and 
degradative activities 
6
. 
                                                          
1
 Tang L, Sheu MS, Chu T, Huang YH. Biomaterials, 1999; 20(15), 1365-1370 
2
 Gristina AG., Clin Orthop 1994, 298, 106-118 
3
 Balasubramanian V., Grusin N.K., Bucher R.W., Turitto V.T., Slack S.M., J. Biomed. Mater. Res., 
1999; 44(3): 253-260 
4
 Anderson JM, Rodrigez A, Chang DT., 2008; 20 (2), 86-100 
5
 Sutherland K, Mahoney 2nd JR, Coury AJ, Eaton JW., J. Clin. Invest., 1993; 92 (5): 2360-2367 
6
 Fialkow L, Wang Y, Downey GP., Free Radic. Biol. Med., 2007;42 (2): 153-164 
129 
 
The inflammatory reaction is beneficial if its effects are limited to the pathogen agents. 
The insufficiency of a component of the inflammatory reaction such as the production 
of ROS leads indeed to bacterial infections. On the other hand, an overproduction of 
ROS is deleterious because it leads to oxidative stress (imbalance of oxidants and 
antioxidants). High levels of free radical species can damage lipids, proteins, enzymes, 
carbohydrates, and DNA in cells and tissues. These damages are involved in many 
pathological conditions such as cancer, diabetes, cardiovascular and autoimmune 
diseases, and neurodegenerative disorders such as Alzheimer’s disease 7, 8, 9, 10 . 
To slow or inhibit the process of oxidative degradation, antioxidant substances such as 
superoxide dismutase, catalases, ubiquinol and glutathione are synthesized naturally in 
biological systems 
11
. 
Natural or synthetic polymers are better candidates for the development of medical 
devices thanks to their physico-chemical properties that allow to fulfill different 
applications. 
It is well known that polymers become more resistant to photo-oxidation reactions if 
small amounts of antioxidants are added. Taking this as a cue, many studies have shown 
that oxidative stress induced by body response to polymer device can be slowed down 
or suppressed by conjugation of antioxidant molecules to polymer matrix 
12, 13, 14, 15, 16, 17
 
. 
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Among antioxidants, cathecolic compounds have gained increasing research attention 
due to their ortho-diphenolic moiety that extends their biological activity from free 
radical scavangers to metal chelators. In this regard, hydroxytyrosol (HTy), the main 
natural polyphenolic compound occurring in virgin olive oil and in olive oil 
wastewaters, possesses important pharmacological potential related to its antioxidant, 
anti-inflammatory and antiplatelet aggregation activity. In addition, hydroxytyrosol and 
its derivates possess a strong chelating ability of metals and a broad-spectrum 
antimicrobial activity against a series of microorganisms including Staphylococcus 
epidermidis and aureus, Vibrio cholerae and Salmonella species 
18
. 
The chelating properties of catechols towards some metals such as iron (III), cadmium 
(II), copper (II) with high complexation constants are well known
 19
. A line of research 
in the environmental field concerning adsorption of metals by catechol has been 
developed for a long time 
20,21
. In addition, also polymer materials have been provided 
with a side chain containing the catechol group to be used as resins 
22
. 
The ability to form complexes with metals can be exploited in chelation therapy.
 
 An 
example is the study of L-DOPA complexes with some metals 
23
. Chelation therapy 
could be a promising therapeutic approach since metals are considered to be a 
pharmacological target for development of new therapeutic agents for 
neurodegeneration or cancer treatment. 
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Nut Rev, 2010 68, 191-206 
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Burlington House, London, 1964. 
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Indeed, while many neurodegenerative diseases as well as multiple sclerosis are 
associated with iron elevated levels, cancer patients show significantly high copper 
levels.  Copper during the process of metal cellular uptake, being a potent oxidant, is 
reduced from Cu (II) to Cu (I). 
In this work, to develop a multi-function polymer endowed with antioxidant and 
antimicrobial activity a novel hydroxytyrosol-based polyacrylate (pAcHTy) was 
synthesized. After physical characterization, the antimicrobial and antioxidant activities 
of pAcHTy as well as its chelanting ability for copper ions were evaluated. 
The scavenging and antibacterial properties tested toward 2,2-diphenyl-1-picrylhydrazyl 
(DPPH) and Staphylococcus epidermidis respectively, have demonstrated that the 
pAcHTy polymer can be employed in the field of medical devices as biomaterial able 
not only to suppress the oxidative stress but also to prevent infections frequently 
associated to the implant of medical devices. In addition, the high chelating capacity for 
copper ions shown by this polymer suggests a possible use of pAcHTy in chelating 
therapy. 
 
4.2.  Materials and Methods 
 
4.2.1 Materials 
 
Sodium metabisulphite was purchased from Carlo Erba. Tyrosol (2-(4-
Hydroxyphenyl)ethanol, Ty) was purchased from Wako Chemicals GmbH. Acrylic acid 
(AA), hydroquinone, potassium persulfate, sodium metabisulphite, p-toluensyulfonic 
acid (pTSOH), sodium dithionite, 2,2-Diphenyl-1-picrylhydrazyl (DPPH) were 
purchased from Sigma Aldrich as were all of other solvents and reagents. All chemicals 
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were of analytical grade and used as received. 2-iodoxybenzoic acid (IBX) was 
prepared in the laboratory as described in the literature 
24
. 2-(3′,4′-
dihydroxyphenyl)ethanol (Hydroxytyrosol, HTy) was prepared in the laboratory as 
described in the literature 
25
. Staphylococcus epidermidis, strain ATCC 35984, and 
Muller Hinton broth (MH, Oxoid) were employed for microbiologic tests. The methanol 
used for the antioxidant activity and tetrahydrofuran for the GPC analysis were of 
HPLC grade from Sigma Aldrich.  
 
4.2.2 Synthesis of poly 2-(3,4-hydroxyphenyl)ethyl acrylate 
 
The procedure to obtain the hydroxytyrosol-containing polymer is reported in the 
scheme 1. The first step consisted in the Fischer esterification of acrylic acid with 
Tyrosol (Ty) to obtain 2-(4-hydroxyphenyl)ethyl acrylate (AcTy) (product 1 in the 
Scheme 1). 
Particularly, Ty (0.1 mol) was dissolved in 75 ml of toluene in presence of 20 mg of 
hydroquinone and 750 mg of p-toluensulfonic acid (pTSOH). Then, acrylic acid (0.12 
mol) was added and the mixture was refluxed for 1.5 h in a flask equipped with Dean-
Stark apparatus. At the end of the reaction, the mixture was cooled and treated with 
sodium bicarbonate (6 g) and water (1.5 ml) until carbon dioxide evolution ended. The 
mixture was then dried with sodium sulfate anhydrous, filtered and toluene was 
removed under vacuum. 
                                                          
24
 Frigerio M., Santagostino M., Sputore S., J. Org. Chem., 1999, 64, 4537–4538. 
25 Applicant: Università degli Studi della Tuscia. Inventors/Applicant: Bernini R., Inventors: Mincione 
E., Barontini M., Crisante F. “Method for preparing hydroxytyrosol and hydroxytyrosol derivatives” 
Number: PCT/IB2008/000598. International Pubblication Number: WO2008/110908 A1, 2008.  b) J. 
Agric. Food Chem. 2008, 56, 8897–8904 
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In the second step, the monomer AcTy (1 mmol) was dissolved in a mixture 
water/acetone (1:1 w/w) and submitted to radical polymerization by employing 
potassium persulfate (0.03 mmol) and sodium disulfite (0.1 mmol). After stirring for 50 
min at room temperature, acetone was distilled off by heating at 60 °C. The reaction 
mixture was kept at 80 °C for 2 hr. At the end of reaction, a stable emulsion of 
nanoparticles of tyrosol-containing polymer (pAcTy) was obtained (product 2 in the 
Scheme 1).  This emulsion was then one-pot oxidized with 2-iodoxybenzoic acid (IBX, 
1.2 mmol) and then reduced by sodium dithionite (2 mmol) in order to obtain 
nanoparticles of the hydroxytyrosol-containing polymer (pAcHTy) (product 3 in the 
Scheme 1). After centrifugation at 3500 rpm for 15 min, water  was eliminated and the 
polymer was recovered and washed many times with deionized water to remove sulfur 
by-products of the reduction reaction. Finally, pAcHTy nanoparticles were dried in 
vacuum oven at 25 °C for 1 day.  
 
 
Scheme 1: pAcHTy synthesis. 
 
While the pAcTy polymer was soluble in some organic solvent such as 
tetrahydrophuran, chloroform and toluene, the pAcHTy polymer was totally insoluble in 
both water and normal organic solvent. 
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4.2.3 Characterization of pAcTy and pAcHTy polymers 
 
Size distribution of pAcTy and pAcHTy nanoparticles was assessed by a Laser 
Diffraction Particle Size Analyzer (LS 13320, Beckman Coulter), while their 
morphology was studied by scanning electron microscopy (SEM, LEO1450VP, 
Assing). For SEM observations, pAcHTy films were prepared by casting a THF 
polymer suspension on Teflon plates. Following solvent evaporation under vacuum at 
30 °C, round shaped discs were obtained. 
 
4.2.4 Evaluation of pAcHTy oxidation percentage 
 
To determine the pAcHTy oxidation percentage, 200 mg of polymer were placed in 
contact with 10 ml of 1M NaOH at room temperature for 48 hours. Later, the solution 
was acidified with 1M HCl. The aqueous solution was extracted three times with ethyl 
acetate and the organic phase was washed with saturated NaCl solution and 
subsequently with distilled water. The crude product was recovered and then analyzed 
by 
1
H-NMR.  
 
4.2.5 NMR spectroscopy and elemental analysis 
 
1
H-NMR spectra were performed employing a Varian XL 300 instrument and 
chloroform-d as solvent. All chemical shifts are expressed in ppm (δ scale). Elemental 
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analysis of the synthesized polymers was carried out by Carlo Erba EA 1110 instrument 
and data were reported as C, H, N, S percentages.  
Attenuated Total Reflection spectra (ATR) were acquired by employing a Nicolet 6700 
FT-IR spectrometer and a Golden Gate diamond single reflection device (Specac). The 
spectra were obtained by co-adding 200 interferograms in the range 4000–650 cm-1 at a 
resolution of 4 cm
-1
. 
 
4.2.6 Thermal analysis and GPC measurement  
 
Differential scanning calometry (DSC) analysis was performed from –100 to 200 °C 
under N2 flux using a Mettler TA-3000 DSC apparatus. The scan rate used for the 
experiments was 10 °C/min and the sample weight about 6-7 mg. Thermogravimetric 
analysis (TGA) was carried out employing a Mettler TG 50 thermobalance, at the 
heating rate of 10 °C/min, under N2 flow and in temperature range 30 - 500 °C.  
GPC measurements were carried out at 30 °C using a 150-C Waters GPC apparatus 
equipped with a differential refractive index detector. The calibration curve was 
obtained by using 9 standard monodisperse polystyrene samples of known molecular 
weight ranging from 1.3x10
3
 to 1.5x10
6
 g/mol. Two crosslinked polystyrene (PS) 
columns (Water Ultrastyragel) which were able to separate in the range 2x10
3–1x106 
g/mol (linear) and 200–3x104 g/mol were used. The time required for each analysis was 
30 min with a mobile phase flux of 1mL/ min. The transport solvent was HPLC grade 
chloroform (Fluka). 
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4.2.7 Evaluation of antimicrobial activity of monomer and polymers 
 
The antimicrobial activity of the acrylic monomer AcTy and pAcTy was assessed by a 
disk diffusion test by impregnating cellulose disks with compound solutions (1 mg/ml). 
MH agar plates were seeded with 10
8
 CFU/ml of S. epidermidis (ATCC 35984) and 
cellulose disks were placed in these Petri plates. Following incubation at 37 °C for 24 h, 
the diameters of inhibition zones of bacterial growth around the discs were measured. 
Antimicrobial activity of the pAcTy and insoluble polymer pAcHTy was also estimated 
by turbidimetric analysis. Briefly, various amount of polymer (5, 10 and 15 mg) were 
placed into test tubes containing 2 ml of S. epidermidis suspension having an optical 
density of 0.1-0.2 at 600 nm. A tube containing the bacterial suspension without 
polymer was used as control. Control and test tubes were then incubated overnight at 37 
°C. Since the amount of adsorbed light increases with an increase in cell population, the 
antimicrobial activity of the polymers was correlated to control tube. Analysis was 
repeated until absorbance reached that of the control tube. 
The evaluation of pAcHTy ability to control bacterial adhesion was also evaluated by 
scanning electron microscopy (SEM). Particularly, pAcHTy films, prepared by casting 
method, were put in contact with a bacterial suspension (optical density 0.1-0.2 at 600 
nm) and incubated overnight. Following incubation, films were washed twice with PBS 
(pH=7.4), fixed with 2.5% glutaraldehyde in 0.1 M PBS buffer (pH 7.4) at room 
temperature for 30 min, dehydrated by dipping with different concentrations of ethanol 
(30, 50, 70, 90 %) for 5 min and with  hexamethyl disilazano for 30 seconds. For SEM 
observations, samples were gold coated by sputtering. 
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4.2.8 Antioxidant activity 
 
The antioxidant activity of hydroxytyrosol and polymer pAcHTy was determined by 
using DPPH as free anionic radical 
26
. For each antioxidant compound, different 
concentrations were tested (expressed as the number of moles of antioxidant/mole 
DPPH). 
As for hydroxytyrosol, antioxidant solution in methanol (4 mL) was added to 10 mL of 
a 1.5 × 10
-4
 mol/L methanol DPPH solution. The decrease in absorbance was 
determined at room temperature at 520 nm after 30 min, time in which a plateau was 
reached. The amount of DPPH was evaluated from a calibration curve (absorbance vs. 
concentration). Then, for each concentration tested, the residual DPPH as a function of 
antioxidant agent/DPPH molar ratio was plotted. Antiradical activity was defined as the 
amount of antioxidant necessary to decrease the initial DPPH concentration by 50% 
(Efficient Concentration = EC50,  moles of antioxidant/mole DPPH). EC50 values were 
extrapolated from the graph. 
As for the pAcHTy antioxidant activity, due to polymer insolubility, measurements 
were performed by using the DPPH method with some modifications 
27
. 
Different amount of the powdered polymer were transferred into a vial, and the reaction 
was started by adding 60 mL of methanol and 20 mL of methanol DPPH solution (0.5 
M). The vials was stirred for 30 min to facilitate the surface reaction between the 
insoluble polymer and the DPPH reagent. Following centrifugation at 3500 g for 2 min, 
the absorbance of the optically clear supernatant was measured at 520 nm.  
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   Brand-Williams W., Cuvelier M. E., Berset C., Lebensm.-Wiss.u.,Technol., 1995, 28, 25-30. 
27
   Serpen A.,  Capuano E.,  Fogliano V., Gökmen V., J. Agric. Food Chem., 2007, 55, 7676–7681. 
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4.2.9 Copper adsorption kinetics  
 
The chelanting activity of pAcHty was evaluated versus copper ions. Particularly, 
copper adsorption kinetics were followed in batch at 20 °C by using 20 ml of a copper 
solution at a 350 ppm concentration containing 30 mg of pAcHty. To study the 
influence of pH and temperature on copper adsorption, experiments were performed at 
different pH and T, specifically in the range 2 and 8 for pH and  in the range 20 and 50 
°C for temperature. 
During test, solutions were kept in continuous magnetic stirring. At regular time 
intervals, 100 µl of solution were sampled, stored in a refrigerator at 5 °C and 
subsequently analyzed by Atomic Absorption Spectrophotometry (AAS) by a Shimadzu 
atomic absorption spectrophotometer AA-6300, with flame dual beam optical and range 
of wavelengths  between 185 and 900 nm. 
For analysis of solutions a flame continuous method was used. The combustion air/fuel 
mixture consisted of air and acetylene. Different standard solutions of copper were used 
for calibration. 
The amount of metal ion adsorbed was determined by the equation: 
 
    
      
         
 
      
  
 
        
        
 
 
while the efficiency of the treatment was assessed by the percentage removal: 
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Where C0 is the initial concentration of the solution and C the concentration of the 
solution at  the different sampling times.  
To evidence the affinity of copper towards pAcHTy polymer, after the adsorption cycle 
a desorption cycle was performed by putting in contact the copper ion-containing 
polymer with 20 ml of 0.1 HCl for 3 hr under stirring. Later, the supernatant was 
collected and 100 µl were taken and analyzed by AAS. 
Analysis of variance comparisons
 
were performed using MiniTab. Differences were 
considered significant
 
for P values of <0.05. Data were reported as means ±
 
1 SD.
 
 
 
 
4.3 Results and Discussion 
 
In the last two decades, there is increasing interest in cathecolic compounds thanks to 
their various biological activities related to the ortho-diphenolic moiety. Particularly, 
hydroxytyrosol, the main natural polyphenolic compound occurring in virgin olive oil 
and in olive oil wastewaters, possesses important pharmacological potential related to 
its antioxidant 
28, 29
, anti-inflammatory 
29,
 
30
 and antiplatelet aggregation activity 
31
, 
which may help the prevention of cardiovascular and neurodegenerative diseases. In 
addition, hydroxytyrosol and its derivates possess a strong chelating ability of metals. 
Given elevated copper and oxidative stress levels in a variety of malignances, including 
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 Torres de Pineto A., Penalver P., Morales J. C., Food Chem., 2007, 103, 55-61 
29
 Visioli F., Bellomo G. F., Galli C., Med. Res. Rev., 2002, 22, 65-75 
30
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31
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Cruz J. P., Br. J. Nutr., 2009, 101, 1157-1164 
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solid tumor and blood cancer, the use of copper chelating material as anti-angiogenic 
agent could be useful in cancer treatment 
32
.  
In the field of biomaterials, the oxidative stress resulting from tissue-material 
interaction plays a central role in the biological toxicity of many materials, including 
polymers and metals. Recently, it has been demonstrated that also polymers generally 
considered biocompatible can induce the oxidative stress response 
33, 34
. At this regard, 
the synthesis of antioxidant polymers could represent a new and promising strategy to 
tune the biological response thus improving material biocompatibility.  
In this study, a new antioxidant and antimicrobial polyacrylate containing 
hydroxytyrosol was synthesized. This dual-function polymer could be employed in the 
field of medical devices as a biomaterial able to suppress the oxidative stress biological 
response, to prevent infections frequently associated to the implant of medical devices 
35
 
as well as to reduce copper concentration in cancer patients 
36
. 
The obtainment of a hydroxytyrosol containing polymer was verified by FTIR and 
1
H-
NMR analysis. Particularly, the infrared spectroscopic analysis was useful for a 
qualitative confirmation of the occurred synthesis of the monomer AcTy and the 
corresponding  polymer pAcHTy. 
In the IR spectrum of the monomer AcTy (Figure 1), a band at approximately 3400-
3300 cm
-1
 relative to OH stretching can be observed. In addition, in the region between 
1730-1500 cm
-1
, the absorbance bands corresponding to the ester stretching C = O, the 
stretching of the double bond of the acrylic moiety and the stretching of the C=C 
                                                          
32
 Gupte A., Mumper R. J., Cancer Treatment Reviews, 2009, 35, 32-46 
33
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 Fu K., Pack D. W., Klibanov A. M., Langer R., Pharm. Res., 2000, 17, 100-106 
35
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belonging to the phenyl-ring are present. At 800 cm
-1
 a broad peak related to the 
bending in the plane and out of plane due to the aromatic CH is also observable. 
 
80012001600200024002800320036004000
AcTy
cm
-1
 
Figure 1. IR spectrum of the monomer AcTy 
 
In the IR spectrum of pAcHTy (Figure 2), the disappearing of the acrylic double bond 
peak at around 1410 cm
-1
 confirmed the successful of polymerization. 
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Figure 2. IR spectrum of pAcHTy 
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In Figure 3, the 
1
H -NMR spectrum of the monomer AcTy is reported. The obtainment 
of the monomer was confirmed by the presence of the resonance peaks at 4.3 ppm due 
to the CH2 adjacent to the ester oxygen and those in the range 5.8-6.4 ppm due to the 
protons of the acrylic moiety. These last signals were absent in the spectrum of the 
tyrosol-containing polymer pAcTy (Inset of Figure 3), thus confirming monomer 
polymerization.  
After oxidation and reduction, the polymer pAcHTy was obtained as an insoluble resin 
presumably caused by cross-linking of the quinones 
37
.
 
 
In literature, it has been highlighted that conjugate systems such as cinnamic acid can 
undergo free-radical polymerization obtaining thermoset resins 
38
. Also compounds 
containing phenolic groups were used for the preparation of chelating 
39
 or grafted 
40
 
insoluble polymer systems. Indeed, the phenolic group could be directly involved in 
the polymerization process forming a phenolic radical that undergoes a dimerization 
processes by reaction between OH and the aromatic ring 
41
. On the basis of these 
findings, it is possible to hypothesize that the polymerization mechanism may involve 
the reaction of both acrylic double bonds and OH of hydroxytyrosol leading to the 
formation of crosslinks. 
Therefore, the 
1
H-NMR spectrum of this sample (Inset of Figure 3) was recorded on the 
poor water soluble fraction. A variation of the integral intensities relative to the 
aromatic signals (6.4-6.6 ppm), due to the achievement of a metha-para- arrangement 
after reaction of the pAcTy (para-structure) with IBX and Na2S2O5, was observed.  
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38
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Figure 3. 
1
H-NMR of AcTy. In the inset, spectra of pAcTy and pAcHTy in the range 6-7 
ppm are reported. 
 
To determine the pAcHTy oxidation percentage, a de-esterification reaction was carried 
out under conditions described in Materials and Methods. Following de-esterification, 
the sample was submitted to 
1
HNMR analysis (spectrum not shown). A yield of 
oxidation of about 60% was determined. Elemental analysis confirmed the composition 
of the polymer repetitive units.  
DSC analysis evidenced that the synthesized polymers were mainly amorphous showing 
a glass transition at approximately 60 °C for pAcTy and 135 °C for pAcHTy (Figure 4). 
The higher glass transition temperature of pAcHTy is in agreement with the cross-
linking hypothesis 
42,
 
43
.  
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Figure 4. DSC curves of synthesized polymers 
 
To verify polymer thermal stability, thermogravimetric analysis (TGA) was carried out. 
The thermal profile of the two polymers (Figure 5) showed less stability of pAcHTy 
than pAcTy. The presence of two decompositions, one around 230 °C and the other at 
330 °C, in the pAcHTy, can be probably attributed to the coexistence of the two type of 
side residues, tyrosol and catechol moieties, that do not allow a good "packing "of the 
polymer chains. 
GPC analysis, performed only on the soluble polymer pAcTy, evidenced a molecular 
weight of pAcTy of about 5000 g/mol.  
Radical polymerization lead to a stable emulsion of pAcTy nanoparticles having an 
average size, measured by Laser Diffraction Analyzer, of about 60±5 nm. SEM 
observations, instead, showed nanoparticles possessing average size of about 400 nm 
(Figure 6), probably due to aggregation phenomena occurring during drying in vacuum 
oven. 
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Figure 5. TGA curves of synthesized polymers 
 
Indeed, the sample observed by SEM was obtained by preparing pAcHTy films by a 
solvent casting method. Breakable films were obtained showing differently colored 
surfaces: the face in contact with the teflon plate showed a white coloration while the 
face exposed to air a pale brown. This latter effect suggested a partially oxidation 
phenomenon. As can be observed from the figure 6, the film was made of spherical 
nanoparticles attached one another, with a rather narrow size distribution. 
The subsequent reaction of oxidation/reduction carried out on pAcTy did not 
significantly changed size and morphology of nanoparticles (data not shown).  
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Figure 6. SEM micrograph of pAcHTy nanoparticles. 
 
When submitted to disc diffusion test, AcTy monomer, pAcTy and pAcHTy polymers 
did not show any inhibition zone probably due to their poor diffusion in the agar. To 
evaluate the efficacy in the prevention of bacterial colonization and biofilm formation, 
pAcHTy films were observed by SEM after 24 hr of incubation with a bacterial 
suspension. SEM micrographs of the films evidenced a total absence of microorganisms 
(data not shown).  
The antimicrobial activity of pAcTy and water-insoluble pAcHTy nanoparticles was 
also assayed by turbidimetric analysis. Despite the totally insolubility in water of these 
polymers the absorbance of the bacterial solutions in contact with nanoparticles (test 
tubes) did not reached the value of the control tube in 24 hr of incubation. A MIC value 
of 2.5 mg/ml and 7.5 mg/ml against S. epidermidis for pAcHTy and pAcTy respectively 
was determined.  
Polyphenols possess biocide activity against a wide number of pathogenic bacteria 
44
. 
Oxidized polyphenols, such as hydroxytyrosol, also have inhibitory activity against 
bacterial growth. The MIC value reported in literature for hydroxytyrosol against the 
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Gram-positive (S. pyogenes and S. aureus) and the Gram negative bacteria (E. coli and 
K. pneumoniae) was of about 0.4 mg/ml 
45
. Since the antimicrobial activity of the 
insoluble pAcHTy was only due to surface functional groups, it is possible to 
hypothesize a lower MIC value in case of soluble polymers. In addition, taking into 
account the different molecular weight of the antioxidant polymer and hydroxytyrosol, 
the good MIC value found for pAcHTy suggests its potential use for prevention or 
treatment of bacterial infections. 
Oxidative stress may be ascribed to the unbalancing in the oxidant-antioxidant 
equilibrium, favoring the oxidant side 
28
. Oxidative stress has been associated to 
disorders such as cancer 
46
, diabetes mellitus 
47
, atherosclerosis 
48
 , neurodegenerative 
disorders such as Alzheimer’s disease and Parkinson’s disease 49, autoimmune disorders 
such as arthritis 
57
 and has also been indicated to be involved in aging 
50
.  
The antioxidant activity of HTy and pAcHTy was determined by using DPPH as free 
anionic radical. In the DPPH method, the reaction degree depends on hydrogen-
donating ability of antioxidant species.  
It has been well documented that cysteine, glutathione, ascorbic acid, tocopherol, and 
polyhydroxy aromatic compounds (e.g., ferulic acid, hydroquinone, pyrogallol, gallic 
acid) are able to reduce and decolorize 1,1-diphenyl-2-picrylhydrazine thanks to their 
hydrogen-donating capabilities 
51
 . 
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Also, synthetic and natural polymers modified with antioxidant molecules have been 
reported to have a good scavenging activity on DPPH radicals 
52, 53
. 
In our case, by plotting the residual DPPH percentage as a function of antioxidant 
agent/DPPH molar ratio, EC50 values of 0.18 ± 0.02 mmol HTy/mmol DPPH and 0.80 ± 
0.02 mmol pAcHTy/mmol DPPH were found (Figure 7). The less activity of PAcHTy 
than HTy is presumably due to insolubility of material that partially hampered 
interactions between DPPH and antioxidant polymer groups. The antioxidant activity 
found for pAcHTy was rather high compared to that reported in literature for modified 
natural or synthetic polymers 
52, 53
. 
 
Figure 7. Residual DPPH percentage as a function of pAcHTy/ DPPH molar ratio. 
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As previously mentioned, several studies have reported that in tumor patients copper 
levels are over the normal concentration threshold and that such high copper levels can 
be directly correlated to cancer advancement. In addition, transition metals (copper, 
iron) promote the production of ROS in biological systems. To play a positive action in 
the body, a good balance between ROS and endogenous antioxidants able to swallow 
the excess ROS is needed.  
Radicals can give chain reactions such as formation of superoxide anion (radical anion). 
The hydrogen peroxide is converted by catalase in H2O, but can also generate highly 
reactive hydroxyl radicals via the Fenton reaction. This reaction is catalyzed by Fe
 2 +
 or 
Cu
2+
, which can be generated by the same anionic radicals. An example of chain 
reaction is the lipid peroxidation, which leads to the fragmentation of lipids of cell 
membranes. In genetic diseases causing extremely low levels of cholesterol and 
triglyceride, deficiency of selenium and vitamin E, peroxidized radicals are able to 
reach vital structures such as DNA and mitochondria, thus creating damage sometimes 
irreversible. These diseases can however be modulate by chelating therapy with 
antioxidants that bind and remove iron and copper excess. In particular, therapies based 
on copper reduction by chelation are currently under investigation 
54, 55 
as alternative 
ways to develop new anti-cancer agents able to change oxidative-stress conditions.  
For these reasons, in this study the ability of the hydroxytyrosol-containing polymer 
pAcHTy to chelate copper ions was also evaluated.  
The amount of adsorbed metal at different pH is shown in Figure 7. The maximum 
copper removal percentage (Rem %) at different pH was 12 %, 65 % and 100% at 
pH=3, 6.5 and 8 respectively.                  
                                                          
54
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Figure 7. Kinetics of Cu
+2
 adsorption on pAcHTy at different pH.  
 
At all of the experimented pH, the equilibrium was reached in about 150 minutes. In 
fact, even after 24 hours of contact, the concentrations of the supernatant remained 
constant in all of cases. It should be noted that kinetics at pH 6,5 and 8 have a first 
plateau in the range of 15-120 minutes, probably due to the organization of surface 
groups complexing the metal. In particular, given the coexistence of phenolic and 
catechol groups, it can be assumed that the first metal complexation occurs with 
catechol groups while the second one with phenol groups. The structural variation of 
polymers induced by metals has already been highlighted in other studies 
56
. 
In general, pH significantly influences the ability of polymer to chelate copper ions. In 
our case, high pH values caused an increase in polymer ability to remove copper ions in 
solution. Probably this is due to deprotonation of catechol and phenol groups occurring 
at basic pH that make them available for adsorption of metal ions. 
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In fact, the hydrogen ion concentration is one of the factors affecting the adsorption 
capacity of a material. At acidic pH, [H3O
+
] ions can compete with the metal cations in 
the adsorption mechanism while, at alkaline pH, phenomena of precipitation of metal in 
the form of hydroxides can occur. 
Temperature is another factor affecting the polymer adsorption ability. To verify this 
effect, tests at different temperatures (20, 30, 40 and 50 °C) were carried out (Table 1).  
 
 
 
 
 
 
Table 1. Adsorption of Cu +2 by pAcHTy as a function of time. Operating conditions: 
30 mg of pAcHTy, 20 ml of 350 ppm copper, pH = 8. 
 
 
 
Knowing that     
 
 
  
   
 
  
   
  
  and plotting the ln x/M as a function of 1/T, the trend 
reported in Figure 8 was obtained.  
 
 
Temperature 
 (K) 
Time  
(min) 
Ce  
(ppm) 
Rim 
 (%) 
x/M  
(mg/g) 
ln  x/M 
293.15 150 0 100 217 5,38 
303.15 150 131 77 171 5,14 
313.15 150 241 57 126 4,83 
323.15 150 267 52 116 4,75 
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Figure 8.  Copper removed by pAcHTy as a function of temperature. 
 
From this curve, the values of ΔH ° and ΔS °, respectively, from the slope and the 
intercept of the straight line, can be obtained: 
 
Δ °
 
                                
Δ °
 
         
 
From these values, it can be stated that the process of copper adsorption by pAcHTy is 
exothermic. Indeed, the concentration of the adsorbed cations decreases with increasing 
temperature, and is spontaneous at low temperatures. The increase in temperature 
causes, probably, a structural change in surface making the OH catechol less available 
for the adsorption process. 
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In conclusion, the high radical scavenger activity and metal ion chelating ability, 
comparable to those of other phenolic-based polymers reported in literature,
 57, 58
 
demonstrate the potential application of pAcHTy in the medical field. 
 
4.4 Conclusions 
 
A novel hydroxytyrosol-based polyacrylate (pAcHTy) endowed with antioxidant and 
antimicrobial activity was synthesized. Since hydroxytyrosol is only produced by some 
chemical companies with not inexpensive prices, in this work the polymer was obtained 
by free radical polymerization of a monomer containing its precursor, Tyrosol (Ty). 
Hydroxylation of Ty phenol group in ortho position by IBX reagent, with a yield of 
60%, leaded to an insoluble polymer (pAcHTy) possessing nanometric size (about 60 
nm). Besides the strong antioxidant activity in DPPH assay, pAcHTy showed a good 
chelating activity with respect to Cu
2+
 ions. Such properties suggest that this polymer 
can be employed in the medical field to suppress the oxidative stress, to prevent 
infections frequently associated to the implant of medical devices as well as to reduce 
copper high levels in tumor patients. 
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CHAPTER V 
 
AMPHIPHILIC RANDOM COPOLYMERS AS ANTIMICROBIAL 
AND ANTIOXIDANT AGENTS. 
  
5.1 Introduction 
 
Increasing antibiotic resistance and development of medical device-related infections, 
caused by multiple bacterial species, require a continuous update in the strategies of 
microbial killing
1
. 
In addition, the bacterial and fungal cells grown embedded in microbial biofilms have 
resistance higher than to the planktonic ones
2, 3
.  
The efficacy of devices coated with various antimicrobial agents such as rifampicin, 
clindamycin, chlorhexidine and silver has been widely demonstrated
1, 4
. 
However, the main limitation related to these use of the drug-coated devices is the rapid 
release of the antimicrobial agent absorbed (in first hours from the implant) and as a  
consequent short antibacterial action. In addition, the low systemic antibiotic 
concentration reached in the patient after few days from the device implant can increase 
the risk for selecting of antimicrobial resistant strains. 
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A valid approach to prevent the emergence of resistant pathogens should require the use 
of two antimicrobial agents possessing different antimicrobial spectrum and mechanism 
of action
1, 5
. 
During the last decades, numerous efforts has been focused on the synthesis of 
antimicrobial polymers able to inhibit the bacterial adhesion or kill parasite cells. 
Mainly two strategies have been pursued to develop antimicrobial polymers: i) polymer 
impregnation/adsorption with antibiotics or other biocides; ii) polymer functionalization 
with groups exerting antimicrobial activity 
6
. 
In the first approach, the polymer acts as a carrier for one or more antimicrobial agent 
that once released from the polymer exerts its action (antimicrobial releasing polymer).  
Polymers able to adsorb high amount of antibiotics have been generally obtained 
through modifications of their surface with specific functional groups capable to interact 
directly with the drug 
5
. The binding of the active compound to the polymer offers the 
opportunity to extend the residence time of the drug within the body, limit problems of 
drug residual toxicity as well as increase the efficacy and selectivity of the drug.
 
 
In the second approach, bactericidal functionalities, such as phosphonium salts or 
quaternary amine compounds, are introduced in the polymer to obtain intrinsically 
antimicrobial polymers (biocidal polymers). 
Since quaternary ammonium compounds are by far the most useful antiseptics and 
disinfectants developed 
7, 8
, tertiary amine groups then quaternized have been introduced 
in the side chain of polymers, thus developing cationic polymers (polymer 
disinfectants).  
                                                          
5
 Ruggeri V., Francolini I., Donelli G., Piozzi A., 2007, J Biomed Mater Res A, 81, 287-298. 
6
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7
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8
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Polymer disinfectants bearing cationic quaternary ammonium salt (QAS) have been 
often modified with hydrophobic long alkyl chain capable of breaking the bacterial 
membrane 
9
. 
In literature, different derivatives of polyvinyl-pyridine, polyacrylates (or 
polyacrylamides), polyvinyl-alcohol (or polyphenols) and other polymers containing as 
side chain QAS modified with long hydrophobic chain have been reported 
6, 10, 11
. 
Although the antimicrobial moieties in these synthetic polymers have been designed to 
confer high selectivity and sensibility towards bacterial membranes respect to the 
mammalians ones, often they showed toxic effects even for human cells 
12,13
. 
For this issue, the synthesis of novel cationic and/or amphiphilic polymers obtained by 
employing hydrophobic monomers or neutral macromonomers to be copolymerized 
with the cationic monomers has been needed. 
Since three decades, a class of novel intrinsically antimicrobial polymers has been under 
investigation: host defense peptides.  
The host defense peptides 
14
, importants component of innate immune system, are 
released to counteract the invasion of pathogenic and virulent microorganisms by 
mammalian or plant cells. They are potent antibiotics possessing an unusual broad-
spectrum, antimicrobial activity and showing a lower onset of bacterial resistance 
compared to common drugs 
15
.   
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 Tiller J.C., Liao C.J., Lewis K., Klibanov A.M., Proc. Natl. Acad. Sci. USA, 98, 5981–5985. 
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157 
 
However, their application in the medical field as well as their marketing has been 
hampered by high manufacturing costs, partially unknown pharmacokinetics and high 
enzymatic deactivation 
16
. 
The understanding of the correlation between structural parameters and biological 
activity of the host defense peptides and synthetic polymer disinfectants allowed the 
development of  synthetic materials called peptido-mimetic antimicrobial polymers or 
amphiphilic cationic polymers (synthetic mimics of antimicrobial peptides SMAMPs) 
17, 18
. 
SMAMPs have emerged as promising candidates for the developments antimicrobial 
agents that not only show high efficacy but also are less susceptible to resistant 
development in the bacteria they target.  
Although, action mechanism of SMAMPs is still under debate, it is generally believed 
that they can exert their action by cell wall and/or membrane disruption, causing 
breakdown of the transmembrane potential, leakage of cytoplasmic material and then 
cell death
19,20
. 
It has been widely demonstrated that the key parameters which regulate the 
antimicrobial and hemolytic activity, for both the host defense peptides and synthetic 
polymers, are positive charge at neutral pH 
21,21
, low molecular weight 
22
, spatial 
arrangement 
23
 and amphiphilicity 
24, 25
.  
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To obtain antimicrobial amphiphilic cationic polymers from the common QAS's 
polymers, three different strategies have been employed: i) decreasing of polymer 
hydrophobicity via coupling with neutral hydrophilic moieties such as PEG 
26,27
, ii) 
modification of the nature of the hydrophobic groups 
 17
  and iii) variation of the ratio of 
cationic and hydrophobic side chains in random copolymers 
9, 28
.  
Many of these amphiphilic random and block copolymers showed a good antibacterial 
efficacy and low toxicity for human cells with respect to homopolymers 
17
. The poor 
toxicity of these copolymers has been attributed to an increase of their selectivity versus 
bacterial cells.  
The resistance to normal antibiotics which bacteria in biofilms exhibit compared to the 
planktonic counterpart can raise up to 1000 times
 1
.
  
This feature has been attributed to 
several factors such as poor drug penetration through the biofilm or exchange of 
plasmids and ROS 
29
 among the biofilm-associated microorganisms in order to increase 
the natural mutation phenomena.     
ROS including hydroperoxide, hypochloride, hydrogen peroxide and hydroxyl anions 
are released by activated phagocytes together with other molecules having killing and 
degradative activities 
30
. Such radicals are generated by reaction of ferrous ion (Fe
2+
) 
with hydrogen peroxide. In this process, known as Fenton reaction, the amount of 
radical produced is directly proportional to the concentration of iron or copper. 
An excess of cellular ROS contributes to the processes of aging 
31
 and is implicated in 
the development of cancer and chronic diseases, neurodegenerative and cardiovascular 
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diseases, such as ischemia, multiple sclerosis, atherosclerosis, cataracts, diabetes, 
hepatitis, Parkinson's disease, Alzheimer's disease, dermatitis and muscular dystrophy 
32, 33, 34, 35
. 
As previously mentioned, random amphiphilic cationic copolymers are very interesting 
to fight the emergent risk of microbial resistance. Generally, in these polymers, to 
achieve high antimicrobial activity, a suitable balance of hydrophobic content and 
cationic charges was obtained by employing a monomer containing in side chain 
primary or tertiary amines as cationic functionality, and a hydrophobic monomer 
without any activity. 
In this work, novel antimicrobial amphiphilic cationic polymers have been synthesized 
by copolymerization of two monomers one bearing a positive charge and the other one a 
hydrophobic compound possessing antimicrobial activity, in particular antioxidant 
activity. The development of polymer possessing both antimicrobial and antioxidant 
properties could represent a promising approach to reduce the emergence of drug 
resistant bacteria and better combat biofilm infections.  
Our group has recently synthesized a new acrylamide monomer (AcDED) by reacting 
acryloyl chloride (Ac) with N,N-diethylethylendiamine (DED)
36
. The radical 
polymerization 
37
 of this monomer possessing tertiary amine groups, allowed the 
synthesis of a water-soluble, intrinsically antimicrobial cationic polymer (pAcDED) 
38
.  
In order to obtain a material with also antioxidant properties, the monomer AcDED 
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were copolymerized with a second acrylic monomer possessing a catecholic 
functionality.  
Among antioxidants, cathecolic compounds have gained increasing research attention 
due to their ortho-diphenolic moiety that extends their biological activity from free 
radical scavangers to metal chelators as well as to antimicrobial agents 
39
. In this regard, 
hydroxytyrosol (HTy), the main natural polyphenolic compound occurring in virgin 
olive oil and in olive oil wastewaters, possesses important pharmacological potential 
related to its antioxidant, anti-inflammatory and anti-platelet aggregation activity. In 
addition, hydroxytyrosol and its derivatives possess a strong chelating ability towards 
metals and a broad-spectrum antimicrobial activity against a series of microorganisms 
including Staphylococcus epidermidis and S. aureus, Vibrio cholerae and Salmonella 
species 
40
. 
The only drawbacks related to the use of HTy are its poor availability and high cost.  
For these reasons, in this work, Tyrosol (Ty), a low-cost phenol also present in olive oil, 
was used as a precursor molecule of hydroxytyrosol.  
Particularly, a Tyrosol containing monomer was first synthesized. Then, the catecholic 
function was inserted by a patented  chemo- and regio-selective aromatic hydroxylation 
41
. To obtain polymers with a various amphiphilic balance, different ratios between the 
antioxidant-hydrophobic monomer and the hydrophilic AcDED one were used.  
After physical characterization, the antimicrobial properties of obtained copolymers in 
terms of minimal inhibitory concentration (MIC) and antifouling characteristics were 
tested against S. epidermidis. It was observed that the most hydrophobic copolymer 
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containing 30% mol/mol of HTy possessed the lowest MIC. In addition, this material 
also displayed good antifouling characteristics after coating of a commercial catheter.  
 
5.2 Materials and methods 
5.2.1 Materials 
Sodium metabisulphite (Na2S2O5) and potassium monobasic phosphate (K2HPO4) were 
purchased from Carlo Erba. Achryloyl chloride 96%  and N, N-diethylethylendiamine 
(DED)  were supplied from FLUKA. Tyrosol (2-(4-Hydroxyphenyl)ethanol, TY), 
acrylic acid (AA), hydroquinone, potassium persulfate (K2S2O8), p-toluensyulfonic acid 
(pTSOH), sodium dithionite (Na2S2O4), Ferrozine, Ferrous sulphate (Fe2SO4), Ferrous 
chloride ( FeCl2), 2,2-Diphenyl-1-picrylhydrazyl (DPPH) were purchased from Sigma 
Aldrich as well as other solvents and reagents. DMSO-d6 100% were supplied from CIL 
(Cambridge Isotope Laboratories, Inc). All of chemicals were of analytical grade and 
used as received. 2-iodoxybenzoic acid (IBX) was prepared in the laboratory as 
described in the literature 
42
. Staphylococcus epidermidis, strain ATCC 35984, and 
Muller Hinton broth (MH, Oxoid) were employed for microbiologic tests. 
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5.2.2 Monomer and homopolymer synthesis 
Synthesis of AcDED and pAcDED  
 
Synthesis of acrylate monomers based on N,N-diethylethylendiamine (AcDED) and 
tyrosol (AcTy), as well as synthesis of respective homopolymers have been already 
described. Following, shortly, the main synthetic steps were reported.  
AcDED was synthesized by reaction between acryloyl chloride (Ac, Fluka) and N,N-
diethylethylendiamine (DED, Sigma Aldrich). Briefly 0.029 moles of diamine was 
added to a solution of Ac (0.038 moles) in dimethylcarbonate (DMC, 75 ml, Sigma 
Aldrich) containing K2HPO4 (0.08 moles, Carlo Erba), used as base 
36 
. The reaction 
was carried out for 4 h at room temperature. Then, the solution was filtered to remove 
the inorganic and organic salt and the monomer recovered by solvent evaporation (yield 
ranging from 85 to 90%). 
Homopolymer synthesis was carried out at 25 °C for 24 h by using a 1 M water solution 
of AcDED (5 ml) and K2S2O8 (2.8x10
-4
 mmoles, Carlo Erba) plus FeSO4 (2.4x10
-4
 
mmoles, Carlo Erba) as radical initiators. The resulting polyacrylamide (Scheme 1) was 
called pAcDED (pKb=8.61).  
In previous work 
38 
, homopolymers at different chain length were obtained by adding in 
the synthesis sodium metabisulfite (Na2S2O5, Carlo Erba) as chain transfer agent (T). In 
this work, the [T]/[AcDED]=0.1 molar ratio (chain transfer agent/monomer) was 
employed. The resulting polymer, herein called pAcDED, possessed a molecular weight 
of 94x10
3
 g/mol and a polydispersity index  of 1.32. 
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Scheme 1. Synthesis procedure for pAcDED. 
 
 
 
 
Synthesis of AcTy and pAcTy 
 
As for tyrosol-based acrylic monomer (AcTy) synthesis,  0.1 mol of Ty was dissolved 
in 75 ml of toluene in presence of 20 mg of hydroquinone and 750 mg of p-
toluensulfonic acid (pTSOH). Then, 0.12 mol of acrylic acid was added and the mixture 
was refluxed for 1,5 hrs in a flask equipped with Dean-Stark apparatus. At the end of 
the reaction, the mixture was cooled and treated with sodium bicarbonate (6 g) and 
water (1.5 ml), until carbon dioxide evolution ended. The mixture was then dried with 
sodium sulfate anhydrous and filtered. The solvent (toluene) was removed under 
vacuum. In the second step, the monomer AcTy (1 mmol) was dissolved in a mixture 
water/acetone (1/1 w/w) and subjected to radical polymerization by employing 
potassium persulfate (0.03 mmol) and sodium disulfite (0.1 mmol). After stirring for 50 
min at room temperature, acetone was distilled off by heating at 60 °C. The reaction 
mixture was kept at 80 °C for 2 h. At the end of reaction, a stable emulsion of 
nanoparticles of tyrosol-containing polymer (pAcTy) was obtained (Scheme 2). The 
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reaction yield and the presence of the monomer within the repeat unit were assessed by 
1
H-NMR (data previously reported). 
 
 
 
Scheme 2. Synthesis procedure for pAc-Ty. 
 
 
 
Synthesis of  pAcDED-co-pAcTy copolymer 
 
To obtain copolymers containing both the tertiary amine and the phenolic functions a 
variation of pAc-Ty polymerization procedure was performed.  
After dissolution in water (3 ml) of the AcDED monomer (in variable quantity 
according to the chosen ratio between co-monomers), the aqueous solution was added to 
an acetone solution (3 ml) containing AcTy monomer. The mixture was kept under 
continuous stirring until homogeneity. At this point, the initiator (potassium persulfate) 
and the chain transfer agent (sodium metabisulfite) were added. In order to distillate 
acetone, the solution was heated up to a temperature of 80 ° C. Finally, the aqueous 
solution containing the copolymer (named pAcDED-co-AcTy, Scheme 3) was dialyzed 
in water by using a membrane of regenerated cellulose (Spectr/por membrane 
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BIOTECH) with a cut off of 3,500 Dalton. The conversion and the ratio of the 
monomers within the repeat unit of the copolymer were assessed by 
1
H-NMR. 
 
 
 
Scheme 3. Synthesis procedure for pAcDED-co-pAcTy. 
 
 
Oxidation/reduction of pAcDED-co-pAcTy copolymer 
 
IBX (in stoichiometric amount to the phenolic fraction) was added to an aqueous 
solution of pAcDED-co-pAcTy copolymer (200 mg/ml), at 0 °C under magnetic 
stirring. The immediate appearance of opalescence and orange coloration evidenced the 
oxidation of the phenol to ortoquinone group. After adding of an aqueous solution of 
sodium dithionite to the reaction batch (stoichiometric to IBX), the mixture was kept 
under stirring until to observe a chromatic variation from orange to white. Also in this 
case, the obtained solution was purified by dialysis in water. Different molar ratios 
between the monomers AcDED and AcHTy were used. Particularly, AcDED/AcHTy 
molar ratios of 90/10, 80/20, 70/30, 60/40 and 50/50. 
As for copolymers containing AcDED/AcHTy molar ratios of 60/40 and 50/50, after 
reduction of the ortoquinone function to the catecholic one, polymer preipitation was 
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observed. Therefore, the purification of these water-insoluble copolymers was 
performed through several washes in water. All polymers obtained (named pAcDED-
co-pAcHTy, Scheme 4) were further dried in vacuum oven at 25 °C for 1 day. 
 
 
 
Scheme 4. Synthesis procedure for pAcDED-co-pAcHTy. 
 
5.3 Polymer characterization  
5.3.1 NMR spectroscopy and elemental analysis 
 
1
H-NMR spectra were performed employing a Varian XL 300 instrument and 
chloroform-d or  DMSO-d6 100% CIL as solvent. Elemental analysis of the synthesized 
polymers was carried out by Carlo Erba EA 1110 instrument and data were reported as 
C, H, N, S percentages. 
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5.3.2 Thermal analysis 
Differential scanning calometry (DSC) analysis was performed using a Mettler TA-
3000 DSC apparatus in the temperature range from –100 to 200 °C, under N2 flux. The 
scan rate used for the experiments was 10 °C/min and the sample weight of about 6-7 
mg. Thermogravimetric analysis (TGA) was carried out employing a Mettler TG 50 
thermobalance, at the heating rate of 10 °C/min, under N2 flow and in temperature range 
30 - 500 °C.  
 
5.3.3 FT-IR spectroscopy 
Attenuated Total Reflection spectra (ATR) were acquired by employing a Nicolet 6700 
FT-IR spectrometer and a Golden Gate diamond single reflection device (Specac).The 
spectra were obtained by co-adding 200 interferograms in the range 4000–650 cm-1 at a 
resolution of 4 cm
-1
.  
 
 
5.3.4 Scanning electron microscopy (SEM) 
The morphological analysis of polymer nanoparticles and film was performed by 
LEO1450VP scanning electron microscope (SEM), having a resolution of 3.5 nm. The 
samples were sputtered with gold using a SEM coating unit (PS3 coater) at 6 mA for 6 
min. 
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5.3.5 Particle size determination  
Nanoparticle size determination was assessed by a Laser Diffraction Particle Size 
Analyzer (LS 13320, Beckman Coulter). Water or organic solvents were used as 
suspending media. The acquisition time for measurements was 90 s.  
 
5.3.6 UV-Visible spectroscopy  
Electronic absorbance spectra in the UV-Vis region and photometric measurements 
were performed by using a HP U2000 singular beam spectrophotometer. The instrument 
works in the wavelength range between 190-1100 nm with resolution of 0.004 nm.   
 
5.3.7 Gel permeation chromatography (GPC) 
Molecular weight measurements were carried out at 25 °C using a gel permeation 
chromatography (GPC) system equipped with a Shimadzu RID-10A differential 
refractive index detector and Tosoh TSK polyacrylamide gel columns. The calibration 
curve was obtained by using polyethylene oxide standard. Aqueous sample solutions 
containing 0.1 M NaCl were injected by an autosampler Hitachi AS-2000 at a flow rate 
of 0.8 mL/min
-1
. 
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5.3.8 Antiradical activities of compounds  by DPPH 
The antioxidant activity of copolymers was determined by using DPPH as free anionic 
radical 
43
. For each antioxidant compound, different concentrations were tested 
(expressed as the number of moles of antioxidant/mole DPPH). 
Antioxidant-containing copolymer solutions in methanol (4 mL) were added to 10 mL 
of a 1.5 × 10
-4
 mol/L methanol DPPH solution. The decrease in absorbance was 
determined at room temperature at 520 nm after 30 min, time in which a plateau was 
reached. The amount of DPPH was evaluated from a calibration curve (absorbance vs. 
concentration). Then, for each concentration tested, the residual DPPH as a function of 
antioxidant agent/DPPH molar ratio was plotted. Antiradical activity was defined as the 
amount of antioxidant necessary to decrease the initial DPPH concentration by 50% 
(Efficient Concentration = EC50,  moles of antioxidant/mole DPPH). EC50 values were 
extrapolated from the graph. 
As for antioxidant activity of insoluble copolymers, measurements were performed by 
using the DPPH method with some modifications 
44
. 
Different amount of the powdered polymer were transferred into a vial, and the reaction 
was started by adding 60 mL of methanol and 20 mL of methanol DPPH solution (0.5 
M). The vials were stirred for 30 min to facilitate the surface reaction between the 
insoluble polymer and the DPPH reagent. Following centrifugation at 3500 rpm for 2 
min, the absorbance of the optically clear supernatant was measured at 520 nm.  
 
5.3.9 Chelating activity versus ferrous ions 
The chelanting activity of copolymer solutions versus ferrous ions was estimated by 
measuring the formation of  Fe
2+
-ferrozine complex exploiting a modification of Dinis 
                                                          
43
 Brand-Williams W., Cuvelier M. E., Berset C., Lebensm.-Wiss.u.,Technol., 1995, 28, 25-30. 
44
   Serpen A.,  Capuano E.,  Fogliano V., Gökmen V., J. Agric. Food Chem., 2007, 55, 7676–7681. 
170 
 
method (and Carter method 1971) 
45
. Briefly, 50 μl of 2 mM FeCl2 was added to 1 ml of 
polymer solution at different concentrations. The reaction was initiated by addition of 
0.2 ml of 5 mM ferrozine solution. The mixture was vigorously shaken and left to stand 
at room temperature for 10 min. The absorbance of the coloured complex, indicating the 
bond formation between Fe(II) ions and ferrozine, was measured at 562 nm. The 
inhibition percentage of the ferrozine–Fe2+ complex formation was calculated as [(A0- 
As)/As]x100, where A0 was the absorbance of the control and As the one of the polymer 
solutions. 
 
5.4 Biological characterization  
5.4.1 MIC determinations  
 
The antibacterial activity of samples was assessed against Staphylococcus epidermidis 
(ATCC 35984) by the disk diffusion test and broth microdilution assay 
46
. The former 
test was carried out on cellulose disks embedded with 20 µL of a 1 mg/mL polymer 
solution and placed in Petri plates previously seeded with 10
8
 CFU/mL bacterial 
concentration. Following incubation at 37°C for 24 h, diameters of inhibition zones of 
bacterial growth were measured.  
Broth microdilution assay allowed to determine the minimum inhibitory concentration 
(MIC) of all copolymer series.  Staphylococcus epidermidis ATCC 35984 was grown in 
Triptic Soy Agar (TSA) and Tryptic Soy Broth (TSB) at 37 °C. Briefly, 1 mL of 
polymer solution at various concentrations was added to 1 mL of microorganism 
solution at a concentration which gave an optical density reading of  0.1–0.2 at 600 nm. 
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Then, a set of dilutions was prepared and inoculated with a 10
6
 CFU/mL bacterial 
concentration. After 24 h incubation at 37 °C, bacterial growth was determined by 
measuring the absorbance at 600 nm. Broth containing cells alone was used as control. 
S. epidermidis was chosen for its implications in medical device-related infections. All 
the experiments were done in triplicate. Differences were considered significant for P 
<0.05. 
 
5.4.2 Evaluation of antifouling polymer properties  
The evaluation of the ability of copolymers to control bacterial adhesion was performed 
by scanning electron microscopy (SEM). Particularly, a section of commercial catheter 
was coated with pAcDED-co-pAcHTy 70/30 and immersed for 24 h in 2.5 ml of 
bacterial suspension (0.5 Mac Farland) grown in TSB broth. After incubation the coated 
device was washed twice with PBS (pH=7.4), fixed with 2.5% glutaraldehyde in 0.1 M 
PBS buffer (pH 7.4) at room temperature for 30 min, dehydrated through graded ethanol 
and gold coated by sputtering.  
 
Statistics 
Analysis of variance comparisons
 
were performed using MiniTab. Differences were 
considered significant
 
for P values of <0.05. Data were reported as means ±
 
1 SD.
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5.5 Results and discussion 
Intrinsically antimicrobial polymers exert their action according to a sequence of events 
such as absorption on bacterial cell wall, diffusion through the membrane, absorption 
onto cytoplasmic membrane and its disintegration 
19, 20
. To better interact with the wall 
and cytoplasmic membrane, intrinsically antimicrobial polymers must possess both a 
hydrophobic region and a hydrophilic one containing strong positive charges. The 
balance of hydrophobic content and cationic charges is critical to achieve high activity 
since it has been demonstrated that positive electrical charges are cytotoxic and 
hemolytic 
13
.  
In the last years, different statistic and amphiphilic block copolymers, showing a good 
antibacterial efficacy and low toxicity for human cells with respect to their 
homopolymers, have been developed 
47, 48 
. 
Among amphiphilic antimicrobial polymers, those containing primary or tertiary amines 
and an inert hydrophobic side have been widely investigated. Polymers and copolymers 
possessing tertiary ammonium groups, such as polystyrenes 
49
 and polydiallyamines 
50
 
showed a wide spectrum antimicrobial activity higher than the same series containing 
quaternary ammonium groups. However, such materials lysed human red blood cells at 
relatively low concentrations. The lack of discrimination between prokaryotic and 
eukaryotic cells was ascribed to high hydrophobicity of polymer backbone.  
To obtain a suitable balance between antimicrobial activity and toxicity, Sambhy et al. 
51
 synthesized several amphiphilic pyridium-methacrylate copolymers by varying the 
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ratio between positive charges and the alkyl chain length on the polymer. It was 
observed that for polymers having the same charge/alkyl chain ratio, the spatial 
separation enhanced biocidal action and reduced toxicity vs cells. In these copolymers 
the positive charges were born by secondary and tertiary amines.  
Palermo et al.
52
, by comparing polymethacrylate derivatives containing either protonate 
amines or quaternary ammonium groups, revealed that primary amines were the most 
effective at conferring good antimicrobial properties to polymers. In addition, primary 
amines resulted less hemolytic than tertiary ones. As for copolymers containing 
quaternary ammonium groups, a greater amount of hydrophobic comonomer was 
required to express activity and more selectivity for E. coli versus human red blood 
cells 
53
.  
Most of investigated polymers and copolymers are based on acrylic monomers 
containing charged tertiary amine groups bearing methyl residues
 6
.  
Amphiphilic cationic copolymers can be also very interesting to fight the emergent risk 
of microbial resistance. Specifically, by using two different monomers one bearing an 
antimicrobial hydrophobic compound and the other one a positive charge, it could be 
possible to obtain materials hampering the development of resistant strains because of 
the different action mechanisms exerted against microorganisms.  
The main aim of this work was the synthesis of dual-function polymers endowed with 
antimicrobial and antioxidant properties obtained by copolymerization of two 
monomers containing tertiary amine and catecholic groups.   
Particularly, an ethylacrylic amide monomer containing tertiary amine groups bearing 
ethyl residues 
38
, previously synthesized by our group, was copolymerized with a novel 
active hydrophobic acrylic monomer. The introduction in the tertiary amine group of 
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 Palermo E.F., Lee D.K., Ramamoorthy A., Kuroda K., J. Phys. Chem. B, 2011, 115, 366-375. 
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 Palermo E.F., Kuroda K., Biomacromolecules, 2009, 10, 1416-1428. 
174 
 
alkyl residues longer than those used in literature 
6
 was intended to enhance the polymer 
hydrophobicity and then improve its interaction with bacterial membrane 
38
. Instead the 
presence of an active hydrophobic spacer exerting not only biocide action but also 
antioxidant action should ensure the reduction of the emergence of drug resistant 
bacteria, by suppression of ROS present in the biofilm, and better combat biofilm 
infections.  
A first qualitative evaluation of the synthesized copolymers was performed by ATR-IR 
spectroscopy. In Figure 1, the spectra of two homopolymers (pAcDED and pAcTy) and 
70:30 copolymer are reported in the 4000-650 cm
-1
spectral region. 
 
80012001600200024002800320036004000
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pAcDED-co-pAcTy 70:30
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Figure 1: ATR-IR spectra of pAcDED, pAcTy and pAcDED-co-pAcTy 70:30 copolymer 
in the spectral range between 4000-650 cm
-1
. 
 
In the copolymer spectrum, characteristic absorptions of both homopolymers are 
observed. In particular, it can be noted at 1720 cm
-1
 the peak related to the ester 
carbonyl stretching, at 1650 cm
-1
 the stretching of amide carbonyl, at 1554 cm
-1
 the 
peak relative to the amide NH bending and CN stretching and at around 1510 cm
-1
 the 
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stretching of C=C bond belonging to tyrosol aromatic ring. In addition, in the range 
1150-750 cm
-1
 it was possible to evidence the absorptions related to the C-O-C bending 
of ester group, to the CN bending of amide group and finally to the CH bending of p-
aromatic ring. 
Plotting the ratio between the absorbance value at 1720 cm
-1
, referred to the carbonyl 
ester of aromatic moiety, and that one at 1554 cm
-1
, attributed to second amide-band, a 
linear decrement of such ratio with hydrophobic moiety decreasing in the repeat unit of 
(pAcDED-co-pAcTy)s was observed (Figure 2). In this way, by easy spectroscopic 
measurements, it was possible to carry out a semi-quantitative evaluation of the molar 
ratio of the two comonomers in the polymer chain. 
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Figure 2: Abs1720/Abs1554 ratio versus content of AcDED comononer. 
 
The same profile was observed for copolymer bearing hydroxytyrosol moiety, 
pAcDED-co-pAcHTy (data not shown).  
To determine the occurred polymerization reaction and the comonomer molar ratio in 
the repeat unit, 
1
H-NMR measurements were carried out on the various synthesized 
copolymers. First of all, peaks relative to double bond of acrylic group were absent, 
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confirming that the monomer conversion was quantitative. In addition, for all of 
copolymers containing phenolic residues, resonances between 6.5-6.6 ppm, relative to 
aromatic protons, were observed. In the spectral range between 4.2 - 3.1 ppm, the 
copolymer resonances were covered or modified by the peak of water; while in the 1.0 - 
1.8 ppm range, the two broad and very low intensity peaks were attributed to alkylic 
protons of polymer backbone. Finally, at 0.9 ppm the methyl hydrogen resonance 
belonging to AcDED moiety was observed (Figure 3).  
 
 
 
Figure 3: Repeat unit of the copolymer and  
1
H-NMR spectrum relative to copolymer 
pAcDED-co-pAcTy 70:30 . 
 
To evaluate the molar ratio of the comonomers in the repeat unit, the following equation 
that takes into account the integral values of resonances at 0.9 ppm and 6.5-6-6 ppm 
was used: 
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The obtained values were in agreement with the monomer molar ratios used for 
polymerization. Also elemental analysis confirmed 
1
H-NMR results (data not reported).  
1
H-NMR analysis was also exploited to verify the obtainment of catecholic function by 
regio and chemoselective one-pot oxidation/reduction reaction. The resonances of 
methylene protons bound to amide nitrogen and to tertiary amine-related nitrogen could 
be observed between 3-3.5 ppm; while aliphatic protons attributed to polymer main 
aliphatic chain were between 1.5 and 2 ppm. Finally, at about 0.9 ppm the methyl 
proton resonance of tertiary amine residue was observed.  
 
 
                    (a)                                                                                (b) 
Figure 4: Repeat unit of the oxidated copolymer (a); 
1
H-NMR spectrum of pAcDED-co-
pAcHTy 70:30 copolymer after the catecholic function insertion (b). 
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In all of pAcDED-co-pAcHTy copolymer spectra, the peaks relative to aromatic protons 
disappeared (Figure 4). This is probably due to a supramolecular re-structuring of 
pseudo- flower-like micellar morphology. Likely, phenyl rings interact each other by 
stacking interactions leading aromatic protons to be shielded against magnetic field.  
Proton shielding effects were already observed by Bütün et al. 
54
 on block copolymers 
containing two different tertiary amine groups in the side chain of the two employed 
acrylic monomers. In particular, the authors confirmed the micelle formation from the 
disappearance of some 
1
H-NMR signals relative to one of the two blocks containing 
quaternized tertiary amine groups. 
Micellization behaviour of amphiphilic random copolymers have been widely 
investigated. In this regard, Kawata et al. 
55
 proposed flower micelle model of the 
minimum loop size. Particularly, they have investigated dependences of hydrophobicity 
of both hydrophobic and ionic monomer units on the micellar structure. The statistical 
copolymer micelles had a single hydrophobic core and assumed compact conformations 
comparable to typical globular proteins. Tominaga et al. 
56
 studied flower micelle 
arrangement of sodium (2-acrylamido)-2-methylpropanesulfonate and N-
dodecylmethacrylamide p(AMPS/C12) random copolymer, in 0.05 M aqueous NaCl by 
light scattering and atomistic molecular dynamic simulation.   
Summarizing, when dissolved in water, amphiphilic random copolymers, bearing 
hydrophobic and electrolyte units attached to polymer chain, tend to self-assemble to 
form a hydrophobic core, and to force the main chain to take the loop conformation.  
                                                          
54
 Bütün V., Armes S.P., Billingham N.C., Macromolecules 2001, 34, 1148-1159. 
55
 Kawata T., Hashidzume A., Sato T., Macromolecules 2007, 40, 1174−1180. 
56
 Tominaga Y., Mizuse M., Hashidzume A., Morishima Y., Sato T., J. Phys. Chem. B, 2010, 114, 
11403–11408. 
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From 
1
H-NMR data, therefore, a pseudo- flower-like micellar arragment could be also 
hyphothesized for our pAcDED-co-pAcHTy copolymers.  
DLS data (Table 1) showed that the copolymer series soluble in water possessed size 
slightly higher than normal flower micelles reported in literature 
57
. These findings 
could be due to polymer chain swollen-aggregates interacting each other 
58
. Indeed, 
pAcDED-co-pAcAHTy 70:30 bearing the highest aromatic moiety content had size 
smaller with respect to the other soluble copolymers, suggesting greater hydrophobic 
interactions. In order to elucidate particle size and the real structure of polymeric 
aggregates, a more in depth investigation of these systems at different pH by DLS 
analysis and X-rays measurements is needed. In Table 1, the molecular weight and 
polydispersity index of water-soluble copolymers, determined by GPC analysis, were 
also reported. In these measurements, the aggregation phenomena were partially 
reduced by adding NaCl in the eluent.  
 
POLYMER 
Mn x10
3
  
(g/mol) 
I=Mw/Mn Size (nm) 
pAcDEDcopAcAHTy7030 8.0 1.85 90±10 
pAcDEDcopAcAHTy8020 13.0 1.70 215±15 
pAcDEDcopAcAHTy9010 15.0 1.55 300±25 
 
Table 1. Molecular weight, polydispersity index and DLS size of synthesized water-
soluble polymer. 
A particular feature of polymers, especially of copolymers, having hydrophilic and 
hydrophobic regions, is the microphase separation due to the different chemical nature 
                                                          
57
 JeongY.II, Nah J.W., Lee H.C., Kim S.H., Cho C.S., Int. J. Pharm., 1999, 188, 49-58. 
58
 Lee E.S., Oh K.T., Kim D., Youn Y.S., Bae Y.H., J Control Release, 2007, 123(1), 19-26. 
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of the two sides. Thermal transitions, particularly the glass transition temperature (Tg), 
are affected by possible formation of different intermolecular interactions between 
hydrophilic/hydrophobic sides 
59
. In addition, such interactions can be promoted by the 
presence of functional groups in the main or side chain. If phase mixing occurs, the 
mobility of the segments decreases with a consequent increase of Tg value. On the 
contrary, high interactions between hydrophobic segments or steric hindrance of bulky 
substituents can lead to an enhancement of phase separation and then of Tg value 
60
. 
The study of hydrophobic/hydrophilic phase separation of the synthesized copolymers 
was carried out by DSC analysis. Such measurements evidenced substantially 
amorphous materials with a high hygroscopicity. For this latter issue, two heating cycles 
in the temperature range from -50 °C to 200 °C were performed (Figure 5 a).  
In first scan, a broad endothermic peak, around 100 °C,  related to weakly adsorbed 
water can be observed. The disappearance of this peak in the second scan permitted the 
observation of the glass transition. The profile of glass transition temperature (Tg) 
versus the content of aromatic monomer (AcHTy) is shown in Figure 5 b.  
 
 
                                                          
59
 Quattrociocchi G., Francolini I., Martinelli A., D’Ilario L., Piozzi A., Polym Int , 2010, 59, 1052–1057. 
60
 Francolini I., D’Ilario L., Guaglianone E., Donelli G., Martinelli A., Piozzi A., Acta Biomaterialia , 
2010, 6, 3482–3490. 
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Figure 5: DSC thermograms of pAcDED-co-pAcHTy 70:30 copolymer (a); Tg profile 
versus AcHTy content (b). 
 
As it can be noted, a decrease of Tg value with incrising of hydrophobic monomer 
amount was observed. This can be due to a plasticizer effect exerted by AcHTy 
monomer presumably caused by the steric hindrance of the hydroxytyrosol aromatic 
rings. The stacking interactions among aromatic rings probably improved the chain 
flexibility of cationic region leading to a greater phase separetion. In fact, the pAcDED-
co-pAcHTy 70:30 copolymer possessing the lowest molecular size showed the lowest 
glass transition and then the highest phase separation.   
To evaluate the effect of amphiphilic copolymer structure and composition on their 
antibacterial activity against S.epidermidis, the broth microdiluition test was performed 
on all of copolymers bearing catecholic moiety. (pAcDED-co-pACHTy)s showed lower 
MIC against S.epidermidis with respect to both previously synthesized homopolymers 
38, CHAPTER IV
 (Figure 6). This finding could be explained by considering several factors. 
Generally, biological activity increases with hydrophobic side increasing, then with 
aromatic groups 
17
 . In fact, in the copolymer pAcDED-co-pAcHTy 70:30 a probable 
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optimum amphiphilic balance could have been reached
17 
. Also the introduction of high 
amount of a second antimicrobial group (catecholic moiety), such as in pAcDED-co-
pAcHTy 70:30, could have improved the biocidal activity by a synergistic action with 
ammine groups. Moreover, the good killing activity of the copolymers could be 
attributed to their reduced sizes with respect to homopolymers 
38 
that permit an efficient 
cellular uptake of the antimicrobial complexes. 
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Figure 6: MIC values of all synthesized copolymers compared to those of pAcDED and 
pAcHTy homopolymers. 
 
In general, MIC values found for all copolymers were comparable to those reported in 
literature for amphiphilic polymers or polymers based on ammonium salts 
13, 24
. In 
addition, since phenolic groups were found to exert biocidal activity against many fungi 
61, 62
 and different Gram-positive and negative, we can hypothesize that our 
hydroxytyrosol-based copolymers could have a broad spectrum antimicrobial activity.  
                                                          
61
 Iemma F., Puoci F., Curcio M., Parisi O.I., Cirillo G., Spizzirri U.G., Picci N., J. Appl. Polym. Sci., 
2010, 115, 784-789. 
62
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To assess the possible application of synthesized copolymers as materials for coating of 
medical devices, a commercial intravascular catheter in polyurethane was coated with 
the most active copolymer pAcDED-co-pAcHTy 70:30. The coating procedure 
involved the immersion of a catheter segment (approximately 2 cm) in a solution of the 
oxidized copolymer but not yet reduced by sodium dithionite. To obtain an adequate 
coating thickness such a procedure was repeated several times. The reduction reaction 
was then carried out on the polymer film adhered on the catheter surface. The resulting 
coating was assessed by ATR-IR while coating thickness resulted of  about 50 microns 
was measured with a gauge. Finally, the ability of copolymer pAcDED-co-pAcHTy 
70:30 to inhibit bacterial adherence was evaluated through SEM observations.  
 
Figure 7: SEM micrographs of a) uncoated and b)  polymer-coated catheter surface 
after contact with bacteria. 
 
Figure 7 shows SEM micrographs of uncoated and polymer-coated catheter surface 
after contact with bacteria. In particular, the image related to the coated catheter (Figure 
7 b) was taken on a boundary region where the separation between the coated and 
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uncoated surface was evident.  As it can be noticed, uncoated catheter was totally 
colonized (Figure 7 a) contrary to the coated catheter region (Figure 7 b). However, in 
the Figure 7 b, specifically in the uncoated region, bacterial colonization with biofilm 
formation was observed. These evidences showed that the coating of medical devices 
with the most active copolymer synthesized by us is promising for counteracting S. 
epidermidis biofilm formation. 
The use of these copolymers should also permit to fight microbial resistance not only 
because they act against bacteria through two action mechanisms but also because they 
are able to block ROS production inside the biofilm.  
To evaluate this latter property, the antioxidant features of synthesized copolymers were 
evaluated by the DPPH method. DPPH is a stable organic radical that may be converted 
to a colorless neutral molecule when accepting a proton from any hydrogen donor 
(Figure 8). Among the synthesized copolymers, those water-soluble maintained a high 
scavenging activity with respect to hydroxytyrosol-based polymer (EC50 = 0.80 ± 0.02)  
. They exerted their action in a dose dependent manner due to the different amount of 
catecholic moieties (Table 2).  
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Figure 8: Color variation of DPPH solutions after contact with different amount of 
copolymers. 
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POLYMER EC50
* 
% chelate ferrous  
pAcDED-co-pAcAHTy 50:50 0.93 ± 0.06 95 ± 5 %  
pAcDED-co-pAcAHTy 60:40 0.88 ± 0.05 90 ± 6 %  
pAcDED-co-pAcAHTy 70:30 0.48 ± 0.02 85 ± 5  %  
pAcDED-co-pAcAHTy 80:20 0.64 ± 0.03 65 ± 3 %  
pAcDED-co-pAcAHTy 90:10 0.76 ± 0.03 25 ± 7 %  
*EC50= moles of antioxidant/mole DPPH 
Table 2. Antioxidant activity versus DPPH and chelating capacity versus ferrous ions of 
the synthesized copolymers. 
The main strategy to prevent catalysis of hydroperoxide decomposition and Fenton type 
reactions is chelation of transition metals. Particularly, the transition metal ion Fe
2+
 
permits the formation and propagation of many radical reactions.  
To estimate ferrous ion chelating activity of the synthesized copolymers the ferrozine 
assay was used. Ferrozine normally forms stoichiometric complexes with Fe
+2
 ions. In 
presence of other chelating agents, the Ferrozine-Fe
+2
-complex formation is not allowed 
thus causing a reduction of complex red coloration. Therefore, the chelating activity can 
be easily estimated by spectroscopic UV-Vis measurements. The obtained results 
suggested that copolymers had a good ferrous ion chelating ability, thus forming a more 
stable complex than ferrozine (Table 2). In particular, the ferrous ion chelating 
percentage improved with increasing of catecholic moiety concentrationin the 
copolymer repeat unit. 
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5.6 Conclusions 
Herein, we have reported for the first time the synthesis of amphiphilic copolymers 
bearing two different antimicrobial moieties. Particularly, a tertiary amine and a 
catecholic functional group in the side chain of copolymers were introduced at different 
molar ratios. All of the obtained copolymers had amorphous features and up to 0.3 
molar ratio of cathecolic groups they were also water soluble. 
1
H-NMR and DSC 
measurements showed that aromatic pendant groups interact each other probably 
leading to a supra-macromolecular architecture and an enhanced phase separation. The 
phase separation could justify the copolymer size decreasing with the aromatic amount 
increasing. Indeed, the water soluble copolymer with the highest catecholic content 
(pAcDED-co-pAcHTy 70:30) possessed a mean size value of 90 nm, as shown by DLS 
measurements. The better biological activity of the water soluble copolymers was 
probably due to several factors such as their reduced size permitting an efficient cellular 
uptake of the antimicrobial complexes, an optimum amphiphilic balance as well as a 
synergistic biocidal action. In addition, all of the copolymers showed both good 
antioxidant activity and ferrous ion chelating ability. To evaluate the possible use of 
these novel biocidal copolymers in the medical field, the toxicity of these materials on 
animal and human cells will be assessed in future investigations. 
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APPENDIX 
SYNTHESIS AND PRELIMINARY CHARACTERIZATION OF 
SOLUBLE RANDOM COPOLYMERS BASED ON DOPAMINE.  
 
A.1 Introduction 
Amphiphilic random copolymers have been widely employed for developing 
antimicrobial polymer mimics of amphiphilic active structures of antimicrobial helix-
forming peptides such as magainin
1
. Such copolymers can arrange in conformations 
showing separated domains or facially amphiphilic structures obtained by separation of 
cationic side chains and hydrophobic segments under the influence of the cell 
membrane interface
2,3
.  
It has been recently demonstrated 
4,5
 that amphiphilic block copolymers showing 
selective activity against bacteria over human cells can be also good candidates to 
substitute antibiotics
1,4
. 
Indeed, vinyl ether di-block copolymers prepared by cationic-activated polymerization
4 
 
and di-block copolymers of 2-(N,N-dimethylamino)ethyl methacrylate and butyl 
methacrylate, obtained by Atom Transfer Radical Polymerization (ATRP) and 
possessing cationic and hydrophobic segments, displayed both biocidal effects against 
bacteria and poor hemolysis. Random copolymers with the same ratio of cationic and 
hydrophobic groups were instead more hemolytic, although they showed similar 
biocidal activity.  
                                                          
1
 Kuroda K.  and Caputo G.A., WIREs Nanomed Nanobiotechnol, 2013, 5, 49-66. 
2
 Palermo E.F., Vemparala S., Kuroda K., Biomacromolecules, 2012, 13, 1632–1641. 
3 Mowery B.P., Lee S.E., Kissounko D.A., Epand R.F., Epand R.M., Weisblum B., Stahl S.S., Gellman 
S.H., J Am Chem Soc, 2007, 129, 15474–15476. 
4 Oda Y., Kanaoka S., Sato T., Aoshima S., Kuroda K., Biomacromolecules, 2011, 12, 3581–3591. 
5 Wang Y.Q., Xu J.J., Zhang Y.H., Yan H.S., Liu K.L., Macromol Biosci, 2011, 11, 1499–1504. 
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Even if these block copolymers seem to form vesicles or micelles at high concentration, 
it was observed that they display antimicrobial activity even below the critical micelle 
concentration (CMC)
1
. Such a finding suggested that the conformation of single 
polymer chains can be responsible for the biological activity.
 6
 Indeed, it was 
hypothesized that water soluble segments, shielding the hydrophobic segments, lead to 
the formation of a core-shell structure thus avoiding the interaction of the  hydrophobic 
core with the aqueous media. As a result, an intramolecular or intermolecular micellar 
structure is formed. 
Therefore, these micelles are constituted of nano-aggregates with a core of insoluble 
blocks surrounded by flexible soluble blocks. These micelles can be spherical, or 
differently shaped, with narrow size distribution depending on the experimental 
conditions. These sophisticated materials offer many advantages including high drug  
loading efficiency without chemical modification, ease preparation, colloidal stability 
with low critical micelle concentration (CMC), predictable size with narrow size 
distribution, ability to protect drugs from possible deactivation and improved 
pharmacokinetics
7, 8, 9
.  
In order to achieve suitable molecular architectures, it is crucial the synthesis of a 
copolymer with a well-defined structure. This can be obtained employing synthetic 
strategies able to give control of stoichiometry and regioselectivity of each chain 
segment. Therefore,   anionic
10, 11 
or cationic polymerization
4
, ring-opening 
polymerization (ROP)
12,13
, radical living polymerizations, such as Reversible Addition 
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 Chu B., Langmuir, 1995, 11, 414–421. 
7
 Mikhail A.S., Allen C., J Control Release, 2009;138, 214–23. 
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 Yoon H.J., Jang W.D., J Mater Chem, 2010 , 20, 211–22. 
9
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 Tessmar J.K., Mikos A.G., Gopferich A., Biomacromolecules, 2002, 3, 194– 200. 
11
 Zhang S., Qing J., Xiong C., Peng Y., J. Polym. Sci., Part A, Polym. Chem.,  2004, 42,  3527– 3536. 
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 Kang N., Leroux J.C., Polymer, 2004, 45, 8967–8980 
13 Shuai X., Merdan T., Unger F., Wittmar M., Kissel T., Macromolecules, 2003, 36, 5751–5759. 
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Fragmentation Transfer (RAFT)
14
 or ATRP
15,16,17
, as well as  combinations of two of 
these techniques
18 
were used  for  the synthesis of these antimicrobial polymer mimics 
of natural peptides. 
Polymeric micelles thanks to their ability to self-assemble into core-shell nanostructures 
offer attractive features not only for delivery of a large array of drugs but also as 
emulsion stabilizers, surface modifiers and carriers in gene therapy.
19,20 
The aim of this work was to obtain a dopamine –based homopolymer possessing 
antimicrobial and antioxidant properties. Differently from the insoluble hydroxytyrosol-
based one, obtained in the work described in (Chapter IV), this new dopamine-based 
homopolymer is water-soluble. To avoid cross-linking reactions, the catecholic groups 
of dopamine (DOPA) were protected with t-butyldimethylsilyl (TBDMSiCl) chloride. 
Instead, to obtain a homopolymer with narrow molecular weight distribution, ATRP 
polymerization was employed. In addition, in order to improve the biological activity in 
terms of poor cytotoxicity and hemolysis of final materials, random copolymers with 
defined size and segment length were synthesized by using polyethylene glycol 
methacrylate (PEGMA).  
In this appendix, the synthesis and characterization of the DOPA-based monomer, 
homopolymer and three DOPA-PEGMA-based random copolymers was reported. This 
work was carried out in the laboratory of Prof. Nicola Tirelli in Manchester. 
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A.2 Experimental methods 
 
A.2.1 Materials 
 
Hydrochloride Dopamine (DOPA), Imidazole, t-butyldimethylsilyl chloride (TBDMSi), 
acryloyl chloride (Ac), thrietylamine, ethyl 2-bromo-2-methylpropanoate (EBIB), 
1,1,4,7,10,10-Hexamethyltriethylenetetramine (HMTETA), 
polyethyleneglycolmethacrylate (Mn = 360 Da) (PEGMA). 
 
A.2.3 Monomer and polymer synthesis 
 
2-(3,4-bis((tert-butyldimethylsilyl)oxy)phenyl)ethanamine (DOPA-TBDMSi) 
 
 
Sheme1. Synthesis of DOPA-TBDMSi 
 
A mixture of hydrochloride Dopamine (2.12 mmol) and Imidazole (10.6 mmol) was 
added to a dry round-bottom flask equipped with a stir bar. After sealing it with a rubber 
septum, the flask was degassed and filled with argon three times and then left under 
argon flux.  Then, dichloromethane (20 ml) was  added via a syringe. A solution of t-
butyldimethylsilyl chloride (6.37 mmol in 10 ml of dichloromethane) was added to the 
mixture and the solution was stirred overnight at RT (Scheme 1). After precipitation 
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and filtration of imidazole salt,  the filtrate was extracted twice with NaHCO3 saturated 
aqueous solution and twice with 1 N HCl aqueous solution. Finally, the evaporation of 
extracted under vacuum provided a pale yellow oil that was then subjected to flash 
chromatography on SiO2 and CH2Cl2-CH3OH 9/1. 
1
H-NMR spectra were performed employing Chloroform (CDCl3) as a solvent. The 
obtainment of DOPA-TBDMSi monomer-precursor was confirmed by 
1
H-NMR 
(300MHz, CDCl3) : DOPA-TBDMSi δ=  0.17 (s, 12H, -Si(CH3)2C-), 0.95 ( s, 18H, -
Si(CH3)2C(CH3)3), 2.75 ( t, J= 9 Hz, 2 H, NH2CH2CH2Ph), 2.93 ( t, J= 9Hz, 2H, 
NH2CH2CH2Ph), 6.67-6.79 (m, 3H, aromatic protons). 
 
N-(3,4-bis((tert-butyldimethylsilyl)oxy)phenethyl)acrylamide (DOPA-TBDMSi-Ac) 
 
 
Sheme2. Synthesis of DOPA-TBDMSi-Ac 
 
A solution of DOPA-TBDMSi (2.13 mmol in 20 ml of CH2Cl2) was added to a dry and 
previously degassed round-bottom flask equipped with a stir bar and dropping funnel. 
Triethylamine (4.26 mmol) and, drop to drop, a solution of acryloyl chloride (Ac, 4.26 
mmol in 15 ml of CH2Cl2) were further added under argon flux. The solution was 
stirred overnight at RT (Scheme 2).  
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After filtration, the precipitate was subjected to flash chromatography on SiO2 and 
CH2Cl2:CH3OH, 98%:2%. 
To confirm the coupling reaction occurred between the monomer DOPA-TBDMSi and 
the Ac, 
1
HNMR analysis was carried out:  DOPA-TBDMSi-Ac δ=  0.01 (s, 12H, -
Si(CH3)2C-), 0.80 ( s, 18H, -Si(CH3)2C(CH3)3), 2.54 ( t, J= 6 Hz, 2 H, -
CONHCH2CH2Ph), 3.36 ( t, J= 6Hz, 2H, -CONHCH2CH2Ph), 5.43( dd, J1= 1.3 Hz, J2= 
10.3Hz, 1H, CHH=CH), 5.82 (dd, J2= 10.3 Hz, J3= 17 Hz, 1H, CHH=CH), 6.07 (dd, J1= 
1.3 Hz, J3= 17 Hz, 1H, CHH=CH),  6.43-6.59 (m, 3H, aromatic protons). 
 
 
DOPA-TBDMSi-Ac homopolymer 
 
Scheme 3. Synthesis of DOPA-TBDMSi-Ac homopolymer. 
 
ATRP of DOPA-TBDMSi-Ac was carried out by employing 30%wt in Dioxane 
solutions at 25 °C. Typically, EBIB as initiator (0.04 mmol), DOPA-TBDMSi-Ac (1.2 
mmol, target DP = 30), and HMTETA as ligand  (0.04 mmol) were introduced into a 25 
ml schlenk tube.  
The mixture was bubbled with argon for 30 min prior the addition of degassed 1,4-
dioxane. Finally, the copper catalyst was added to mixture under argon purging. The 
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mixture colour turned dark blue-green, indicating the onset of polymerization. The 
polymerization was carried out under magnetic stirring at 20 °C for a required time and 
terminated by dilution with aerated THF. At this point, the solution turned yellow-
green, indicating the copper oxidation.  
The polymerization kinetics was followed by 
1
H-NMR analysis. During the 
polymerization the strong aromatic stacking interactions lead to a split of the aromatic 
proton signals, and then different chemical shifts for the polymer and free monomer 
were observed. 
DOPA-TBDMSi-Ac-homopolymer δ=  0.06 (m, 12H, -Si(CH3)2C-), 0.86 (m, 18H, -
Si(CH3)2C(CH3)3), 2.64 ( t, J= 6 Hz, 2 H, -CONHCH2CH2Ph), 5.51(dd, J1= 1.3 Hz, J2= 
10.3Hz, 1H, CHH=CH), 5.92 (dd, J2= 10.3 Hz, J3= 17 Hz, 1H, CHH=CH), 6.19 (dd, J1= 
1.3 Hz, J3= 17 Hz, 1H, CHH=CH),  6.5-6.7 (m, 3H, aromatic protons), 7.01-7.2 (m, 3H, 
aromatic protons belonging to the polymer). 
 
DOPA-TBDMSi-Ac PEG methacrylate(PEGMA) copolymers  
 
 
Scheme4. Synthesis of DOPA-TBDMSi-Ac PEG methacrylate(PEGMA) copolymers 
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PEGylation reaction concerns the covalent attachment of polyethylene glycol (PEG) 
chains to another molecule. The first example of “PEGylation” was reported in the 70's 
21
. PEG covalent attachment to agents such as drugs, proteins or inorganic-nano-systems 
22
  is used to mask the agent to the host's immune system (reduced immunogenicity and 
antigenicity), and to increase the hydrodynamic volume (size solution) of the agent. 
This can enhance the circulation time of active systems in the blood avoiding an 
immune response.  
PEGylation can also provide hydrophobic drugs and proteins with more water solubility 
and higher mobility in solution, as well as decrease their toxicity and immunogenicity. 
ATRP copolymerisation of DOPA-TBDMSi-Ac and PEGMA (Mw=360 Da) was 
performed in 30%-wt dioxane solutions at 25°C by employing different PEGMA: 
DOPA-TBDMSi-Ac molar ratio, precisely 0.65, 0.75 and 0.85. As an example, to 
achieve a PD=30 (polymerization degree), EBIB as an initiator (7.9 mg, 0.04 mmol), 
DOPA-TBDMSi-Ac (80 mg, 0.18 mmol), PEGMA (370 mg, 1.02 mmol, 0.85) and 
HMTETA as a ligand (9.3 mg, 0.04 mmol) were introduced into a 25 ml schlenk  tube 
(Scheme 4).  
From this point, the experimental procedure was the same of that used for the 
homopolymer synthesis. Also in this case, the polymerization kinetics was followed by 
1
H-NMR analysis. 
DOPA-TBDMSi-Ac-copolymer δ= 0.62 (s, 12H, -Si(CH3)2C-), 1.42 ( s, 18H, -
Si(CH3)2C(CH3)3), 1.49-1.58 (m, 3H, CH3-CH2-O- of EBIB), 1.63-1.72 (m, 6H, poly-
C(CH3)2- of EBIB; 2H, polymer backbone), 2.34 ( d, J=6.5 Hz, 3H, CCH3=CH of PEG), 
2.62( d, J=7.2 Hz, 3H, CCH3=CH of PEG into the polymer), 2.78 ( t, J= 9 Hz, 2 H, -
                                                          
21
 Siegwarta D.J., Oh J.K., Matyjaszewski K., Progress in Polymer Science, 2012, 37, 18-37. 
22 Kotsokechagia T., Zaki N.M., Syres K., Leonardis P.D., Thomas A., Cellesi F., Tirelli N., Langmuir, 
2012, 28, 11490-11501. 
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CONHCH2CH2Ph into the polymer) 3.11 ( t, J= 6.9 Hz, 2 H, -CONHCH2CH2Ph), 3.78-
4.27 ( m, PEG monomer and the same protons in the polymer backbone, dioxane, 4.67 ( 
t, J= 6Hz, 2H, O-CH2CH2-), 6.02 ( s, 1H, CHCH3=CH ), 6.5 (s, 1H, CHCH3=CH), 7.08-
7.20 (m, 3H, aromatic protons). 
 
A.3 Results and discussion 
 
Phenol- or benzoic acid-based polymers are biocidal agents having the bacteria 
membrane as a target. They can either interact with the surface of the cell, causing the 
membrane disintegration, or promote intracellular coagulation of cytoplasmic 
components, leading to the cell growth inhibition or death.  
The main natural antioxidants are characterized by the presence, in their chemical 
structure, of phenolic groups, particularly, catechol, hydroquinone or gallic moieties. 
Such compounds are very effective in protecting plant against insects
 9
  but are highly 
toxic. 
The peculiar antioxidant activity of these phenols, in particular of the catechol structure 
system, is due to semiquinone, formed in the first stage of the reaction, which can 
inactivate a second radical converting to quinone (Scheme 5) 
23
 . 
 
Scheme 5. Antioxidant activity of catechol moieties. 
The monomer precursor DOPA-TBDMSi was obtained taking advantage of the Corey's 
reaction
24
 where imidazole behaves both as a base and catalyst with a yield of 75 %. 
                                                          
23
 Amatori R., Ferrani F., Lucarini M., Pedulli G. F., Valgimigli L., J. Org. Chem., 2002, 67, 9295. 
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The reaction proceeds via N-tert-butyldimethylsilylimidazole, a very reactive silylating 
agent:
 
Corey discovered
25
 the rapid cleavage of the silyl ethers to alcohols by treatment with 2-
3 eq. tetra-n-butylammonium fluoride (TBAF) in THF at 25 °C. Nucleophilic attack of 
fluoride anion leads to a pentavalent silicon centre which is permitted due to 
hybridization of the vacant d-orbitals of silicon. Moreover, the formation of the strong 
Si-F bond is the driving force for a fast and quantitative cleavage 
 
Tert-butyldimethysilyl ether protectors are stable in alkaline environment but can be 
converted back to alcohols under acidic conditions (2:1 acetic acid / water at 25 °C). 
The coupling reaction between Ac and DOPA-TBDMSi was carried out in CH2Cl2 with 
55% yield, after flash chromatography purification. The resulting monomer  DOPA-
TBDMSi-Ac was a viscous yellow oil. 
The occurred reaction was verified  by  
1
H-NMR and ATR-FTIR spectroscopy. In 
particular, in the spectrum of DOPA-TBDMSi-Ac new peaks around at 1663 cm
-1 
related to the carbonyl stretching (first amide peak) and at 1550 cm
-1
 due to the second 
amide peak (C-N stretching and NH bending) were observed (Figure 1).  
                                                                                                                                                                          
24 Corey E. J., J. Am. Chem. Soc. 1972, 94, 6192 
25
 Corey E. J., J. Am. Chem. Soc., 1972, 94, 6190-6191 
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DOPA-TBDMSi-Acr DOPA-TBDMSi
1.0001.2001.4001.6001.8002.000
cm-1
 
Figure 1: Spectra of DOPA-TBDMSi and DOPA-TBDMSi-Ac. 
Polymerization kinetics were performed directly in sealed NMR tubes by adding CuBr 
to the reactant mixture under vigorous argon flux. The 
1
H-NMR spectra were collected 
after 20 minutes in order to achieve the complete monomer conversion. As for 
copolymer series, the reactivity ratio (r1 and r2) was also taken out. 
For evaluating the monomer conversion, ln([Mo]/[M]) vs time was plotted, where [Mo] 
was the monomer concentration in the feed and [M] was the monomer residue 
concentration after each 
1
H-NMR measurements. As it can be observed in Figure 2 b, a 
straight line showing a 1st order kinetics was obtained. To determine the [M] value, the 
ratio between the peak integral at 5.51 ppm, due to one of the vinylic proton, and the 
integral peak at 0.06 ppm, related to the 12 protons of the silicon group, which remained 
stable during the polymerization, was exploited (Figure 2 a).  
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Figure 2:
 1
H-NMR spectrum of homopolymer and ln([Mo]/[M]) vs time plot. 
 
Conversion studies showed that methacrylic monomer resulted by far more reactive 
than the acrylamide one. The same result was obtained by using the Fineman-Ross and 
Kelen-Tudos methods.   
The fastest and oldest model is the Fineman-Ross 
26
 one. The model is due to the 
following equation:  
G=r1H-r2  (a) 
where 
 
Y
YX
G
1
 , 
Y
X
H
2
 , 
2
1
f
f
X  , and 
2
1
F
F
Y    (b) 
f1, f2, F1 and F2 represent PEG-360 and DOPA-TBDMSi-Ac molar fractions in the 
feed (f1,  f2), determined from the monomers ratio, and in the copolymer (F1, F2), 
determined by 
1
H NMR. In particular, F1 is due to the equation  
                                                          
26 Finemann M., Ross S., J. Polym. Sci. A, 1964, 2, 1687-1692. 
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while F2 is calculated as 1-F1. 
By plotting G versus H (Figure 4) a straight line was obtained, the slope of which 
provided  r PEG-360  while  r DOPA-TBDMSi-Ac was deduced from the negative intercept 
value. Values of r PEG-360=1.35 and DOPA-TBDMSi-Ac =0.41 were found respectively. 
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Figure 3: Kinetics studies were carried out by 
1
H-NMR. a) ln([Mo]/[M]) vs time for 
both monomers. B) Copolymer peaks chosen for Fineman-Ross and Kelen-Tudos's 
models. 
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Figure 4: G versus H for Fineman-Ross plot (where G and H are given by equation (a) 
and (b)) 
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The Kelen-Tüdos model 
27
 can also be applied to the experimental data. For that, the 
factor  has to be introduced from (c) equation: 
maxmin .HH  (c) 
where Hmin and Hmax correspond to the lowest and the highest values of H defined in the 
Fineman-Ross model. The Kelen-Tüdos model is based on the following equation: 



 2
2
1
rr
r 





   (d) 
where 
H
G



 , 
H
H



  (e) 
and G and H are the values obtained from the Fineman-Ross model. 
The plotting of  versus  (Figure 5) led to a straight line, the slope of which was 
rPEG360+r DOPA-TBDMSi-Ac / and the intercept was -rPEG360. Values of rPEG360 = 6.45 and r 
DOPA-TBDMSi-Acr = 1.42 were found. 
                                                          
27 Kelen T., Tüdos F., J. Macromol. Sci. Chem., 1975, A9, 1-27. 
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Figure 5:  versus  for the Kelen-Tüdos plot (where  and  are given by equation (d)) 
 
It was verified the occurred cleavage of the silyl-moieties using the NH4F in methanol 
or the already mentioned acidic condition. In both cases after 20h of reaction, it was 
possible to notice a black precipitate onset due to the dopamine-group oxidation. After 
the lysis reaction, every dopamine 
1
H-NMR signals disappeared leading to a whole 
cleavage.  
The here synthesized pegylated-macromonomer possessing a well defined chain length 
will be used to prepare water soluble block copolymers. Such copolymers should 
display both selective biocidal effects against bacteria and poor hemolysis and then they 
could be excellent substitutes of antibiotics. 
 
